Alcohol and Cardiovascular Disease by Henderson, Louise M.
Alcohol and Cardiovascular Disease
Louise M. Henderson
A dissertation submitted to the faculty of the University of North Carolina at Chapel 
Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in 
the Department of Epidemiology, School of Public Health.
Chapel Hill
2006
Approved by:
Wayne D. Rosamond, PhD
Kelly Evenson, PhD
Sara Huston, PhD
Charles Poole, MPH, ScD
Ross Simpson, Jr, MD, PhD
ii
© 2006
Louise M. Henderson
iii
ABSTRACT
Louise M. Henderson: Alcohol and Cardiovascular Disease
(Under the direction of Wayne D. Rosamond, PhD)
The relationship between alcohol consumption and three cardiovascular 
diseases (ischemic stroke, hemorrhagic stroke, and heart failure) was examined in a 
population sample of middle-aged U.S. adults who were participants in the 
Atherosclerosis Risk in Communities (ARIC) cohort.  Alcohol intake was self-
reported at two time periods.  Stroke events were ascertained by contacting study 
participants and reviewing hospitalization and death certificate data.  Heart failure 
(HF) events were identified from hospital discharge diagnoses and death certificates.
To assess the association between alcohol consumption and each 
cardiovascular disease outcome separately, age-adjusted incidence rates by level of 
alcohol intake were calculated.  Alcohol intake was categorized based on American 
Heart Association guidelines.  Poisson regression was used to estimate incidence 
rate ratios (RRs) comparing levels of alcohol intake with never drinkers.  Results 
were stratified by race.
The crude RRs for all stroke showed an inverse association for occasional 
drinkers (RR=0.57, 95%CI:0.42-0.77) and light/moderate drinkers (RR=0.74, 
95%CI:0.59-0.94) as compared with never drinkers.  After adjustment for age, race, 
sex, and socioeconomic status the RRs were attenuated (comparing occasional with 
never drinkers RR=0.91, 95%CI:0.67-1.25 and light/moderate with never drinkers 
iv
(RR=0.99, 95%CI:0.77-1.28).  Results for ischemic stroke were similar to those for 
all stroke.  The crude RRs for hemorrhagic stroke were 1.16 (95%CI:0.51-2.63) for 
former drinkers, 1.13 (95%CI:0.48-2.69) for occasional drinkers, 0.74 (95%CI:0.32-
1.71) for light/moderate drinkers, and 1.67 (95%CI:0.66-4.25) for heavy drinkers, as 
compared with never drinkers.  Adjustment for age, race, sex, and socioeconomic 
status resulted in an increase in RRs.  The RRs comparing each level of alcohol 
intake with never drinkers for HF incidence were 1.12 (95%CI:0.95-1.31) for former 
drinkers, 0.67 (95%CI:0.54-0.82) for occasional drinkers, 0.65 (95%CI:0.54-0.78) for 
light/moderate drinkers, and 0.75 (95%CI:0.59-0.95) for heavy drinkers.  Similar 
patterns were seen for blacks and whites.
We found no compelling evidence that occasional or light/moderate alcohol 
intake reduces stroke incidence rates.  Adjusted RRs suggest that any level of 
alcohol intake increases hemorrhagic stroke incidence rates.  We found a positive 
association for former drinking and an inverse association for current drinking for HF 
incidence.  While the association between former drinkers and HF incidence was 
evident for whites, the evidence among blacks was less strong.
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CHAPTER 1
STATEMENT OF HYPOTHESES
1.1 Study Objective
The primary objective of the proposed research is to better understand the 
role of alcohol consumption on the development of cardiovascular diseases, in 
particular stroke and heart failure, among African-American and white men and 
women of middle-age in the U.S.
1.2 Specific Aims and Hypotheses
Specific Aim 1:  Examine the association between alcohol consumption and stroke 
incidence among African-American and white men and women ages 45-64 years at 
baseline (the ARIC study participants) during an average follow-up of 11 years.
Hypothesis 1:  The association between alcohol intake and ischemic stroke 
incidence varies according to the level of alcohol consumed.  Using never 
drinkers as the referent group, there is an inverse association between 
alcohol intake and ischemic stroke incidence among light to moderate 
drinkers and there is a positive association between heavy consumption and 
ischemic stroke incidence.
Hypothesis 2:  There is a positive association between alcohol intake and 
hemorrhagic stroke incidence.  Compared with those who do not drink 
2alcohol, those consuming light to moderate amounts will have increased rates 
of hemorrhagic stroke and those consuming heavy amounts will have even 
higher hemorrhagic stroke rates.
Hypothesis 3:  The alcohol and stroke relations found in hypotheses 1 and 2 
above do not differ by race. 
Specific Aim 2:  Describe and evaluate the association between alcohol 
consumption and heart failure (HF) incidence among African-American and white 
men and women ages 45-64 years at baseline (the ARIC study participants) during 
an average follow-up of 11 years.
Hypothesis 1:  Compared with never drinkers, there is an inverse association 
between alcohol intake and HF incidence among those who consume light to 
moderate amounts of alcohol and there is a positive association for those who 
consume heavy amounts of alcohol.
Hypothesis 2:  The association between alcohol intake and HF incidence 
does not differ by race.
1.3 Rationale
Previous studies have shown light to moderate alcohol consumption to be 
cardio-protective, with national guidelines and recommendations supporting the 
consumption of one to two alcoholic drinks per day among those who drink (1, 2).  
Although the benefits of light to moderate alcohol intake on the cardiovascular 
system have been well established for reducing the risk of coronary heart disease 
and myocardial infarction, the impact of alcohol consumption on other cardiovascular 
diseases is less well understood.  Given the heterogeneity of cardiovascular disease 
3and the numerous pathways through which alcohol may afect the cardiovascular 
system, an in-depth look at how alcohol consumption is associated with individual 
cardiovascular diseases is warranted.
The role that alcohol plays within the cardiovascular system is complex, 
probably involving multiple factors acting together to create potentially beneficial or 
harmful effects.  The relationship between light to moderate alcohol consumption 
and stroke incidence, for example, has been previously studied and is thought to be 
protective against ischemic stroke but detrimental for hemorrhagic stroke (Figure 
1.1).  However (as detailed below), the findings are inconsistent and more diverse 
populations need to be studied.  As another example, the harmful effects of chronic 
heavy alcohol use on the development of heart failure (termed alcoholic 
cardiomyopathy) are well documented, but the extent to which light to moderate 
alcohol intake may be beneficial in preventing HF from other etiologies (for example 
ischemic cardiomyopathy) remains unclear (Figure 1.2). The few studies that have 
examined the relationship between HF and moderate alcohol intake focused on 
white populations in the northeastern portion of the U.S., leaving a gap in the current 
literature.  The proposed research is needed to support the recommendations that
light to moderate intake is protective of cardiovascular disease, especially in the 
areas of stroke and HF.
4Figure 1.1: Theoretical Framework for Light/Moderate Alcohol 
Consumption and Stroke Incidence
Legend:  The effect of alcohol intake on the body is a complex process with many factors influencing alcohol intake, 
alcohol metabolism, and other biologic responses.  Alcohol leads to immediate and long-term effects on the body, 
some of which are beneficial (increased HDL cholesterol, decreased LDL cholesterol, and decreased stress) and 
some of which are harmful (increased blood pressure) to the cardiovascular system.  Atherosclerotic plaques may 
decrease in size and become less likely to rupture.  In contrast, the increased blood pressure may result in increased 
risk of bleeding and thus hemorrhagic stroke.
* Sociodemographic characteristics include age, race, gender, and socioeconomic status; Dietary factors include 
intake of cholesterol, saturated fat, and antioxidants; Lifestyle factors include smoking, stress, physical activity; 
Comorbid conditions include diabetes, hypertension, and previous myocardial infarction.
Alcohol
Metabolism
Alcohol
Intake
Immediate effects on the body:
 HDL cholesterol
  LDL cholesterol
/ BP
 Fibrinogen levels
 Platelet aggregation
     Improved insulin sensitivity
 Stress
Long-term effects on the body:
     changes in arterial wall
     changes in carotid wall thickness
     changes in atherosclerotic plaques
     impact on inflammation
Implications for stroke event:
 thrombosis
 embolism
 hemorrhagic
Influencing Factors:
- sociodemographic characteristics
- comorbid conditions
- lifestyle factors
- medication use
- dietary factors
- genetics
- BMI
5Figure 1.2: Theoretical Framework for Light/Moderate Alcohol 
Consumption and Heart Failure Hospitalization
Legend:  The effect of alcohol intake on the body is a complex process with many factors influencing alcohol intake, 
alcohol metabolism, and other biologic responses.  Alcohol leads to immediate and long-term effects on the body, 
some of which are beneficial (increased HDL cholesterol, decreased LDL cholesterol, and decreased stress) and 
some of which are harmful (increased blood pressure) to the cardiovascular system.  Light to moderate intake may 
reduce the rates of coronary heart disease and lessen the risk of myocardial infarction.  These changes are 
beneficial and thought to protect against the development of heart disease, decreasing the incidence of heart failure.
* Sociodemographic characteristics include age, race, gender, and socioeconomic status; Dietary factors include 
intake of cholesterol, saturated fat, and antioxidants; Lifestyle factors include smoking, stress, physical activity; 
Comorbid conditions include diabetes, hypertension, and previous myocardial infarction.
Alcohol
Metabolism
Alcohol
Intake
Immediate effects on the body:
 HDL cholesterol
  LDL cholesterol
/ BP
 Fibrinogen levels
 Platelet aggregation
     Improved insulin sensitivity
 Stress
Long-term effects on the body:
 atherosclerotic plaques
     Impact on inflammation
 myocardial infarction
 CHD mortality & risk
Influencing Factors:
- sociodemographic characteristics
- comorbid conditions
- lifestyle factors
- medication use
- dietary factors
- genetics
- BMI
Implications/effects on the heart:
- protection against CAD
- less IHD
- no cardiomyopathy (heart pumps effectively, maintains normal size)
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CHAPTER 2
BACKGROUND
2.1 Introduction
The burden of cardiovascular diseases in the U.S. is staggering.   An 
estimated 62 million U.S. adults have some type of cardiovascular disease and 
during 2000, cardiovascular diseases accounted for 950,000 deaths (1).  The 
National Heart Lung and Blood Institute (NHLBI) estimates the cost of 
cardiovascular diseases (including stroke) during 2003 will be $351.8 billion. The 
term cardiovascular diseases is heterogeneous and encompasses diseases of the 
heart and the arterial circulation supplying the heart, brain and peripheral tissues(2).  
The most common cardiovascular diseases are high blood pressure (HBP), coronary 
heart disease (CHD), congestive heart failure (CHF), and stroke (Table 2.1).
Established risk factors for cardiovascular disease include smoking, high 
blood cholesterol, hypertension, physical inactivity, overweight/obesity, and 
diabetes(1).  In a study which combined data from the Multiple Risk Factor 
Intervention Trial (MRFIT) and the Chicago Heart Association Detection Project in 
Industry (CHA), researchers compared cardiovascular disease mortality rates of 
those with a favorable risk profile (cholesterol <200mg/dl, SBP/DBP of 
120/80mmHg, and not a current smoker) to others who did not have a low-risk 
profile (i.e. they had elevated cholesterol, elevated BP, or were a current smoker).  
8The researchers found cardiovascular disease mortality was 72- 85% lower among 
those non-smokers with normal blood pressure and normal serum cholesterol 
levels(3).  
In addition to the established (traditional) cardiovascular disease risk factors, 
emerging risk factors have been identified (Table 2.2) (2, 4, 5).  For example, light to 
moderate alcohol consumption has been proposed to play a beneficial role in the 
prevention of cardiovascular disease, in particular in the reduction of CHD risk and 
mortality.  The findings of several prospective cohort studies indicate a positive, 
strong, consistent, dose-response relation between moderate alcohol consumption 
and decreased CHD incidence(6-8).  In contrast, epidemiology studies examining 
the relation between alcohol consumption and stroke or alcohol consumption and 
CHF, two of the leading causes of death and hospitalization in the U.S., are less 
consistent and warrant further research.
Although the role of alcohol consumption on cardiovascular disease incidence 
and mortality has been explored, most studies focused specifically on CHD or the 
endpoint of all cardiovascular diseases combined.  Since the biologic mechanisms 
through which alcohol impacts disease occurrence is likely to vary from disease to 
disease, examination of specific cardiovascular diseases, such as CHF, systemic 
hypertension, or stroke will lead to a more detailed and comprehensive 
understanding of the role of alcohol on the cardiovascular system.  The proposed 
dissertation work will explore the relationship of alcohol and three cardiovascular 
diseases, namely hemorrhagic stroke, ischemic stroke, and CHF.
92.2 Stroke
2.2.1 Definition and Pathophysiology
While cerebrovascular diseases typically have an abrupt onset with loss of 
neurologic function due to an acute interruption of the blood supply to the brain, the 
underlying disease process of atherosclerosis usually begins in early adulthood(9).  
Over time atherosclerosis, thought to be caused by inflammation, weakens the 
arterial wall with lesions protruding into the lumen resulting in restricted or obstructed 
blood flow or possibly rupturing of the plaque(10).  Atherosclerotic plaques occur in 
large and medium sized vessels of the arterial tree and thus may affect multiple 
areas of the circulation, including the heart, brain, or aorta(2).  Damage to the 
atherosclerotic plaques is a precursor of ischemic stroke(11) and hence the major 
etiology of strokes is attributed to atherosclerosis(9) . 
Since 1975, a loss of functioning lasting less than 24 hours with subsequent 
return of normal functioning has been termed a transient ischemic attack (TIA).  If 
loss of function remains for more than 24 hours, the event is termed a stroke(12, 
13).  Recently, a new definition for TIA has been proposed which focuses on if an 
injury to the brain has occurred rather than on the amount of time until normal 
functioning returns (14, 15).  The proposed TIA definition change has caused debate 
over the practicality of implementing the new definition (in terms of available imaging 
resources) and the possibility of using a shorter time period from symptom onset to 
resolution (one hour instead of 24 hours) (16-18).
Strokes can be classified into two broad groups: ischemic and hemorrhagic 
(Figure 2.1).  Ischemic strokes are caused by an obstruction of a major artery either 
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by local blood clot formation (thrombosis) or lodging of a clot from elsewhere in the 
body (embolism)(2).  Within this category, the major disease subsets include large 
artery stenosis occlusion, lacunar infarction, embolisms attributed to cardiac 
sources, and those with an undetermined cause(19, 20).  Large artery stenosis 
occlusions occur when atherosclerotic narrowing of the major arteries causes an 
acute occlusion.  Lacunar infarctions, thought to account for approximately 15-20% 
of all strokes, refer to small, deep infarcts which occur in the basal ganglia(19).   
Cardioembolisms, which occur when a thrombus develops in the heart and lodges in 
the brain, are usually the result of atrial fibrillation, mural thrombus, dilated 
cardiomyopathy, valvular disease, or ventricular akinesis following myocardial 
infarction.(20) Although classification of ischemic strokes into subtypes has 
improved with the use of CT scans, MRI, and angiography, the exact mechanism of 
cerebral infarction is often unknown(19).
In contrast to ischemic strokes, those termed hemorrhagic strokes are the result 
of ruptured blood vessels in the brain and are subdivided into intracranial 
hemorrhages (ICH) and subarachnoid hemorrhages (SAH) based on the location of 
the bleeding.  ICH occur in the deep portions of the cerebral hemispheres such as 
the putamen or cerebellum(21).  Hypertension and cigarette smoking are important 
risk factors for ICH and hypertension may play a causative role in the development 
of ICH(21).  SAH results from bleeding into the subarachnoid space surrounding the 
brain, usually caused by an aneurysm (balloon like swelling in an artery wall) in the 
circle of Willis(20).  Risk factors for SAH are similar to those for ICH, including 
hypertension and cigarette smoking.
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2.2.2 Epidemiology of Stroke in the U.S.
Stroke ranks as the third leading cause of death in the U.S. with an estimated 
700,000 new or recurrent strokes each year(1).  Stroke incidence rates are higher 
for males than females, are higher for African-Americans compared with whites 
(Table 2.3)(1, 22) and increase with age.  Similarly, disparities in stroke mortality 
rates exist with African- Americans experiencing higher death rates than whites (23, 
24).  In 1998, the age-adjusted stroke mortality rate among those ages 35 and older 
was 156 per 100,000 for African-Americans, and 113 per 100,000 for whites (23).  
Intriguingly, stroke mortality rates appear to vary by geographic region, with 
increased rates in the southeastern portion of the country, although the patterns 
appear to be shifting westward(23-26).  Despite the decline of stroke mortality rates 
during the 20th century(2, 24), stroke continues to be a leading cause of death and 
disability.  In 1999, an estimated 1.1 million Americans reported functional limitations 
and difficulties carrying out everyday activities as a result of suffering a stroke(27).
Risk factors for stroke include high blood pressure, diabetes, existing/prior 
cardiovascular conditions, atrial fibrillation, older age, lower educational attainment, 
physical inactivity, obesity, and smoking(1, 2, 4).  While many of the risk factors for 
stroke are similar to those for CHD, not all of the risk factors apply to both disease 
processes.  A meta-analysis of 45 cohort studies examining the relation of blood 
cholesterol and blood pressure to stroke risk (predominately deaths) found total 
cholesterol was not predictive of stroke outcomes but that higher diastolic blood 
pressure was predictive, especially among those at younger ages(28).  Additionally, 
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data from the Atherosclerosis Risk in Communities (ARIC) cohort study found that 
increased blood cholesterol levels, which are known to be associated with CHD, 
were not associated with increased stroke risk(29).  In contrast to the findings of no 
association between blood cholesterol levels and stroke risk, results from a meta-
analysis of 13 randomized placebo-controlled double blind trials reported a reduction 
in stroke risk (but not in fatal stroke occurrence) among those receiving lipid lowering 
drugs (statins) compared to those in the placebo group (30).
2.3 Congestive Heart Failure
2.3.1 Definition and Pathophysiology
CHF is the inability of the heart to pump blood effectively from the left 
ventricle throughout the body, resulting in reduced blood flow to the aorta and to the
peripheral arterial circulation(2).  The initiation of CHF begins when an index event 
(such as a myocardial infarction) either damages the heart muscle or disrupts the 
myocardium from being able to generate force(31).  Once the event has occurred, 
the heart pumps less effectively, impairing the ability of the left ventricle to fill with 
blood or to eject blood(32).  In an attempt to make up for the decreased pumping 
capacity, the heart enlarges, develops more muscle mass, and pumps faster (33).  
“Chronic CHF either reflects its persistence following an acute onset and partial 
recovery or indicates gradual ventricular decomposition occurring over weeks, 
months or years”(2), p.106.  Symptoms of heart failure include shortness of breath 
(dyspnea), persistent coughing or wheezing, edema, fatigue, loss of appetite or 
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nausea, confusion, and increased heart rate (34).  The New York Heart Association 
developed a classification scheme for CHF based on patient symptoms: class I (~ 
35% of patients) consists of those with no symptoms and no limitations in physical 
activity; class II (~ 35% of patients) consists of those with mild symptoms and slight 
limitations during ordinary activity; class III (~ 25% of patients) consists of those with 
marked limitations in activity due to symptoms and comfortable only at rest; and 
class IV (~ 5% of patients) consists of those with severe limitations who experience 
symptoms while at rest(35).  The symptoms mentioned above (dyspnea, edema, 
fatigue) comprise a syndrome which is referred to as CHF.
CHF is identified using several diagnostic tests, including electrocardiogram 
(ECG), echocardiography, or radionuclide ventriculography/ multiple-gated 
acquisition scanning.  Causes of CHF can be classified into several groups based on 
pathophysiology, including dilated, hypertrophic, restrictive, and valvular(36).  
Dilated cardiomyopathy is often caused by ischemic heart disease, aortic 
regurgitation, toxins (such as alcohol), or viral infections of the heart.  Hypertrophic 
cardiomyopathy is usually a result of hypertension, aortic stenosis, or genetic 
disorders of the cardiac muscle. Aortic regurgitation may result in increased left 
ventricular size through dilation and hypertrophy.  Restrictive cardiomyopathy can 
result from amyloidosis or pericarditis (i.e. cardiac tamponade and chronic 
constrictive pericardial disease)(36).  Thus, it is evident that CHF is a heterogeneous 
entity with many different possible causes.
In the United States, CHF is usually a consequence of coronary heart 
disease, hypertension, or myocardial infarction(2, 37).  Based on data from the 
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Framingham Heart Study, 7% of women and 19% of men who developed CHF had 
coronary heart disease alone, 40% had hypertension alone, and the remaining had 
both CHD and hypertension(38).  Population attributable risk estimates indicate that 
hypertension accounts for 39% and 59% of the CHF burden in men and women, 
respectively and that MI accounts for 34% and 13% of the CHF burden in men and 
women, respectively(39).  While treatment can improve function and prolong life, 
progressive decompensation and complications lead to a high mortality rate(2).  
Thus, the most cost-effective approach is to focus on modifiable risk factors, 
including the reduction of hypertension, dyslipidemia, obesity, and smoking(40).
The Framingham Study, the first prospective population-based study 
designed to investigate the epidemiology of cardiovascular disease in the U.S., has 
monitored cohort members through active surveillance for the development of 
CHF(41).  Based on Framingham Study data from clinic examinations and hospital 
records, criteria for identifying cases of CHF were established (Table 2.4)(42) (38).  
According to these criteria, to be classified as a CHF case two major and one minor 
or one major and two minor criteria must be present.  The use of these criteria is 
based on clinical criteria that have been validated(38) (43).
2.3.2 Epidemiology of Congestive Heart Failure in the U.S.
Over the past two decades, CHF incidence and mortality rates have been 
increasing.  It is estimated that almost 5 million U.S. adults ages 20 and older suffer 
from CHF, with 550,000 new cases each year and 51,000 deaths.  The number of 
hospital discharges for CHF increased by over 260% from 377,000 in 1979 to 
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999,000 in 2000 and in 1998 approximately $3.6 billion was paid for CHF 
hospitalizations among those ages 65 and older(1).  Clearly, CHF hospitalizations 
impact the health care system and the growing costs associated with health care as 
the population continues to age.
Few epidemiologic studies have been designed to study the prevalence, 
incidence, and long-term prognosis of CHF, probably due to the fact that heart 
failure is difficult to study(2).  Since heart failure develops gradually it is difficult to 
know at what point to label CHF a disease and thus it is often thought of more as a 
constellation of symptoms.  Also, heart failure often develops after the occurrence of 
other conditions such as a myocardial infarction or the development of CHD, leading 
to difficulties in the identification of CHF in hospital and mortality statistics.  CHF that 
is mild may not require hospitalization and since CHF symptoms are nonspecific, 
diagnosis can be difficult(2).  Adding to the difficulty, co-morbid conditions such as 
emphysema have similar symptoms. 
Despite the challenges of studying CHF, the Framingham Heart Study 
provides national estimates of CHF prevalence and mortality in a cohort of white 
U.S. adults living in the northeastern portion of the country.  For white men, the 
prevalence of heart failure increased from 8 per 1000 among those 50-59 years to 
66 per 1000 among those 80-89 years and for white women from 8 per 1000 to 79 
per 1000 (40).  It has been estimated that the prevalence of CHF in the black 
population is approximately 25% higher than for whites (40).  According to data from 
the Framingham Study, the lifetime risk of developing CHF is similar for men and 
women and is approximately 1 in 5 (20%).  However, the lifetime risk of developing 
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CHF among those without a previous MI is much lower, ranging from 11 to 14% for 
men and 15 to 16% for women (44).  Additionally, Framingham study data report low 
survival times following CHF diagnosis with a mean of 1.7 years for men and 2.3 
years for females and 5-year survival rates of 25% for men and 38% for women (40).  
In another study which examined survival after CHF hospitalization among Medicare 
participants, 6-year survival rates were 19% for black males, 16% for white males, 
25% for black females and 23% for white females (45).
Although the number of CHF hospitalizations increased by 260% from 1979 
to 2000 (1), this rise does not necessarily indicate an increase in the actual number 
of cases of CHF.  Many factors (eg. new diagnostic technologies and treatments, 
increased patient and physician awareness, changing coding and reimbursement 
practices) may lead to an apparent increase in CHF.  While hospitalization data do 
not capture the incidence of disease in the population, hospitalization data do 
facilitate in estimating the burden of disease (on the medical system and society) 
and probably represent the most severe CHF cases.
Risk factors for heart failure have been identified from several population 
based epidemiologic studies and include male sex, lower education, physical 
inactivity, cigarette smoking, diabetes, obesity, hypertension, valvular heart disease, 
and coronary heart disease (summarized in Table 2.5)(39, 42, 46-48).  In three of 
the four studies, coronary heart disease, valvular heart disease, and diabetes were 
identified as CHF risk factors.  In two of the four studies, hypertension, 
obesity/overweight, and elevated pulse pressure were reported as risk factors.  The 
role of alcohol as a risk factor for development of CHF was evaluated in two of these 
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studies(47, 48) and was found to be associated with CHF in one of the two.  He et 
al. found regular alcohol intake at least twice per week reduced the risk of CHF 
among women but not among men(48).
2.4 Alcohol Consumption 
2.4.1 Physiologic Responses to Alcohol Consumption
Once alcohol has been consumed, it passes into the stomach and intestines 
where it is absorbed into the blood.  From the bloodstream, alcohol passes into the 
liver where it is metabolized by enzymes, including alcohol dehydrogenase (ADH) 
and cytochrome P450IIE1.  The rate of alcohol absorption and metabolism depends 
on several factors including gender, body weight, food intake, sex hormones, and 
some medications(49).  The effects of alcohol intake on the body are most evident in 
the liver and nervous system.  Consumption of alcoholic beverages leads to 
physiologic changes including altered membrane fluidity, dose dependent effects on 
neurotransmitters, and at high concentrations, a slowing of central nervous system 
functions(50).  Chronic heavy alcohol intake causes injury to the liver, resulting in 
cirrhosis, fatty infiltration of the liver, and hepatitis(51).
One way to determine how alcohol consumption affects the body and protects 
against CHD would be to conduct a randomized controlled trial (RCT).  Because of 
ethical concerns that study participants assigned to drink alcohol may become 
dependent as well as the high cost involved and the difficulty in finding participants, 
no long-term RCT of alcohol use has been conducted.  However, several short-term 
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RCT have been conducted to study physiological changes related to alcohol 
consumption(52).  Since the majority of the RCTs have small sample sizes, the 
results of a meta-analysis of 42 published RCTs conducted to assess the effect of 
alcohol consumption on biological markers of cardiovascular risk was conducted and 
will be discussed(7).  Among non-alcohol dependent men and women without 
chronic disease, 30g of ethanol per day (2.5 drinks/day) increased HDL cholesterol 
by 4mg/dl, increased apolipoprotein AI by 8.8mg/dl, and increased triglycerides by 
5.7mg/dl.  Despite the mixed effects of alcohol on cardiovascular risk factors, the 
findings predict that 30g of alcohol per day would result in a 25% decrease in CHD 
risk(7).
Although many possible biologic mechanisms have been proposed in the 
alcohol – CVD relationship, the exact role of alcohol in the pathophysiology of CVD 
is not fully understood. It is currently hypothesized that light to moderate alcohol 
consumption has a beneficial effect on atherosclerosis by affecting blood pressure, 
cholesterol levels, plasma apolipoprotein (a) levels, platelet aggregation, fibrinolytic 
activity, insulin sensitivity, and stress (see Table 2.6)(53-57).  Each of these will be 
discussed in detail below.
The effect of alcohol consumption on blood pressure  depends on the length 
of use and the amount of intake, with both a “J” shaped relationship(58, 59) and a 
strictly monotonic dose-response relationship between the two proposed to 
exist(55).  In the Chicago Western Electric Company study, male workers who 
consumed six or more drinks per day had mean systolic blood pressure of 146.5 
mmHg and mean diastolic BP of 94.3 mmHg as compared with workers who 
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consumed no alcohol or occasional alcohol, who had SBP of 132.9 mmHg and 
mean DBP of 95.8 mmHg(60).  Data from the Honolulu Heart Program indicate a “J” 
shaped relation between SBP and alcohol intake and a linear relationship for DBP 
and alcohol intake among males of Japanese ancestry(61).  The Kaiser-Permanente 
Study examined SBP and DBP for men and women(62).  Interestingly, SBP for 
women who drank but limited intake to two or fewer drinks per day was lower than 
for women who were non-drinkers.  For men there was no difference between non-
drinkers and those consuming 2 or less drinks per day.  Among both men and 
women, consumption of three or more drinks per day as compared with non-drinkers 
increased SBP and DBP(62).  The effects of alcohol on blood pressure are evident 
in days to weeks following consumption.  Although no biologic mechanism has been 
identified, a link between alcohol and hypertension clearly exists with heavy alcohol 
intake a risk factor for hypertension (63).
Alcohol consumption also has effects on high density lipoprotein (HDL) 
cholesterol levels(64, 65), although these effects are probably modified by factors 
such as gender, drinking pattern and beverage type, diet, smoking, and 
exercise(66). Those who consume at least three drinks per day typically have higher 
mean HDL cholesterol levels (about 10mg/dL higher)(67) than those who consume 
less than three drinks per day.  The Collaborative Lipoprotein Phenotyping Study 
found increased levels of HDL cholesterol with higher alcohol consumption(68).  For 
the Framingham study, the Albany center study, and the San Francisco cohort 
study, as alcohol intake increased so did HDL cholesterol levels (Figure 2.2).  In the 
Honolulu Heart Program, mean HDL cholesterol levels increased from 42.2 mg/dl in 
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nondrinkers to 56.7 mg/dl in those who reported consuming >20 ounces of alcohol 
per week(61).  Alcohol intake may increase HDL cholesterol levels via several 
possible mechanisms.  Alcohol consumption may increase the production of 
apolipoproteins and lipids, slow the catabolism of HDL particles resulting in 
increased HDL cholesterol, or cause alcohol-induced changes in proteins influencing 
HDL metabolism, leading to an increase in HDL concentrations(66).
In addition to affecting HDL cholesterol levels, alcohol may play a role in the 
oxidation of low density lipoprotein (LDL) cholesterol.  In particular, the consumption 
of red wine, which contains antioxidant phenolic compounds, is thought to reduce 
oxidation of LDL(69).  Observational studies have shown that oxidation of LDL 
cholesterol is important in the progression of atherosclerotic vascular disease(70).  
Hence, the antioxidant effect of drinking red wine probably affects the oxidation of 
LDL cholesterol, working to impede atherosclerotic plaque formation(57, 71).
As well as the role of lipids on the cardiovascular system, alcohol drinking is 
thought to affect several hemostatic factors including fibrinogen levels, platelet 
aggregation, and fibrinolytic factors.  Alcohol consumption decreases platelet 
aggregation, lowers fibrinogen levels, and increases fibrinolytic activity(67, 72, 73), 
which decrease the risk of myocardial infarction but increase the risk of bleeding and 
hemorrhage(67, 72).   Several studies, including ARIC, have found fibrinogen levels 
to be inversely related to alcohol consumption(74, 75).
Positive psychological benefits associated with moderate alcohol 
consumption may include improved subjective health, perceived stress reduction, 
mood enhancement, and lowered levels of depression (reviewed in (76), (77)).  A 
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cross-sectional survey conducted in Finland found alcohol intake of 3.3-9 drinks per 
week was associated with optimum levels of self-reported good health (78).  The 
majority of respondents to U.S. surveys regarding perceptions of drinking report 
positive reactions to alcohol consumption (reviewed in (77)). While the notion that 
alcohol drinking reduces stress is documented in self-reported surveys, the results of 
studies examining the alcohol-stress reduction association have been inconclusive 
and a mechanism for this effect is unknown (reviewed in (77, 79)).  With regard to 
depression, one study reported that those who consume large amounts of alcohol 
and those who abstain have higher rates of clinical depression as compared with 
moderate consumers(76).
Studies have shown that regular, low to moderate alcohol intake improves 
insulin sensitivity, which can lead to decreased diabetic tendency(80-85). In the 
Health Professionals’ follow-up study, incident diabetes was diagnosed at a lower 
rate among those who consumed moderate amounts of alcohol as compared with 
abstainers or with heavy drinkers, even after controlling for other risk factors(82). 
During 1998-1999, a randomized controlled cross-over trial of 51 healthy 
postmenopausal women was conducted to assess if low to moderate alcohol intake 
effected insulin resistance(81).  Consumption of two drinks per day (compared with 0 
drinks/day) was associated with an increased insulin sensitivity of 7.2% and 
decreased fasting triglyceride concentrations by 10.3%(81).  A case-control study 
examining the effects of light to moderate alcohol intake on insulin sensitivity among 
40 healthy volunteers (20 male and 20 female) used history of alcohol intake to 
categorize participants into nondrinkers and light/moderate drinkers (10-30g/day). 
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The study found light/moderate drinkers had lower insulin responses to the glucose 
challenge and higher HDL-cholesterol concentrations, independent of age, BMI, 
waist:hip girth, and physical activity levels(85).
Harmful Effects of Heavy Drinking on the Cardiovascular System:
In contrast, the damaging effects of heavy alcohol intake on the body are 
better understood.  The first association between heavy alcohol intake and 
hypertension was documented in middle-aged French servicemen in 1915 but it was 
not until the 1970s that the relationship was further explored(63).  Despite the fact 
that many prospective studies have established a link between heavy alcohol intake 
and hypertension(86-90) and that clinical experiments have confirmed the 
association(91), a biologic mechanism has not been established(63).  Since 
hypertension is an important risk factor for stroke, it is possible that an effect of 
heavy alcohol consumption on hypertension might be responsible for the observed 
relationship between heavy drinking and stroke.  The relation between alcohol intake 
and hypertension is thought to develop in days to weeks(63, 92).
Large quantities of alcohol ingestion have toxic effects on the heart that can 
lead to alcoholic cardiomyopathy (heart muscle disease)(93).  Three main categories 
of cardiomyopathy include hypertrophic (heart chambers thickened but not dilated), 
restrictive (heart chambers infiltrated by abnormal tissue), and dilated (heart 
chambers enlarged with weakened contractions)(63).  The relation between chronic 
alcohol use and heart disease was first recognized by several 19th century 
physicians and in 1902 MacKenzie first used the term “alcoholic heart disease” to 
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describe cases of heart failure attributed to alcohol(63).  Today, the existence of 
alcoholic cardiomyopathy is well established with chronic heavy alcohol intake 
thought to be a cause of dilated cardiomyopathy(94); however, lack of good 
diagnostic tests makes distinguishing types of dilated cardiomyopathy problematic 
and the proportion of heavy drinkers who develop cardiomyopathy is unknown(63).
Since the calorie content of alcohol is fairly high (7.1kcal/g), alcohol intake 
may affect body weight(95).  Light to moderate alcohol consumers typically add 
alcoholic beverages to their usual food intake patterns, leading to more caloric intake 
than expenditure, which in turn may result in increased weight gain.  In contrast, 
heavy alcohol consumers are more apt to substitute alcoholic beverages for regular 
food intake, resulting in malnutrition and not overweight/obesity(96).  Epidemiologic 
studies examining the relation between alcohol intake and body weight have 
reported inconsistent results(97).  One possible explanation for the conflicting results 
is that alcohol is metabolized differently among different populations and is based on 
factors such as the amount of alcohol consumed, the frequency of consumption, the 
drinking pattern, family history of obesity and the genotypes of alcohol-metabolizing 
enzymes which were not controlled for in some of the studies(95, 98).  Future 
epidemiologic studies addressing the relation between alcohol and body weight 
should consider if alcohol is added to the diet or is substituted for normal food intake 
since these behavior patterns can produce different effects on body weight and 
health in the long-term(95) .
Despite the positive psychological benefits of light to moderate alcohol 
consumption (76), the chronic use of heavy alcohol intake to reduce stress may play 
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an important role in the development of acute stroke events.  High stress intensity 
and weekly stress have been reported as risk factors for fatal stroke, and those who 
reported being stressed more frequently also reported higher levels of mean alcohol 
intake(99).
2.4.2 Measurements of Alcohol Consumption
Although alcohol consumption is considered a component of diet, it has 
unique implications because of the known adverse health and social problems 
related to heavy intake.  Categorization of alcohol intake can be based on the 
amount of alcohol and the type of beverage consumed.  Those who have abstained 
from alcohol throughout their entire lives are often termed “abstainers” or 
“teetotalers”.  Classification of those who have used alcohol at some point is typically 
grouped into past or current, both of which can be further categorized by the 
amount.  Beverage type determines the ethanol content (Table 2.7), with a 12oz 
serving of beer and a 4oz serving of wine containing 0.42 ounces of ethanol and a 
1.5oz serving of spirits containing 0.40 ounces of ethanol(67).  In addition to the type 
of and frequency of alcohol consumption, the number of drinks over a time period is 
also of interest to help in identifying patterns of binge drinking and chronic alcohol 
abuse.
Accurately assessing alcohol consumption is difficult because of recall bias, 
changes in behaviors over time, and social stigmas attached to certain patterns of 
drinking.  Measurements of the amount of alcohol consumed are obtained via self-
report, surrogate measures (biochemical markers or proxy respondents), or 
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measurement of blood alcohol level (BAL – the amount of alcohol in the blood 
stream).  Self-reported alcohol consumption data is collected by mailed 
questionnaires, daily food journals, telephone interviews or in-person interviews.  
Surrogate measures of alcohol consumption are often used as a means of 
comparison to try and determine the accuracy of self-reported information.  For 
example, measurements of serum gamma-glutamyl transferase (GGT), 
carbohydrate-deficient transferrin (CDT), and mean corpuscular volume (MCV) have 
been used as biological markers of alcohol drinking(100, 101).  These markers 
(GGT and MCV) are not measures of the quantity of alcohol consumed but rather of 
organ response to alcohol intake which may also be affected by factors other than 
alcohol (102). Collecting alcohol intake by measuring the BAL is difficult in 
epidemiologic studies because ethanol is rapidly cleared from the body(103).  As 
stated by Doll, correctly assessing alcohol consumption is challenging.
“Reliable quantitative evidence is … difficult to obtain.  Information about 
drinking habits has to be obtained not from direct measurement but from 
answers provided by individual people about themselves or their close 
relatives and friends.  Unless the amount usually drunk is close to zero it is 
intrinsically difficult to describe, and the description is peculiarly liable to 
bias”.(104)
In an attempt to verify self-reported alcohol consumption, many validation 
studies have been conducted(105-124) (summarized in Table 2.8).  While issues 
related to the validity of self-reported alcohol consumption need to be addressed, no 
gold standard for measuring alcohol intake currently exists.  In 1987, the director of 
the National Institute on Alcohol Abuse and Alcoholism defined the ideal marker for 
monitoring alcohol intake to be a test reflecting the mean blood alcohol level over a 
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period of weeks, not dependent on the presence of organ damage, and remaining 
positive even when the drinker is briefly abstinent(109).  To date, no such marker 
exists making the study of the effects of alcohol subject to potential biases.
Methods to validate self-reported alcohol use include comparisons of (1) 
collateral reports (reports by family members or significant others), official records 
and biochemical tests, (2) population level self-report and alcohol sales data, and (3) 
various self-reported alcohol consumption measures.  During the 1980s, Midanik 
published two literature reviews of the validity of self-reported alcohol 
consumption(107, 110).  A review of collateral reports (reports by significant others) 
used to validate self-reported data indicates that agreement on the frequency of 
drinking between the two sources ranges from poor to excellent, and probably
depends on the population being studied(107, 110).  Among the general population, 
the agreement on the frequency of alcohol intake ranges from 49-91% but 
information related to ever intoxicated in the past year probably has lower 
agreement(107, 110).  It should be noted that many of these studies were conducted 
several decades ago, in the 1960s and 1970s, and social attitudes regarding alcohol 
intake have changed, making the generalizability of these findings a concern.  
Although studies have shown that alcohol intake recorded by observers was 
correlated with subsequent self-reported intake(110) , the study design raises 
concern since the participants knew they were being monitored, which may have 
influenced their behaviors.
Biochemical markers such as CDT, GGT, and MCV (mean corpuscular 
volume) have also been used in an attempt to validate self-reported alcohol 
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consumption(117, 121).  Poikolainen et al. found GGT but not CDT to have good 
correlation with self-reported questionnaire data and diary methods (GGT: r=0.57 to 
0.67 for questionnaire reports and r=0.55 for diary vs. CDT: r=-0.16 to –0.12 for 
questionnaire reports and r-0.13 for diary) (121).  A study using data from 76 male 
twin pairs compared self-reported alcohol consumption from a mailed questionnaire 
to biochemical markers of alcohol intake and to a dietary history interview (101).  
Self-reported alcohol intake via the mailed questionnaire had correlations of 0.46 
with CDT, 0.32 with GGT, and 0.36 with MCV.  The correlations between alcohol 
intake assessed by the dietary interview and biochemical markers were similar (0.44 
for CDT, 0.30 for CDT, and 0.38 for MCV) (101).  Interestingly, those who reported 
higher levels of alcohol intake via either self-report method also had higher levels of 
biochemical markers as compared with those reporting lower alcohol intake levels.  
This finding suggests that self-reports of alcohol consumption are a useful tool in 
distinguishing between levels of drinkers (101).  Another study assessed the 
feasibility of using biologic markers in conjunction with clinical information to identify 
heavy drinkers (>6 drinks/day for men and >3 drinks/day for women) and found that 
levels of MCV and GGT were higher among the heavy drinker group (125).
A comparison of alcohol sales data and self-reported alcohol intake estimates 
finds self-reports are typically underestimates of intake(116, 121-123).  Survey 
results from a study conducted among US Air Force personnel indicate that self-
reported alcohol estimates were approximately 20% less than alcoholic beverage 
sales(122).  The Svalbard Study also found self-reported alcohol intake to account 
for only 40% of reported alcohol sales data(116).
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Differences in reporting may occur based on interview mode with in-person 
interviews reducing concerns about confidentiality and telephone interviews 
increasing perceptions of anonymity(126).  Greenfield and colleagues compared 
face-to-face with telephone interviews of reported alcohol consumption and found no 
differences between the two methods(105).  Another method frequently used to 
assess alcohol intake is to use prospective diaries.  Comparison of diary methods 
with questionnaires have also been evaluated(112, 118, 119, 121).  Several studies 
- one of volunteers from the San Francisco Bay(112) area, another of college 
students(119), and one of volunteers(121) - found prospective diaries and recall 
techniques gave similar results, although issues related to the study participants and 
selection raise concerns regarding the generalizability of the findings.
In addition to assessing the validity of alcohol intake measurements, many 
studies have examined the reliability of alcohol consumption measures.  In a study 
of the general population, reliability of alcohol intake was assessed using a test-
retest method (the 2nd survey was conducted 5-7days following the 1st survey) with 
alcohol information obtained via telephone interviews among ~80 adults in 
Greensboro, Baltimore, and Chicago(127).  The telephone interviews consisted of 
quantity-frequency questions about the intake of beer, wine and liquor with some 
asking about consumption in the previous 14 days and some asking about 
consumption in the previous 28 days. The correlations between the test and re-test 
surveys ranged from 0.84 to 0.99 for 14-day recall and from 0.92 to 0.99 for 28-day 
recall(127).  Although not directly reporting estimates for alcohol, Willett et al studied 
the reproducibility of nutritional data obtained from two semiquantitative food 
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frequency questionnaires and dietary records among women participating in the 
Nurses’ Health Study and found good correlation (range: Pearson r=0.54 to 0.71) 
between the two questionnaires (128).  Several years later, the reproducibility of 
alcohol intake was assessed in the Nurse’s Health Study (n=176) and the Health 
Professionals Follow-up Study (n=136) (114).  The correlation between alcohol 
intake assessment on the two questionnaires (approx 1 year apart) was high, 
ranging from 0.78 to 0.90 for women and 0.85 to 0.92 for men, depending on the 
type of alcoholic beverage(114).  Overall, the reliability of alcohol assessment 
among the general U.S. population appears to be high.
To determine the influence of various methods of alcohol consumption 
measurements on categorization of drinking status, Rehm and colleagues conducted 
a sensitivity analysis that compared three standard assessments of alcohol intake: 
quantity frequency (QF), graduated frequency (GF), and weekly drinking (WD) (113). 
Measurement of QF involves asking two questions and is a measure of average 
consumption over a set period of time, usually a year.  The GF asks for the highest 
number of drinks consumed on any occasion within the previous year and based on 
this response, asks questions regarding the frequency of times a certain number of 
drinks were consumed.  The final assessment, WD, asks for alcohol use during the 
seven days prior to the survey, which could be none for occasional drinkers.  Using 
random digit dialing, U.S. adults ages 18 and older were interviewed and alcohol 
information was collected using all three methods outlined above.  Results, as 
shown in Table 2.9, indicate that the WD assessment method categorized most 
(80%) respondents into the abstainers/light drinker group.  In contrast, the GF 
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categorization classified 8% as hazardous or harmful, the largest proportion of the 
three methods.  This result was probably due to the fact that the GF method 
captures periods of high intake.  This analysis clearly demonstrates that different 
methods of alcohol assessment can impact the categorization of individuals into 
particular groups and reinforces the need for measurement techniques to be specific 
to the objectives of the study and thus relevant to the current public health 
recommendations/guidelines.  As will be discussed later, the ARIC study 
incorporates alcohol consumption measurements in terms of usual weekly intake, 
most similar to the WD method.
Measurement of alcohol consumption using self-reported information or 
biochemical markers almost certainly introduces misclassification since no method 
of alcohol ascertainment is 100% sensitive or specific.  While measurement of 
alcohol intake by self-report is typically thought to underestimate intake levels, the 
assumption that all participants underestimate their alcohol intake proportionally 
allows researchers to adequately rank individuals’ according to intake (129, 130)).  
This assumption of similar underreporting across alcohol intake levels allows for 
associations to be examined, but safe levels of drinking are impossible to estimate.  
Instead, researchers are limited to “reported drinking levels” which are 
underestimates of true intake.  Underreporting that is not consistent across groups 
(heavier drinkers vs. lighter drinkers) may lead to differential misclassification of 
alcohol intake.  If, for example, heavy drinkers systematically underestimate their 
levels of alcohol intake compared with other drinkers, the study findings may be 
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biased (101, 131).  This issue is major concern for all epidemiologic studies 
examining alcohol consumption. 
Differential reporting of alcohol consumed by gender, behavioral 
characteristics, or other factors may vary according to the method of alcohol 
ascertainment.  Data from the Whitehall II longitudinal study compared a seven-day 
diet diary and a food frequency questionnaire and found quartile agreement between 
the two methods for alcohol to be 57% among males and females (132).
2.4.3 Alcohol Consumption Data Sources
Estimates of alcohol consumption in the general U.S. population are available 
from several different national surveillance systems and surveys.  The National 
Health Interview Survey (NHIS) is a large, population-based survey of the 
noninstutionalized U.S. population.  The NHIS began in 1957 and continues today 
with redesigns approximately every 10 years based on data needs.  In 1977 the 
NHIS began including questions on alcohol use in supplemental questionnaires, and 
collected alcohol use data in 1983, 1985, 1988, 1990, and 1991(133).  With the 1997 
redesign, alcohol use questions were incorporated into the basic core questionnaire 
for one sample adult per family.  The alcohol related questions in the NHIS are 
intended to measure alcohol consumption among the general U.S. population ages 
18 and older(134).  Data from the NHIS allow estimates of lifetime prevalence and 
current drinking levels for the US adult population by using alcohol consumption 
questions which inquire about consumption in the past 12 months.  According to 
data from the 1999 NHIS, the majority (48.4%) of U.S. adults 18 and older report 
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being current drinkers (having at least 12 drinks in the preceding year) and 22% 
report being lifetime abstainers(135).  Women were less likely to be current drinkers 
than men and current drinking status was inversely associated with age (as age 
increased the percentage of current drinkers decreased)(135).
The National Health and Nutrition Examination Survey (NHANES) is another 
data source for obtaining estimates of alcohol consumption among the US 
population age 20 and older.  Respondents are asked the number of drinks they 
have had in the past year, how often they drank in the preceding 12 months, the 
number of days they usually drink alcohol per week, month and year, and the 
average number of alcoholic drinks per day over the past 12 months (136).  The 
1999-2000 NHANES data report that 62% of respondents had at least 12 alcoholic 
drinks in the previous year.
The Institute for Survey Research of Temple University conducted the 
National Alcohol Surveys in 1984, 1990, and 1995.  Data were collected from in-
person interviews conducted in the 48 contiguous states with adults’ ages 18 and 
older.  Participants were asked about current drinking, weekly drinking and 
consumption of 5 or more drinks on one occasion(137).  In 1995 approximately 65% 
of respondents reported current drinking (drinking at least 1 drink per year), 29% 
reported weekly drinking, and 4.5% reported drinking 5 or more drinks one a single 
occasion(137).
The Behavioral Risk Factor Surveillance System also asks questions related 
to alcohol consumption (138).  Among participants aged 18 and older, several 
questions are asked, with the number of questions differing by year.  Alcohol intake 
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questions from 1991 to 2000 included questions related to beer, wine and liquor 
consumption in the past month, the number of days during which alcohol was 
consumed in the previous month, the number of drinks consumed in the previous 
month, and the number of times 5 or more drinks were had during a single occasion.  
In 2001 the questionnaire was modified and asked three questions: How many times 
at least 1 drink was consumed in the previous 30 days, on days when alcohol was 
consumed how many drinks per day were had on average, and how many times 
were 5 or more drinks consumed during a single occasion. From these 
questionnaires, a measure of binge drinking (have you had five or more drinks on an 
occasion one or more times in the past month) and a measure of chronic drinking 
(do you have an average of two or more drinks per day) are calculated.  Binge 
drinking ranged from 14.1-15.3% from 1990 to 2001 and was higher among males 
than females and decreased with age.  Less than 1% of females reported chronic 
drinking (2 or more drinks per day) from 1990 to 1999 and approximately 6% of 
males reported chronic drinking (Figure 2.3).  The apparent increase in chronic 
drinking levels among females may be due to the fact that the definition for chronic 
drinking for females changed in 2001, from >2 drinks/day to >1 drink/day.  Similar to 
binge drinking, there was a decline in reported chronic consumption with age (data 
not shown).
2.4.4 Epidemiology of Alcohol Consumption in the U.S.
Alcohol consumption patterns in the US vary among demographic groups, 
across geographic locations, and over time.  Data from the US National Alcohol 
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Survey show rates of 12-month abstinence increased during the 1980s after being 
stable for approximately 50 years(139, 140).  In an analysis of the National Alcohol 
Survey data, Greenfield et al found that levels of consumption decreased from 1984 
to 1990 but remained stable from 1990 to 1995(137).  In 1995, the proportion of US 
adults who reported being current drinkers (consumption of more than 1 drink per 
year) was 65% and those who reported weekly drinking was 29%(137).  Data on the 
proportion of US adults who consumed at least 12 drinks in the previous year range 
from the 1999 NHIS estimate of 48% to the 1999-2000 NHANES estimate of 62%.  
Findings from the National Health Interview Survey indicate the proportion of 
self-reported current drinkers was higher among males than females, was higher for 
younger than older adults, and was positively associated with higher levels of 
income and education (Table 2.10)(135, 137).  These results are similar to those 
from the U.S. National Alcohol Survey data(137).  However, results examining the 
proportion of current drinkers by race were inconsistent; one study reported higher 
consumption among African-Americans compared with whites(137) while another 
study reported higher intake among whites compared with African-Americans(135).
Since no standard method of classifying alcohol consumption exists, 
comparisons of how frequently alcohol is consumed are problematic.  As noted from 
the NHIS, the NHANES, the National Alcohol Survey, and the BRFSS, current and 
weekly drinking definitions and estimates vary widely.  Despite these limitations, a 
best estimate of the proportion of current drinkers is somewhere between 48% and 
65% with striking differences among demographic groups.
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2.4.5 Recommendations / Guidelines
Every five years, the U.S. Department of Health and Human Services 
(USDHHS) and the U.S. Department of Agriculture (USDA) publish dietary 
guidelines for the U.S. public, with the goal of promoting health and preventing 
disease.  In 2005, the dietary guidelines related to alcohol consumption stated that 
those who drink alcoholic beverages should do so in moderation, with moderation 
defined as up to 1 drink per day for women and up to two drinks per day for 
men(141) (142).  Specific guidelines relevant to alcohol consumption and 
cardiovascular disease risk have also been published by the American Heart 
Association (AHA) and the National Stroke Association (NSA)(143-146).  The 2002 
update to the AHA guidelines for the primary prevention of CVD and stroke is in 
agreement with the 2005 USDA publication, both recommend that among those who 
currently drink alcohol intake be limited to < 2 drinks/day for men and < 1 drink/day 
for women (147).
In 1996, the AHA examined the relation of alcohol consumption and CHD by 
taking an in-depth look at the current evidence.  Based on their review of the 
scientific literature, the AHA recommended consulting a physician periodically to 
assess the benefits and risks of consuming alcohol and that those who drink do so in 
moderation(146).  Another AHA science advisory, published in 2001, focused 
specifically on wine consumption and heart disease(143) probably due to the 
“French paradox” (CHD mortality rates in France are much lower than in the U.S. 
despite similar consumption of animal fats(148)) and the fact that several studies 
suggested red wine as more beneficial than beer or liquor in the alcohol-CHD 
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relation(149-151).  In reviewing the current literature, the AHA states that no clear 
evidence exists to support the hypothesis that wine is more beneficial than other 
forms of alcohol in protecting against coronary heart disease and that more research 
is needed to address this topic(143).
In an effort to aid primary care physicians on the prevention of a first stroke, 
two consensus statements establishing guidelines and recommendations have been 
published, one from the NSA in 1999(144) and one from the AHA in 2001 (4).  For 
both the NSA and AHA, advisory boards reviewed the current literature related to 
stroke risk factors including hypertension, myocardial infarction, atrial fibrillation, 
diabetes, asymptomatic carotid artery stenosis, and lifestyle factors (cigarette 
smoking, alcohol use, physical activity, and diet) and put forth recommendations.  
For alcohol use, the NSA is in agreement with the AHA, recommending the 
elimination of heavy drinking and the reduction to moderate drinking (up to 2 drinks 
per day) for those who drink alcohol and have no contraindications.  For those who 
do not currently drink alcohol, physicians should not recommend alcohol as a means 
of preventing stroke occurrence(4, 144).  Among patients who have had a stroke or 
TIA, the AHA recommends cessation of excessive drinking, with the goal of reducing 
consumption to < 2 drinks/day for both men and women (152).
Guidelines specific to the prevention, evaluation and management of chronic 
HF include the recommendation that patients at high risk of developing HF avoid 
behavior that may increase the risk of HF, including alcohol consumption.  Patients 
at high risk include those with systemic hypertension, CAD, diabetes, history of 
alcohol abuse, and family history of cardiomyopathy.  The guidelines do not address 
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patients with low to moderate risk and do not discuss light to moderate alcohol 
intake(32).
2.5 Summary of the Stroke and Alcohol Consumption Literature
Numerous studies have previously examined the relationship between alcohol 
consumption and stroke risk (Tables 2.11 and 2.12).  For ischemic stroke, the 
evidence for increased risk among heavy drinkers has been fairly consistent; 
however, the data for stroke risk among those consuming light to moderate amounts 
of alcohol have been inconclusive.  The results of studies examining stroke risk and 
light to moderate amounts of consumption report either no association or a 
protective effect (a “J” shaped relationship).  In contrast, studies of hemorrhagic 
stroke have found either an increase in risk with increasing amounts of alcohol 
consumption or no association between the two.
In early 2003, a meta-analysis of cohort and case-control studies examining 
the relation between alcohol consumption and stroke was published(153).  The 
authors reviewed 122 abstracts and manuscripts and included those which met the 
following criteria: (1) observational cohort or case-control studies which used stroke 
(ischemic, hemorrhagic, or all) as an end point; (2) those that reported relative risk or 
odds and the variance for the stroke and alcohol relation; (3) those that quantified 
alcohol intake; and (4) those which used abstainers as the reference group.  Of the 
originally identified abstracts and manuscripts, 35 met the above criteria (19 cohort 
studies and 16 case-control studies) and were examined for the meta-analysis.  The 
findings support a J-shaped relationship between alcohol intake and the relative risk 
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of ischemic stroke and a strictly monotonic, positive relation between alcohol intake 
and relative risk of hemorrhagic stroke.  Light to moderate alcohol intake (up to 
24g/day or 2 drinks/day) appeared protective for ischemic stroke but heavy intake 
(>60/day or 5+ drinks/day) increased the relative risk of both ischemic and 
hemorrhagic stroke.  Although the meta-analysis has the advantage of a larger 
number of stroke cases than the individual studies (resulting in a gain of statistical 
power and precision of the estimates), combining studies that measure outcomes by 
different methods (CT scan, death certificates, and hospital discharge codes) raises 
issues of outcome misclassification.  Additionally, the meta-analysis combines 
heterogeneous population groups, yet fails to discuss how this factor may impact the 
findings.  The lack of studies assessing the association between alcohol intake and 
stroke risk among African-Americans is evident from the meta-analysis.
2.5.1 Cohort Studies
Numerous cohort studies have examined the relation between alcohol 
consumption and stroke in the U.S., Japan, and Western Europe (summarized in 
Table 2.11).  These studies have sample sizes ranging from 1,621 with 26 years of 
follow-up for a study of Japanese men and women(154) to 107,137 with 6 years of 
follow-up in a study of men and women enrolled in the Kaiser Health Plan in 
California(155).  Although the study populations represent several diverse 
geographic regions (Japan, the United Kingdom, Sweden, Finland, and the U.S.), 
data on the relationship between stroke and alcohol consumption among African-
Americans is lacking.
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In these published cohort studies alcohol intake was assessed using self-
administered questionnaires (9 studies), in-person interviews (12 studies), biologic 
markers (1 study), or some combination of these methods (2 studies).  Outcomes for 
the cohort studies varied and included all stroke occurrence, all stroke 
hospitalization, all stroke mortality, ischemic stroke event, hemorrhagic stroke event 
(ICH and SAH both separately and combined), and cerebral infarction.  Several of 
the cohort studies did not validate the stroke diagnosis and relied solely on death 
certificate data or hospital discharge codes(156-161), which can result in systematic 
errors of selection bias and misclassification. Additionally, some of the cohort 
studies did not specify the type of stroke and included various subtypes 
together(156, 160-165).  Since the categorization of “all strokes” includes a 
heterogeneous mixture and ischemic and hemorrhagic strokes have very different 
etiologies, the classification of stroke subtype is important in trying to elucidate the 
role of alcohol consumption.  The cohort studies reported inconsistent results, 
ranging from no association to increased ischemic and hemorrhagic stroke risk for 
heavy drinkers to decreased ischemic stroke risk for light/moderate alcohol intake.
Among those cohort studies examining the relation between hemorrhagic 
stroke and self-reported alcohol consumption, four reported no association(157-159, 
166) and six reported increased risk with increased alcohol consumption(8, 154, 
155, 167-169).  None of the studies found alcohol intake to reduce the risk of 
hemorrhagic stroke.  Differences in study methods and populations could account 
for some of the contradictory findings.  For example, three of the four Japanese 
studies reported increased hemorrhagic stroke risk with alcohol intake.  The study by 
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Kioyhara et al. found increased hemorrhagic stroke risk for those with 
hypertension(154), the study conducted among rural Japanese men found increased 
hemorrhagic stroke risk with heavy intake (> 5.8 drinks/d)(168), and another study by 
Sankai et al. found increased risk for males but not females(170).  The gender 
differences in risk are interesting and warrant further evaluation.
Hemorrhagic stoke and alcohol consumption studies among U.S. populations 
include the Physicians Health Study, the Honolulu Heart Study, the Kaiser Health 
Plan study, and the Nurses’ Health study.  The Physicians Health study found no 
association between alcohol and hemorrhagic stroke risk among men(166) whereas 
the Kaiser Health Plan found hemorrhagic stroke risk increased with >3 drinks/day 
among both men and women(155).  Both the Honolulu Heart study(167) and the 
Nurses’ Health study(8) reported increases in stroke risk with increased alcohol 
intake.
The Nurses’ Health Study allows evaluation of the SAH and alcohol 
relationship among women in a well-designed setting because of the prospective 
study design, the large sample size, and the appropriate assessment of outcomes 
via clinical diagnosis rather than death certificate data.  The Nurses’ Health Study 
found that risk of hemorrhagic stroke increased with reported alcohol intake, but the 
number of cases was small, leading to imprecise estimates(8).  Given that this study 
was published in 1988, it would be interesting to re-analyze the data with an 
additional 10-15 years of follow-up data and re-examine the association.
Cohort studies assessing the relationship between ischemic stroke risk and 
self-reported alcohol consumption also report inconsistent results, ranging from no 
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association(158, 171) to decreased risk among those consuming light to moderate 
amounts of alcohol(8, 166) to increased risk among those consuming heavy 
amounts(168).  Of the cohort studies examining the ischemic stroke and alcohol 
relationship, study populations include white American males and females, western 
European populations, and Japanese populations; few cohort studies included 
African-Americans.
Several cohort studies examining the relation between ischemic stroke and 
alcohol consumption that warrant discussion include the Physicians’ Health Study, 
the Framingham Heart Study, and the Nurses Health Study(8, 166, 171).  These 
cohort studies are prospective, have large sample sizes, ascertained cases using 
clinical diagnoses (rather than relying on ICD-9 codes or death certificates), and 
specified ischemic stroke as an outcome (as compared with all strokes).  Alcohol 
information was collected by mailed questionnaires, in person interviews, and self-
administered questionnaires.  While the Physicians’ Health Study and the Nurses’ 
Health Study used alcohol intake at baseline in their analyses, the Framingham 
Study measured alcohol intake at multiple points in time and used this data to 
update alcohol exposure for study participants every 10 years(171).  The majority of 
studies assessing the alcohol and stroke relation incorporate one measurement of 
alcohol in the analyses.  In cohort studies, alcohol exposure is typically defined as 
the reported level at baseline and while this allows for prospective follow-up, it is 
also a concern because people change their patterns of alcohol consumption over 
time.  In particular, alcohol has both short- and long-term effects on the body 
(reviewed in Figures 1.1 and 1.2 above) so changes in alcohol drinking may be 
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related to risk of disease.  The ARIC study is able to improve upon previous cohort 
studies by incorporating two measures of alcohol intake, approximately six years 
apart.  For those who have not had a stroke by the time of the second alcohol 
measurement, alcohol intake will be updated to reflect changes in drinking patterns.
2.5.2 Case-Control Studies
Several case-control studies have also reported on the association between 
stroke occurrence and alcohol intake (Table 2.12).  Poorly designed case-control 
studies have inherent limitations including recall bias, misclassification of exposure, 
and selection of appropriate controls.  Of the 16 case-control studies, 14 used in-
person or proxy interviews to obtain information on alcohol exposure.  Of the other 2 
studies, one measured alcohol exposure by interviewing the patient, relative or 
physician by telephone(172) and the other study used an alcohol diary method(173).  
Studies have reported that measuring alcohol intake using a proxy does not lead to 
biased estimates of consumption(174) and the diary method has been found to 
produce similar results to alcohol consumption recall methods(112, 121).  
The control groups in case-control studies should be selected from the source 
population (the population from which the cases arise)(131).  In the case-control 
studies examining the alcohol and stroke relationship, the control groups were 
comprised of hospital/clinic based controls(172, 175-179), community controls(173, 
180-186), or a combination of the two(187, 188).  Identifying the source population 
when hospital-based controls are used may be difficult because controls are not 
based on a geographic area but rather on characteristics of those patients who 
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attend a specific hospital(189).  Using community controls (such as neighborhood or 
population) requires a register or a method of matching cases with controls based on 
location.  The selection of controls from the community may introduce bias into the 
study depending on the method of community case ascertainment.  Random-digit 
dialing for control recruitment is troublesome since not all households have 
telephone access (especially those of lower income) and certain groups of 
individuals are more likely to be home during the day (unemployed, women, and 
elderly) and thus have a higher probability of being recruited to serve as controls 
compared with the actual population of the area(131, 189).
The majority of cases in the stroke/alcohol intake case-control studies were 
identified based on hospital admissions.  Ascertaining cases in this manner will 
exclude those with the more severe strokes because they may die prior to hospital 
admission.  Cases admitted to the hospital were confirmed and classified with the 
use of clinical exam and/or CT scan.  Identification of stroke cases by clinical exam 
and imaging is important because these are currently the best methods available to 
validate and confirm the diagnosis.  In contrast, those cases identified by ICD codes 
or death certificates alone will lead to incomplete case ascertainment.
Several studies reported an increased risk for hemorrhagic stroke with heavy 
alcohol intake(179, 180, 186).  Since long-term alcohol use increases blood 
pressure and one of the major risk factors for hemorrhagic stroke is hypertension, 
this finding is as expected based on known biologic mechanisms. 
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2.6 Summary of the Heart Failure and Alcohol Consumption Literature
Although the harmful effects of heavy alcohol intake on the development of 
cardiomyopathy are well documented, few studies have examined the association 
between light to moderate alcohol consumption on the development of heart failure 
in the general population (table 2.13).  Two prospective cohort studies of men and 
women in the northeastern U.S. measured alcohol consumption by conducting in-
person interviews. Although both identified incident heart failure based on annual 
follow-up and medical/hospital record review, the study findings were different.  
Results from the Framingham Heart Study by Walsh et al. reported a protective 
effect of light to moderate alcohol intake but no increased HF risk with heavy intake 
(>15 drinks/week in men and >8 drinks/week in women)(190).  In contrast, the 
Establishment Populations for the Epidemiologic Study of the Elderly Program 
(EPESE) found that heavy intake (>1.5 drinks/day) decreased heart failure risk(191).  
The analysis of the EPESE study did not stratify on history of MI while the 
Framingham Study attempted to take this into account.  Finally, it is important to 
note the differences in definitions of heavy drinking between the two studies.
To understand the effect of light to moderate alcohol intake on the prognosis 
of patients with left ventricular dysfunction, Cooper et al examined data from the 
Studies of Left Ventricular Dysfunction (SOLVD).  Alcohol consumption was 
assessed at baseline by asking for the average number of drinks consumed per 
week over the previous two years.  Participants were then followed for an average of 
33 months.  Among those with ischemic LV dysfunction, light to moderate alcohol 
consumption (1-14 drinks/week) was associated with a decreased risk of 
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cardiovascular mortality and HF hospitalization as compared with non-drinkers.  
However, in patients with non-ischemic LV dysfunction, light to moderate alcohol 
intake (vs. never intake) was unrelated to cardiovascular mortality or HF 
hospitalization(192).  This study emphasizes the importance of separating those with 
ischemic and non-ischemic disease since progression to HF is different in these two 
groups.
Given the findings from these cohort studies, more data on the effects of light 
to moderate alcohol intake on the risk of HF are needed, especially for diverse 
populations including African-Americans and other geographic locations.  
2.7 Conclusions and Questions
The role of alcohol consumption on the cardiovascular system is complex, 
involving behavioral as well as biologic mechanisms.  While previous studies have 
found light to moderate consumption to be beneficial with respect to HD, the role 
alcohol plays on other components of CVD remain unclear.
The previous work examining ischemic and hemorrhagic stroke have 
produced conflicting results.  Issues related to study design, outcome 
measurements, and generalizability leave room for improvement in future studies.  
Although heavy alcohol intake has been established as a risk factor in the 
development of alcoholic cardiomyopathy, the role of light to moderate alcohol in the 
progression from CAD to HF warrants further study.  As the U.S. population 
increases in age and survival following acute myocardial infarctions improves, the 
incidence and prevalence of HF is expected to increase.
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Specific concerns regarding the use of alcohol as a means of protecting 
against disease still warrant consideration.  Despite the fact that the true benefit of 
alcohol intake at any level is unknown, current guidelines do not discourage the use 
of alcohol among current drinkers as long as the amount consumed is in moderation.  
With an estimated 48-62% of the U.S. population being current drinkers, the role 
alcohol plays in the development of cardiovascular diseases needs attention, as it is 
likely to have an impact on public health.
A well-designed long-term prospective cohort study, such as the ARIC cohort, 
will help to better understand this complex relationship.  The ARIC study improves 
upon previous studies and is well suited to evaluate the association between alcohol 
and CVD because:
• The ARIC study population is racially and geographically diverse, including 
both whites and African-Americans from MD, MN, MS, and NC.
• The ARIC study has complete case ascertainment with validated stroke 
occurrence and complete data on CHF hospitalizations.
• The ARIC study is prospective in nature with alcohol exposure measured 
prior to disease occurrence.  Additionally, alcohol intake was measured at 
visits one and three, allowing for alcohol exposure to be updated in the 
analyses.  If no event has occurred by visit three, both measures of alcohol 
intake will be used to obtain a more accurate exposure history than is 
available with only baseline information.
• The ARIC study uses in-person interviews to obtain extensive information on 
alcohol consumption.  The method of alcohol assessment uses questions that 
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allow a distinction to be made between former drinkers and abstainers, an 
important distinction since these two groups are likely to be heterogeneous.
• The ARIC study measures numerous demographic, clinical, and behavioral 
characteristics of the study participants which will allow for the control of 
potential confounding factors.
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Table 2.1: Prevalence and Incidence of Specific Cardiovascular Diseases in the U.S.
Prevalence (millions)* Incidence (new cases/ year in US)
All CVD 61.8
High Blood Pressure 58.4
Coronary Heart Disease 12.9 1,100,000**
Congestive Heart Failure 4.9 550,000^
Stroke 4.7 500,000^^
*Source: National Health and Nutrition Examination Survey (NHANES) III 1988-94 and NHANES 1999-2000 for 
high blood pressure prevalence estimates(193).
** Source: Atherosclerosis Risk in Communities, NHLBI
^ Source: Framingham Heart Study, NHLBI
^^ Source: Various studies, NINDS
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Table 2.2:  Traditional and Emerging Risk Factors for Cardiovascular Disease (2)
Established / Traditional Emerging
Atrial fibrillation Alcohol intake
Diabetes Fibrinogen
High blood cholesterol Homocysteine
High blood pressure Inflammation markers (CRP)
Increased Age Lipoprotein(a)
Male gender Metabolic syndrome
Overweight/Obesity Nutrition
Physical inactivity
Smoking
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Table 2.3:  Age-Adjusted Stroke Incidence Rates per 1000 person-years and 95% Confidence Intervals (22)
Ischemic Stroke
Rate          95% CI
Hemorrhagic Stroke
Rate          95% CI
All Stroke
Rate          95% CI
Black Males 4.44          3.31, 5.97 0.77          0.38, 1.57 5.32          4.10, 6.93
White Males 1.78          1.35, 2.34 0.12          0.05, 0.28 2.00          1.56, 2.57
Black Females 3.10          2.34, 4.10 0.58          0.30, 1.10 3.96          3.10, 5.06
White Females 1.24          0.93, 1.65 0.09          0.04, 0.22 1.49          1.16, 1.92
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Table 2.4:  Framingham Study Congestive Heart Failure Criteria(38)
Major Criteria
     Paroxysmal nocturnal dyspnea
     Neck vein distention
     Rales
     Radiographic cardiomegaly (increasing heart size on chest x-ray)
     Acute pulmonary edema
     Third sound gallop
     Increased central venous pressure (>16cm water at the right atrium)
     Circulation time >25 seconds
     Hepatojugular reflux
     Pulmonary edema, visceral congestion, or cardiomegaly at autopsy
     Weight loss >4.5kg in 5 days in response to treatment of CHF
Minor Criteria
     Bilateral ankle edema
     Nocturnal cough
     Dyspnea on ordinary exertion
     Hepatomegaly
     Pleural effusion
     Decrease in vital capacity by 33% from maximal value recorded
     Tachycardia (rate >120 beat/min)
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Table 2.5:  Identified Risk Factors for Congestive Heart Failure
Framingham 
Heart 
Study(39, 42)
Established Population 
for Epidemiologic Study 
of the Elderly 
program(46)
East Boston Senior 
Health Project(47)
NHANES I(48)
Coronary heart 
disease
  
Hypertension  
LVH 
Valvular heart 
disease
  
Obesity/overweight  
Diabetes    
Elevated pulse 
pressure
 
Use of 
antihypertensive 
medication

Atrial Fibrillation 
Male sex 
Less education 
Physical inactivity 
Cigarette smoking 
LVH=left ventricular hypertrophy
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Table 2.6: Putative biological mechanisms underlying cardioprotection by low-moderate alcohol consumption
Parameter Cardioprotective effect of low-moderate alcohol intake
Lipid & lipoprotein profile Increases HDL-cholesterol
Inhibits oxidation of LDL-cholesterol
Thrombosis Reduces platelet aggregation
Reduces fibrinogen levels
Increases fibrinolysis (the process by which clots dissolve)
Cardiovascular system Increases coronary blood flow
Reduces blood pressure (<1-2 drinks/day)
Lifestyle Reduces stress
Other effects Decreases plasma homocysteine levels
HDL = high density lipoprotein; LDL = low density lipoprotein
Adapted from: Agarwal, DP.(57)
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Table 2.7: Quantities of Alcohol (Ethanol) Consumption(67)
Type of Beverage Ethanol 
Content 
(%)
Unit of 
Measure
Ethanol Amount 
in oz (ml)
Beer (US) 3.5 12-oz bottle, 355 ml 0.42 (12.43)
Wine 12.1 3.5-oz glass, 104ml 0.42 (12.58)
Distilled spirits, 80 proof 40.0 1-oz shot, 30ml 0.40 (12.00)
Ethanol in grams = 23 x (ethanol in oz).
Ethanol in spirits = 0.411 x (oz of spirits), not x (volume of mixed drink).
1 gram = 0.035 ounces
Table 2.8 Summary of Alcohol Reliability and Validation Studies
Author & Year Population Comparison Methods        Outcome         Results______
Giovannucci E(114) 144 women from Nurses’ Health      Alcohol consumption measured by        Completed FFQ1; 2-4 months Spearman rank correlation        FFQ1 & FFQ2 
1991 Study & 136 men from Health         self-administered questionnaire with       later recorded food intake for 4 coefficients, Fisher’s method        high correlation  
Professionals Follow-up Study        detailed diet records (DR)         weeks during 3 month intervals; test differences, & linear        (r>0.9); FFQ &
        then completed FFQ2 regression for covariate control      DR r>0.86
Greenfield TK(105) 1990 Alcohol Survey (face to         Alcohol consumption measured by        Drinking measured with graduated Comparison of mean drinks/day    No difference
2000 face data) & 1990 Warning         random digit dialing with face to        frequency approach in each of the by age, race, gender, income &      b/t telephone &
Labels Survey (telephone data)      face interview survey in 48 states           two samples educational levels        face to face
Gronbaek(115) 493 Danish men & women from      Alcohol consumption measured by        Completed general health Average daily intakes calculated    Mod correlation
1996 the Danish MONICA Study         frequency questionnaire & dietary        questionnaire & 1 week later & compared using multiple linear   b/t 2 methods
        interview        interviewed by dietician regression       (r>0.72)
Hilton ME(112) 83 volunteer subjects from the        Alcohol consumption measured by        30-day recall series, 2-week Diary assumed to be gold      Both recall
1989 San Francisco Bay area who          prospective food diary & two recall        recall series, & 10-week standard & recall measures      measures gave
drank at least twice/week         series        diary assessed against diary      high correlation
     w/ diary (r>.88)
Hoyer G(116) 818 men & women participating      Alcohol consumption measured by       Alcohol sales data were obtained Comparison of mean annual      Self-reported
1995 in the Svalbard Study on the         recorded alcohol sales & self-       from all agencies selling alcohol &     liters of alcohol by self-report      intake was 40%
Norwegian island         administered questionnaire       questionnaire data was self-report     & sales data      of reported
      at study baseline      sales data
Laatikainen T(117) North Karelia, Finland &         Alcohol consumption measured by       At study baseline, self-admin. Comparison of questionnaire       Both bologic
2002 Republic of Karelia, Russia         self-reported questionnaire &       questionnaire re: alcohol intake & responses with GGT and CDT     markers gave
        biological markers, GGT & CDT       blood specimen for GGT & CDT separately      higher estimates
      measures
Lemmens P(118) Dutch population sample         Alcohol intake measured by in-       In-person interview conducted Comparison of the two           Diary estimates
1988         person interview of previous 7          first and then kept diary for 2 methods      higher than 
        days & diary for 2 week period       weeks      weekly estimate;
     rank order same
Midanik LT(106) 112 men & women volunteers          Alcohol consumption measured via      Comparison of 2 self-reported Correlations between the Reported alcohol
1992 who drank alcohol > monthly          telephone interview before & after       recalls of drinking during 12- two measures     intake lower after
         December       month period     December
Midanik LT(108) 535 men & women who were          Interview of alcohol intake during During clinic exams, participants Spearman rank correlations     Correlation b/t
1989 members of Northern Kaiser          previous 7 days and two alcohol        completed questionnaires – 2 at between (1) 7-day recall &     7-day & QF =
Permanente Medical Care          use questionnaires: quantity/        beginning of exam & 7-day recall quantity/frequency index and     0.66 and b/t
Program during 1st 4 months          frequency index and overall        at the end of exam (2) 7-day recall & overall    7-day & overall
of 1986          summary measure summary measure     summary = 0.74
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Table 2.8 Summary of Alcohol Reliability and Validation Studies (con’t)
Author & Year Population Comparison Methods        Outcome  Results______
Midanik LT(111) 65 adult alcoholics admitted to         Alcohol intake measured by        During clinic visit participants Calculated estimated blood      Self-reported 
1982 a treatment program/clinic          interviewer administered question        were interviewed re: recent alcohol concentration from      estimates higher
         & breath test to obtain blood        alcohol intake (prev 24hr) & questionnaire & compared      than breath test
         alcohol concentration (BAC)        given breath test with BAC from breath test
O’Callaghan F(119) 122 college students          Alcohol intake assessed using Correlation between the 2       High correlation
1992          questionnaire & 2-week diary measurements       b/t 2 measures
Poikolainen K(121) 34 volunteer subjects (men &          Alcohol consumption measured by       At study baseline & follow-up Pearson correlation coefficients   Correlation b/t
2002 women) from workplaces          self-admin questionnaire, daily        participants completed two between diary, QF & GF and      QF and GF with 
recruited via advertisements          diary, & biomarkers        questionnaires (GF & QF), blood biomarkers & QF, GF, diary      daily intake r=0.9
       samples taken at baseline &      Correlation b/t
       daily diary kept for 31 days     biomarkers & self
     report was good
Poikolainen K(120) 49 male volunteer subjects           Alcohol intake assessed by       At baseline questionnaire given Correlation coefficients     Correlation b/t 
1983           questionnaire and two diary       followed by diary measurements     two measures
          time points     was good
Rehm J(113) 3961 adult men & women           Alcohol consumption measured by      Data from 4 probability surveys Cross-tabulation, spearman      QF highest drink
1999 from Ontario, Canada           QF, GF, and WD for each subject       using telephone interviewing correlation coefficients      estimates, WD 
lowest; QF & GF
r=0.76-.73
Smith PF(123) Data from 21 states participating       Alcohol intake assessed via self-    Data for alcohol sales from Correlation coefficients to       Correlation for
1990 in 1985 BRFSS           report and through alcohol sales       state-specific per capita sales compare estimates of alcohol        21 states r=.81
          records intake
Townshend J(124) 55 university students recruited         Alcohol consumption measured by       After initial AUQ, participants Differences b/t AUQ & diary      Correlation b/t 2
2002 by advertisement for social           initial questionnaire (Alcohol Use        completed daily diary for 4 examined with paired-sample       sources r=0.975;
drinkers           Questionnaire – AUQ) & then 4        weeks, returning diary each t-tests; Pearson correlation      Low drinkers 
          week daily diary        week coefficient comparing AUQ &      underestimate &
diary      high drinkers
     overestimate
_________________________________________________________________________________________________________________________________________________
FFQ=food frequency questionnaire; QF=quantity frequency; GF=graduated frequency; WD=weekly drinking
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Table 2.9:  Proportion of respondents according to drinking categories by assessment method and gender (113)
Abstainers/light drinkers Low Risk Hazardous Harmful
QF GF WD QF GF WD QF GF WD QF GF WD
Male 41.3 48.3 74.3 52.3 40.6 22.5 3.6 3.8 1.6 2.8 7.3 1.6
Female 70.7 72.9 85.6 26.5 21.7 12.3 2.5 3.7 1.9 0.3 1.7 0.2
Total 56.3 61.0 80.0 39.2 30.8 17.3 3.0 3.8 1.7 1.5 4.4 0.9
Abstainers/light drinkers = 0-2.5g pure alcohol per day, Low risk = males: 2.6-40.0g/day & females:2.6-
20.0g/day, Hazardous = males:40.1-60.0g/day & females: 20.1-40.0g/day, Harmful= males >60.1g/day & 
females >40.1g/day.
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Table 2.10:  Proportion (in %) of US population ages 18 and older by alcohol drinking status, NHIS 1999(135)
Lifetime 
Abstainer*
Former 
Infrequent*
Former 
Regular*
Current 
Infrequent*
Current 
Regular*
Total 22.4 8.1 6.7 14.3 48.4
Male 14.7 6.9 8.4 11.0 59.0
Female 29.4 9.3 5.2 17.3 38.8
18-44 yrs 20.7 5.6 4.4 14.3 55.0
45-64 yrs 19.6 10.3 8.1 15.4 46.6
65+ yrs 33.1 12.8 12.1 12.1 29.8
< $20,000 33.3 10.2 8.4 12.5 35.6
$20,000-34,999 23.2 10.6 7.8 14.9 43.6
$35,000-54,999 18.9 8.0 6.7 15.7 50.5
$55,000-74,999 15.4 7.0 5.7 14.7 57.2
> $75,000 11.8 4.6 4.4 13.8 65.3
* Lifetime abstainer had fewer than 12 drinks in lifetime; Former infrequent had at least 12 drinks in their lifetime 
but fewer than 12 drinks in any year and no drinks in the previous year; Former regular drinkers had at least 12 
drinks in any one year and no drinks in the previous year; Current infrequent had as least 12 drinks in their 
lifetime and fewer than 12 drinks in the previous year; Current regular has at least 12 drinks in the previous year.
Table 2.11 Stroke and Alcohol Consumption Cohort Studies
Outcome    Follow-up
Author & Year Setting Population Alcohol Exposure Outcome Assessment events     (years)            Results____
Berger K(166) Physicians’ 21,870 male physicians Self-administered Ischemic & Self-report & isch=557      12.2 no association b/t
1999 Health Study aged 40-84 yrs mailed questionnaire hemorrhagic verified w/ med. hem=88 alco & hem stroke; 
at baseline & 84 months stroke incidence record review unk=34 for isch, >1drink/wk
RR=0.8
Djousse L(171) Framingham 5,209 males & females In-person interview Ischemic stroke Clinical dx or 441       30 No sign association
2002 Heart Study in Massachusetts at several exams incidence radio images but among 60-69yr
olds, drinking  risk
Donahue RP(167) Honolulu 7,878 males aged In-person interview hemorrhagic Hospital disch, 76       12 mod alco RR=3.5 &
1986 Heart Study 45-69yrs in Hawaii stroke death certificate, heavy alco RR=3.8
or autopsy vs. never drinkers
Elkind (194) Northern 3176 males & females, In-person interview hemorrhagic & Telephone IS=172      5.9  IS risk with one 
2006 Manhattan Study including Hispanics, blacks ischemic stroke interview & SAH=4 drink/mo to 2 drink/
and whites hospital surveillance day
Gaziano JM(156) Physicians’ 89,299 US males Self-administered all stroke death Death certificate 150       5.5 No association b/t
2000 Health Study aged 40-84 yrs mailed questionnaire by ICD-9 430- alco consumption &
Enrollment 438 stroke mortality
Goldberg RJ(161) Honolulu 6069 males in In-person interview all stroke death & Death certificate, 70 15  stroke mortality 
1994 Heart Study Hawaii at baseline & year 6 event by ICD-9 hospital discharge w/  alcohol intake
Hansagi H(157) Swedish pop- 15,077 twin males & Self-administered all, hem & isch Death certificate 769       20 No association b/t
1995 based twin females aged >40yrs questionnaire stroke death alco & hem stroke;
registry in Sweden by ICD-8 430-438 mixed results for IS
Hart CL(165) Scottish 5,766 males aged In-person interview all stroke death NHS register 133       21 No association b/y
1999 cohort 35-64yrs in Scotland by ICD-9 430- in Edinburgh alco & all stroke
438 mortality
Iso H(168) Rural Japan 2,890 males aged In-person interview Hemorrhagic & Physician report, hem=58      10.5 Increased hem & 
1995 40-69 yrs in Japan ischemic stroke claims, medical isch=104 isch stroke risk 
incidence records & death for heavy (>70g/d)
certificate drinkers
Iso H (195) Japan Public 19,544 middle-aged Self-administered Hemorrhagic & Hosp surveillance SAH=73      11.0  hem stroke risk
2004 Health Center Japanese males questionnaire ischemic stroke & death certificates IS=319 with  alco intake; 
Study  IS risk 1-149g/wk
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Table 2.11 (continued) Stroke and Alcohol Consumption Cohort Studies
Outcome    Follow-up
Author & Year Setting Population Alcohol Exposure Outcome Assessment events     (years)            Results____
Jousilahti P(158) Eastern & 14,874 males & females Self-administered Hemorrhagic & Hospital disch hem=79       10 No association b/t 
2000 Southwestern aged 25-64 yrs in mailed questionnaire ischemic stroke registry or death isch=345 self-report alco 
Finland Finland & from GGT obtained incidence certificate drinking & stroke; 
from blood samples  stroke risk w/ 
GGT levels
Kiyohara Y(154) Hisayama Study 1,621 males & females In-person interview Hemorrhagic & Clinical dx, CT hem=60       26 For pts w/ HTN, 
1995 aged >40yrs in Japan cerebral infarct scan, or autopsy cer=244 hem & cereb stroke 
risk in heavy drnkrs
Klatsky AL(155) Kaiser Health 107,137 males & Self-administered Hemorrhagic & Hospital disch hem=69       6  hem stroke risk
1989 Plan, CA females aged <50yrs questionnaire occlusive stroke codes occ=292 with >3drk/d;  occ
strk risk w/ alco use
Kono S(159) Japanese 5,135 males Self-administered Hem stroke & Death certificate 230       19 No association
1986 physicians questionnaire all other stroke
by ICD-8 codes
Leppala JM(196) Finland 26,556 male smokers Self-administered Incident stroke Clinical dx or isch=733       6.1 SAH & ischemic
1999 aged 50-69yrs questionnaire identified by link- death certificate SAH=83 stroke risk  NS
ing to ICD codes ICH=95 w/  alcohol intake
Maskarinec G(160) Hawaii 27,678 males & In-person interview All stroke death Death certificate 433       20 No association
1998 females aged >30yrs by ICD codes
Mukamal (197) Cardiovascular 4,410 US adults aged Annual self-report Incident ischemic Hospital IS=434      9.2 Slight  in IS risk
2005 Health Study 65 and older stroke surveillance among 1-6 drink/wk
Palmer AJ(198) England 6369 males & In-person interview & All stroke death Death certificate 159       11 Among males, 
1995 females aged 18-90y self-admin questionnaire by ICD codes stroke mortality
for light drinkers
Romelsjo A(162) Swedish 49,618 males aged Self-administered All stroke Clinical dx or 223       25 No association
1999 conscripts 17-45 yrs questionnaire incidence death certificate
Sankai T(169) 6 communities 12,372 males & females In-person interview Incident SAH Clinical diagnosis 71      9.4 Among males, 
2000 in Japan aged 40 to 69 yrs stroke & CT scan SAH risk; no 
assoc. for females
Shaper AG(163) General practice 7,735 British men In-person interview All stroke NHS registry 110       8 heavy alco intake
1991 offices in UK aged 40-59 yrs incid & mortality  >42dk/wk, RR=3.8
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Table 2.11 (continued) Stroke and Alcohol Consumption Cohort Studies
Outcome    Follow-up
Author & Year Setting Population Alcohol Exposure Outcome Assessment events     (years)            Results____
Stampfer MJ(8) Nurses’ Health 87,526 female nurses Self-administered Hemorrhagic Participant hem=35       4  ischemic risk for
1988 Study aged 34-59 yrs questionnaire & ischemic questionnaire & isch=141 light/mod drinking;
stroke medical record  hem stroke risk
Truelsen T(199) Copenhagen City 13,329 males & females In-person interview Incident ischemic Clinical dx or all=833      16  stroke risk for
1998 Heart Study aged 45-84 yrs & hemorrhagic death certificate hem=81 wine drinkers
hospitalization isch=310
Wannamethee(164) British Regional 7,273 males aged In-person interview at Stroke event & Clinical dx, self fatal=59      13.5 No association for
1996 Heart Study 40-59 yrs year 1 & year 5 mortality report, med rec. nonfatal=191 mortality or event
or death certif.
_________________________________________________________________________________________________________________________________________________
alco=alcohol, dx = diagnosis, yrs=years
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Table 2.12 Stroke and Alcohol Consumption Case Control Studies
Author Setting Cases Controls Alcohol Exposure Outcome Assessment Results__
Beghi E(187) Hospitals in 200 males & females 170 hospitalized In-person or proxy clinical or neurological   stroke risk among
1995 Italy aged >20 yrs with controls & 202 interview exam, or CT scan moderate & heavy
any stroke diagnosis                community  controls drinkers using 
either control group
Ben-Shlomo Y(188) 3 Hospitals in 115 males & females 119 hospital controls In-person or proxy Clinical exam, CT scan, No association
1992 UK aged 15 to 69 yrs & 717 community interview or lumbar puncture
with isch or hem stroke controls
Caicoya M(180) Spain 467 males & females 477 community In-person or proxy Clinical exam or CT Moderate drinking 
1999 aged 40 to 85 yrs controls interview scan isch stroke risk;
with isch or hem stroke heavy drinking 
hem & isch strk risk
Gill JS(175) District hospital 230 males & females 230 hospital In-person or proxy Clinical exam, CT scan, Heavy drinking in
1986 England aged 20 to 70 yrs with controls interview angiography, or autopsy men  all stroke risk
any stroke diagnosis
Gill JS(181) District hospital 230 males & females 577 community In-person or proxy Clinical exam, CT scan, No association
1988 England aged 20 to 70 yrs with controls interview angiography, or autopsy
any stroke diagnosis
Gill JS(182) 2 hospitals in 621 males & females 573 community In-person or proxy Clinical exam, CT scan, Moderate drinking 
1991 England aged 20 to 70 yrs w/ hem controls interview angiography, or autopsy SAH in women; NS
stroke or cerebral infarct J-shape association
Gorelick PB(176) 3 medical 201 males & females 405 outpatient In-person interview Clinical diagnosis & CT No association
1989 centers in aged > 44 yrs with clinic patients scan
Chicago incident ischemic stroke
Henrich JB(172) Connecticut 89 males & females 178 hospital based Telephone interview Clinical exam & CT scan No association
1989 aged 15 to 65 yrs with controls with patient, relative,
ischemic stroke or physician
Herman B(177) 2 hospitals in 132 males & females 239 hospital based In-person or proxy Clinical exam No association
1983 the Netherlands aged 40-74 yrs with controls interview
any stroke dx
Jamrozik K(183) Western 501 males & females 931 community based In-person or proxy Clinical exam, CT scan, No association
1994 Australia aged > 18yrs with isch or controls from electoral interview MRI, or autopsy
hem stroke diagnosis roles
62
Table 2.12 (continued) Stroke and Alcohol Consumption Case Control Studies
Author Setting Cases Controls Alcohol Exposure Outcome Assessment Results__
Malarcher AM(184) 59 hospitals in 224 females aged 392 community based In-person or proxy Hospital discharge dx, Up to 24g/d in past
2001 Baltimore, 15 to 44 yrs with female controls interview clinical dx, neuroimaging yr,  stroke risk;
Washington incident cerebral infarct or autopsy wine consumption 
protective
Palomaki H(178) Hospital in 156 males with ischemic 153 hospital based In-person or proxy  Clinical diagnosis, Heavy alco intake 
1993 Finland stroke dx controls interview neuroradiological methods ischemic stroke risk
Sacco RL(200) New York area 677 males & females 1139 community based In-person or proxy Brain imaging & clinical Up to 2 drinks/day 
1999 community aged > 39 yrs with controls identified via RDD interview diagnosis stroke risk & >7 
incident cerebral infarct drinks/day  risk
Shinton R(173) Physician offices 125 males & females 198 community based Alcohol diary Clinical exam, CT scan, No association
1993 in England aged 35 to 74 yrs with controls or autopsy
incident stroke
Thrift A(186) 13 Hospitals in 331 males & females 331 neighborhood In-person or proxy CT scan, MRI, or autopsy  hem stroke risk 
1999 Melbourne, aged 18 to 80 yrs with matched controls interview for heavy drinkers
Australia hemorrhagic stroke &  hem stroke risk 
for wine drinkers
Zodpey SP(179) Hospital in 166 males & females 166 hospital matched In-person interview CT scan  hem stroke risk 
2000 India  with hemorrhagic stroke controls for heavy drinkers
_________________________________________________________________________________________________________________________________________________
alco=alcohol, CT=computed topography, dx = diagnosis, hem=hemorrhagic, isch=ischemic, yrs=years
* adapted from Reynolds K(153)
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Table 2.13 Heart Failure and Alcohol Consumption Studies
Outcome Follow-up
Author Setting Population Alcohol Exposure Outcome Assessment    events   (years)       Results________
Abramson JL(191) New Haven, CT 2235 males & females In-person incident HF Identified via ICD      281    14  lt drink HR=0.8 (0.6-1.0)
2001 EPESE study aged >65 yrs free of HF interview (fatal or nonfatal) codes; medical & heavy drink HR=0.5 
record review (0.3-0.9) – vs. none
Cooper  HA(192) SOLVD 6609 males & females In-person all cause & CVD by PI at each site     622HF      3     Alcohol consumpt. not
2000 aged 21 to 80 yrs with interview specific mortality associated with worse
an LVEF<0.35 including HF prognosis in pts w/ LVEF
He J(48) NHANES I 13643 males & females In-person incident HF Interview, medical    741(M)     19 Reg alc intake in      
2001 aged 24-74 years free interview (fatal or nonfatal) records, death    641(F) women, RR=0.71
of HF at baseline certificate by ICD-9 (0.52-0.96). No 
codes association in men
Klatsky (201) Kaiser Health 126,235 males and Self-administered Hospitalized HF Identified via ICD    2594     ? Heavy alcohol intake 
2005 Plan Study females enrolled in questionnaire codes; medical increased non-CAD-HF
Kaiser Plan in CA record review
Walsh CR(190) Framingham 2796 males & 3493 In-person incident CHF Medical history,      99(M)     10      No association b/t
2002 Heart Study females aged 28-62 yrs interview physical exam,     120 (F) alcohol consumpt. &
at baseline & free of HF & hosp. records CHF; moderate consumpt.
appears protective
_______________________________________________________________________________________________________________________________________________
alc=alcohol, dx = diagnosis, yrs=years
EPESE = Establishment Populations for the Epidemiologic Study of the Elderly program
HF = heart failure
SOLVD = Studies of Left Ventricular Dysfunction
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Figure 2.1:  Classification of stroke based on data from the NINDS Stroke Data Bank, 1983-1986 (adapted from 
Sacco, et al)(19)
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Figure 2.2:  Mean High Density Lipoprotein (HDL) Cholesterol Levels(68)
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Figure 2.3:  Chronic Drinking Levels among US Adults ages 18+ by Gender, BRFSS 1990-2001
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* No national data for years 1994, 1996, 1998, and 2000.
1990-2000: All respondents ages 18+ who reported an average of > 2 drinks/day.
2001-2002: All male respondents ages 18+ who reported an average of > 2 drinks/day and female respondents 
ages 18+ who reported an average of > 1 drink/day.
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CHAPTER 3
METHODS
3.1 Data Sources
Data to address the specific aims described in section 1 come from the ARIC 
cohort study.  In brief, the ARIC study is an ongoing prospective cohort study funded 
by the NHLBI with 3 objectives: “1) to investigate the etiology and natural history of 
atherosclerosis, 2) to investigate the etiology of clinical atherosclerotic diseases and 
3) to measure variation in cardiovascular risk factors, medical care, and disease by 
race, sex, place and time” (1).
3.2 Study Population
The study population consists of the ARIC participants.  As part of the ARIC 
study, 15,792 study participants aged 45 to 64 years were sampled from 4 sites 
throughout the United States, including Forsyth County, North Carolina; Jackson 
Mississippi; Suburban Minneapolis, Minnesota; and Washington County, Maryland.  
At the Jackson site, only African-Americans were sampled.  The study began 
enrolling participants in November 1986 and completed enrollment in late 1989.  
Probability sampling was used in determining the cohorts at each of the four sites.  
In Forsyth County, households were identified by area sampling, in Jackson and 
Washington County those with drivers’ licenses or state identification cards were 
sampled, and in Minneapolis those eligible for jury duty were sampled(1) . 
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3.3 Data Collection
ARIC cohort baseline data were collected from 1987 to 1989.  At baseline, 
participants underwent a home interview and a clinic examination with participation 
rates of 46% for Jackson, and 65-67% for Forsyth County, Minneapolis, and 
Washington County.  The baseline home interview included questions on 
cardiovascular risk factors, family medical history, employment, and education.  
Eligible participants who decided to participate were scheduled for a clinical exam.  
During the clinical exam, informed consent was obtained prior to data collection.  
The clinical exam consisted of an interview and physical exam.  During the interview 
portion, trained ARIC interviewers asked participants questions related to medical 
history and a detailed food frequency questionnaire.  As part of the physical exam, 
anthropometric measurements (weight, height) were taken, blood pressure was 
measured, blood samples were drawn, an electrocardiogram (ECG) was performed, 
pulmonary function was assessed, and a B-mode ultrasound for wall measurements 
in carotids was conducted.  At the end of the exam, the results were shared with the 
participant and any abnormal results were verified and if necessary participants were 
referred elsewhere for diagnosis or treatment (1 -3).
During annual telephone follow-up, interviewers obtained information about 
hospitalizations and medical events within the preceding year.  If the participant had 
been hospitalized, the medical record was obtained and abstracted for information 
related to coronary or cerebrovascular diseases.  If the patient died, the death 
certificate was obtained and reviewed.  Every 3 years participants underwent a 
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clinical exam, which was similar in content to the first exam described above.  
Currently, follow-up data has been collected, processed and made available through 
2002.  Hence, follow-up for this study is through December 31, 2002.
3.3.1 Alcohol Consumption Measurements
Alcohol consumption in the ARIC cohort was measured at visit 1 (baseline) 
and visit 3 (approximately 6 years later, 1993-1995).  As part of the dietary 
questionnaire, participants were asked if they drank alcoholic beverages and if so, 
the type and amount.  A total of five questions related to alcohol consumption were 
asked and included:
1.  Do you presently drink alcoholic beverages?
2.  Have you ever consumed alcoholic beverages?
3.  How many glasses of wine do you usually have per week? (4oz glasses)
4.  How many bottles or cans of beer do you usually have per week? (12oz 
bottles or cans)
5.  How many drinks of hard liquor do you usually have per week? (1.5oz 
shots)
Alcohol intake is then calculated as the reported grams of alcohol consumed per 
week and is a continuous variable.  Since alcohol intake data is available at two 
points in time, both sources of information will be utilized when appropriate.  For 
example, among those who have an event (stroke, hospitalization, death, or loss to 
follow-up) before the third visit, only alcohol intake from visit 1 will be considered.  
Among those who reach visit 3 without having an event, alcohol information will be 
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updated.  Previous work has examined the change in alcohol consumption among 
the ARIC participants between visit 1 and 3 and found that alcohol intake levels 
declined (4).
Based on findings from the literature, alcohol intake estimates are known to 
be underestimates, with self- reports only accounting for 40-60% of alcohol 
purchases (5).  For our analyses we will assume that alcohol underreporting is 
similar among all levels of alcohol consumption.  There is the possibility of doing a 
sensitivity analysis if good estimates of how much underreporting there is by 
differing levels of reported intake are available.
3.3.2 Measurement of Stroke Events
Clinical stroke events were determined by annually contacting all ARIC study 
participants and identifying all stroke hospitalizations and deaths.  Details of stroke 
case ascertainment in the ARIC cohort have been previously published(6) and are 
summarized in Figure 3.1.  Briefly, medical records from hospitalizations with an 
ICD-9 code of 430-438 (cerbrovascular disease) and/or a stroke related keyword in 
the discharge summary or nurses notes were identified and reviewed by a trained 
nurse.  Abstracted data from the medical record included information on neurological 
symptoms, medical history, treatments and therapies, procedures performed, and, if 
deceased, autopsy information.  Based on criteria from the National Survey of 
Stroke, strokes were classified by a computer algorithm into four categories: 
subarachnoid hemorrhage, intracerebral hemorrhage, thrombotic brain infarction, or 
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embolic brain infarction.  Additionally, a physician independently reviewed the 
abstracted data and classified the stroke cases, with disagreements between the 
computer and physician adjudicated by a second physician-reviewer(6).
Validation of stroke events in the ARIC data from 1987 to 1995 indicates that 
of the 1187 identified stroke hospitalizations, 538 of the medical records had 
documentation of neurologic symptoms lasting more than 24 hours.  Of these 538 
hospitalizations, 329 were determined to be definite or probable strokes by the 
physician reviewer and computer algorithm (agreed on 78% of cases, 
kappa=0.71)(6).
The occurrence of a stroke event is defined as a definite or probable 
hospitalized stroke among those with no history of stroke at the time of baseline 
interview.  Those with a previous stroke or an unknown history of stroke will be 
excluded from the analyses.  Although out of hospital fatal strokes are recorded, 
these events are not validated (6), and will also be excluded from the analyses (in 
1995, 4 fatal strokes).
3.3.3 Measurement of Heart Failure
CHF occurrence in the ARIC cohort study was determined by identifying and 
reviewing all hospital discharges with an ICD-9-CM code of 428.xx during annual 
follow-up.  We will exclude those with prevalent heart failure at baseline.  Prevalent 
HF will be defined as either taking HF medication in the two weeks before baseline, 
as having at least 2 of 3 HF symptoms (edema, PND, or orthopnea), or taking 
diuretics or digoxin.  Similar to the method of heart failure ascertainment used by He 
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et al(7), “incident CHF was based on 1 or more hospital or nursing home stays in 
which the participant had a discharge diagnosis with an ICD-9 code of 428.0 to 
428.9 or a death certificate report in which the underlying cause of death was 
recorded using an ICD-9 code of 428.0 to 428.9”.  Currently a paper examining CHF 
ascertainment in the ARIC cohort is under development.  
3.3.4 Measurement of Covariates
For the proposed analyses, potential covariates include socio-demographic 
characteristics, behavioral characteristics, clinical measurements, and comorbid 
conditions.  Socio-demographic characteristics include age, race, gender, and 
education.  Age is calculated as age at first clinic visit.  Race is self-reported as 
African-American, Asian, Native American, white or other.  Highest level of 
educational attainment was collected at the home interview which occurred prior to 
the first clinic visit.  Participants were asked for the highest level of school completed 
which was grouped into grade school, high school but no degree, high school 
graduate, vocational school, college, or graduate/professional school.  From these 
groups, educational status will be further categorized into less than high school, high 
school graduate, some college, or college graduate.
Data on behavioral characteristics of the study participants includes smoking, 
diet, and physical activity.  Smoking and diet information was collected by self-report 
through interview questions.  Participants were asked detailed questions regarding 
use of cigarettes, pipes, and cigars.  The questions asked about ever smoking, how 
old when regular smoking began, current use, average number smoked per day, and 
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if smoke was inhaled (not at all, slightly, moderately, or deeply).  In addition, one 
question asked about use of chewing tobacco, snuff, and nicotine gum (current, 
never, or past user).  In an attempt to ascertain second-hand smoke exposure, non-
smokers were asked to provide the number of hours per week they were in close 
contact with people who were smoking.  The detailed tobacco use questions in the 
ARIC study are invaluable to the proposed study because tobacco use is more 
common among those who drink (8) and smoking is likely a confounder of the 
alcohol and CVD relation.
To obtain estimates of usual dietary intake, study participants were asked 
about their intake of a variety of food items and specified how often they consumed 
each item (number of times per day, number of times per week, number of times per 
month, or almost never).  This interviewer-administered questionnaire obtained 
information on intake of dairy foods (8 questions), fruits (6 questions), vegetables 
(11 questions), meats (13 questions), sweets/baked goods and cereals (13 
questions), non-alcoholic beverages (5 questions), other frequently eaten food, 
products used in cooking activities, and alcoholic beverages.  The questionnaire, a 
modified version of the semiquantitative food frequency questionnaire and 
developed by Willett, was used because it has demonstrated reproducibility and 
validity (9), is brief, and is thought to characterize individual dietary patterns better 
than some other brief questionnaires.
Physical activity data was also collected through participant interviews and 
was composed of questions regarding leisure time, sport and work related activities 
during the past year.  Participants were asked if they played sports or exercised 
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during their time away from work (leisure time) and also about other activities done 
during leisure time (walking, bicycling, watching television).  Interviewers asked 
about sport and exercise activities, asking for the type and frequency (days per week 
and months per year) of activity.  Work related questions asked participants if they 
sit, stand, walk, or lift during work (never, seldom, sometimes, often, very often) and 
if they are physically tired after work.  Also, participants are asked if they sweat at 
work (due to physical exertion) and how they think their work compares physically to 
the work of others at a similar age (much lighter, lighter, as heavy, heavier, or much 
heavier) (3).
Clinical measurements were obtained from study participants at the initial 
clinic visit.  Participants were requested to fast for 12 hours before the initial clinic 
visit, at which point blood was drawn to obtain data on blood lipids and hemostatic 
factors.  Blood lipid measures included total cholesterol, HDL cholesterol, LDL 
cholesterol, triglycerides, lipoprotein(a), HDL2 and HDL3.  Data from the ARIC 
Intraindividual Variability Study found the measures of total cholesterol, HDL 
cholesterol, LDL cholesterol, triglycerides, and lipoprotein(a) to have high reliability 
(R>0.85)(10).  Hemostatic factors such as fibrinogen, plasma factor VII, plasma 
factor VIII, and von Willebrand factor were also included in the ARIC Intraindividual 
Study and were found to have high to intermediate reliability(11).  Blood pressure 
was measured three times following an initial 5-minute rest period.  The last two 
measures were averaged to obtain the blood pressure measurement used for this 
study.  From the blood pressure, hypertension was defined as SBP > 140 mmHg, 
DBP > 90 mmHg, and/or self-report of antihypertensive medication use.  This 
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definition of hypertension is in agreement with the JNC- 6 guidelines for 
hypertension(12).  Participant weight and height were measured during the first clinic 
examination and body mass index was calculated as weight (kg) divided by height in 
meters squared.
Comorbid conditions of the participants were obtained at the baseline 
interview through questions regarding history of illnesses, including diabetes, 
hypertension, valvular heart disease, history of CHD or MI.
3.4 Data Quality
The ARIC study developed detailed policies and procedures to ensure 
standardization of data collection, and staff were trained and certified in data 
collection procedures.  Using a computer-assisted data collection system, data was 
directly entered into computers at each field center by staff while the participant was 
present in order to prevent transcription errors and to correct implausible values(13).  
Selected ultrasound and anthropometric measures were repeated during the exam 
for quality checks.  In addition, duplicate blood samples were drawn and duplicate 
ECGs were transmitted for validation purposes(1).
Issues of data quality related to alcohol intake in the ARIC cohort can be 
divided into: 1) validity and reliability of responses from the participants and 2) 
accuracy of recording information by the ARIC study staff.  How well the 
respondents’ answers correspond to actual alcohol intake in the ARIC cohort has not 
been validated, probably due to the lack of a gold standard for alcohol assessment 
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and no availability of biologic markers to use as proxies for alcohol intake in the 
ARIC cohort.  Also, the reliability of reported alcohol consumption in this cohort has 
not been evaluated.  Numerous other studies have assessed methods for collecting 
data on alcohol consumption (see section 2.4.2 above for a review) and have found 
that ascertainment of alcohol intake via trained interviewer administered 
questionnaire is reliable (14) and that although self- reported alcohol consumption is 
probably an underestimate, this method does a fairly good job of rank ordering levels 
of drinkers.  
To lessen the variation in question interpretation and allow for those less 
literate to better understand the questions, interviewers were trained on research 
interviewing methods and how to complete the form.  In ARIC, the alcohol intake 
questions are close-ended with the interviewer directly entering the responses into 
the computer.  To reduce inter and intra- rater reliability, approximately 5% of the 
interviews done by each interviewer are monitored by supervisory level staff.
Identification of outcomes occurring during follow-up in the ARIC cohort is via 
three sources of data: death certificates, hospital discharge indexes, and annual 
follow-up telephone interviews with the study participants.  The term ‘outcomes’ 
refers to hospitalized MI or stroke, death from CHD, stroke, or any cause, and all
hospitalizations.  Hospital discharge diagnoses are recorded for all hospitalizations 
that occur among the ARIC participants.  These hospitalizations are identified by 
either review of hospital discharge indexes or by annual participant interviews. If a 
study participant were hospitalized outside of the study area and did not inform the 
interviewer of this event, the hospitalization may not be captured in the ARIC study.  
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Once hospitalizations are identified, medical records are abstracted for those 
hospitalizations with ICD-9 codes of 402, 410-414, 427, 428, 518.4, and stroke (430-
438).  Participants are followed annually from the baseline interview until death or 
loss to follow-up.
3.5 Power Calculations 
Since the ARIC study data has already been collected and follow- up is 
available through December 31, 2002, the power to detect a specific difference is 
addressed rather than the question of sample size.  In the ARIC cohort, there were a 
total of 15,792 participants at baseline and with follow-up through December 2002, a 
total of 564 incident stroke events (57 hemorrhagic and 507 ischemic) and 
approximately 1000 CHF hospitalizations.  Based on previously published papers 
from the ARIC dataset which examined alcohol intake(4, 15) and preliminary 
calculations of alcohol intake from the dataset, categorization of study participants 
into never, light/moderate (up to 2 drinks/day for men and up to 1 drink/day for 
women), and heavy (>2 drinks/day for men and >1 drink/day for women) drinkers 
gives estimates of the proportion in each of these groups to be 39.5%, 48.7%, and 
11.7%, respectively.
Table 3.1 shows the magnitude of the risk ratios that can be detected for the 
comparisons of light/moderate with never drinkers and of heavy with never drinkers.  
The significance level for the power calculations in these two tables is set at 95% 
(=0.05).  Using estimates of risk among the unexposed for each of the three 
outcomes (ischemic stroke, hemorrhagic stroke, and HF), the unexposed to exposed 
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ratio, and the maximum number exposed, risk ratios for varying levels of power 
(ranging from 0.7 to 0.9) are calculated.  Table 3.1, for example, indicates that the 
study has 70% power to detect a risk ratio of 1.31 or 0.71 in the comparison of 
ischemic stroke risk among light/moderate versus never drinkers.  
3.6 Plan of Analysis 
The ARIC Coordinating Center cleaned and edited the data prior to release.  
As part of this project, each variable was examined for missing values, implausible 
values, and other inconsistencies.  Prior to data analysis for this project, additional 
data checks will be implemented and will include examination of the distributions of 
analytic variables using tables and graphs.
The analyses will be limited to study participants who are African-American or 
white (>99% of the ARIC population) because of the small number of events 
occurring in the other race groups.  Additionally, those participants with missing 
information on alcohol consumption will be excluded from the analysis since this 
variable is the main exposure of interest.  While imputation methods reduce the loss 
of power associated with deleting those with missing information, imputation 
techniques require assumptions about the data and can be difficult to implement.  
Currently, no analytic ARIC dataset with imputed values for missing data exists and 
the proportion of data missing in the ARIC cohort is minimal.   Thus, complete case 
analysis is an appropriate choice (16) and will be used in this project.
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3.6.1 Alcohol Consumption and Stroke Incidence
Specific Aim 1:  Examine the relation and association between alcohol 
consumption and stroke incidence among African-American and white men and 
women ages 45-64 years at baseline (the ARIC study participants) during an 
average follow-up of 11 years.
Hypothesis 1: The association between alcohol consumption and 
ischemic stroke incidence varies according to the level of alcohol consumed.  
Using never drinkers as the referent group, there is an inverse association 
between alcohol intake and ischemic stroke incidence among light to 
moderate drinkers and there is a positive association between heavy 
consumption and ischemic stroke incidence.
• To assess the association of varying levels of alcohol intake and ischemic 
stroke risk, alcohol intake will be categorized.  Although there are 
numerous ways in which alcohol intake could be categorized (percentiles, 
predetermined cut points, dichotomized), we will base our categorization 
on the AHA recommendations/ guidelines.  The guidelines categorize 
alcohol intake into never, former, light/moderate (<2 drinks/day for men 
and <1 drink/day for women), and heavy drinkers (>2 drinks/day for men 
and >1 drink/day for women). Since alcohol consumption levels may 
change over time, both alcohol measurements (obtained at visit 1 and visit 
3) will be incorporated in the analyses.  A pooled method similar to that 
used by Djousse et al. (17) will be used to create two 6-year 
nonoverlapping follow-up periods (from visit 1 to visit 3 and from visit 3 
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onwards).  Alcohol intake at the beginning of each period will be used as 
the exposure. Thus, each subject can contribute 1 or 2 observations, 
depending on if and when a stroke occurred.  Follow-up time will be 
calculated as the time from the beginning of each follow-up period to 
stroke occurrence, death, loss to follow-up, or the end of the 6-year 
period.  
• Descriptive statistics of the population (sociodemographic characteristics) 
by categories of alcohol intake will be calculated to ascertain if the groups 
of alcohol consumers are different.
• Crude and adjusted ischemic stroke incidence rates by level of alcohol 
consumption will be calculated using Poisson regression.  Poisson 
regression is used for modeling incidence rates for rare outcomes and is 
thus preferred over survival analysis which is more appropriate when the 
disease is more common (16).  From the Poisson regression models, we 
will calculate incidence rate ratios (IRR) with 95% confidence intervals, 
using the never drinkers as the reference category.
• The identification and evaluation of potential confounding factors will 
involve several steps.  To be a confounder the covariate should be 1) 
associated with stroke incidence, 2) be associated with alcohol 
consumption, and 3) not be affected by alcohol(16).  A directed acyclic 
graph (DAG) has been drawn to represent the relations between 
exposure, disease, and covariates (Figure 3.2) and this drawing will be 
used to identify potential confounding factors (18).  DAGs are graphical 
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representations of subject matter knowledge and indicate how the 
variables are related (19).  Arrows in the diagram indicate possible causal 
relations and missing arrows indicate no causal relation (19).  Creating 
DAGs is useful for helping to determine which variables are potential 
confounders and should be included in the analysis (18).  In DAGs, 
unblocked backdoor paths represent confounding.  To identify unblocked 
paths between alcohol (E) and stroke (D), arrows that originate from E are 
removed and all remaining paths between E and D are documented.  
Paths that are not blocked by a collider are identified and the variables on 
unblocked paths are candidates for adjustment.  In Figure 3.2 (the DAG of 
the alcohol-stroke risk relation), adjustment for A will block all paths 
between E and D.  Thus age, race, gender, and socioeconomic status 
should be considered as potential confounding factors.
Hypothesis 2: There is a positive association between alcohol intake 
and hemorrhagic stroke incidence.  Compared with never drinkers, those 
consuming light to moderate amounts will have increased rates of 
hemorrhagic stroke and those consuming heavy amounts will have even 
higher hemorrhagic stroke rates.  
• Alcohol intake will be categorized according to the methods outlined in 
hypothesis 1.1 above.  
• Descriptive statistics of the population (sociodemographic characteristics) 
by categories of alcohol intake will be calculated to ascertain if the groups 
of alcohol consumers are different. 
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• Crude and adjusted hemorrhagic stroke incidence rates by level of alcohol 
consumption will be calculated using Poisson regression. Follow-up time 
is measured as detailed above.  From the Poisson regression models, 
incidence rate ratios (IRR) will be calculated and precision will be 
estimated with 95% confidence intervals. 
• Evaluation of confounding will be conducted using DAGs, similar to that 
described for ischemic stroke in hypothesis 1.1.  
Hypothesis 3:  The alcohol and stroke relations found in hypotheses 1 and 2 
above do not differ by race. 
• The crude and age-adjusted rates, as well as the Poisson regression 
models will be stratified by race.  This will generate estimates of the 
incidence rates and incidence rate ratios separately for blacks and whites.  
3.6.2 Alcohol Consumption and Heart Failure Incidence
Specific Aim 2:  Describe and evaluate the association between alcohol 
consumption and heart failure (HF) hospitalizations among African-American and 
white men and women ages 45-64 years at baseline (the ARIC study participants)
during an average follow-up of 11 years.
Hypothesis 1:  Compared with never drinkers, there is an inverse 
association between alcohol intake and HF incidence among those who 
consume light to moderate amounts of alcohol and there is a positive 
association for those who consume heavy amounts of alcohol.
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• To compare these results with the AHA alcohol consumption guidelines, 
alcohol will be categorized using the categories outlined in the guidelines 
and described above.  Although the induction time for alcohol to cause HF 
hospitalization is unknown, we hypothesize that changes in alcohol intake 
during the study are sufficient to effect HF hospitalization rates.  Hence, 
alcohol measured at baseline and visit 3 will be incorporated as 
exposures.
• Descriptive statistics of the population (sociodemographic characteristics) 
by categories of alcohol intake and time period will be calculated to 
ascertain if the groups of alcohol consumers are different.
• Crude and age-adjusted HF incidence rates by level of alcohol 
consumption will be calculated using Poisson regression. 
• From the Poisson regression models, we will calculate incidence rate 
ratios (IRR) with 95% confidence intervals, using the never drinkers as the 
reference category.
• A directed acyclic graph approach will be will be used to identify potential 
confounding factors.  The DAG representing the relation between alcohol 
and HF hospitalization can be found in Figure 3.3.  According to this 
graph, the variables which should be included as potential confounders 
are age, race, gender and socioeconomic status.
Hypothesis 2:  The association between alcohol intake and HF incidence 
does not differ by race.
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• The crude and age-adjusted rates, as well as the Poisson regression 
models will be stratified by race.  This will allow for comparisons of the 
incidence rates and incidence rate ratios separately for blacks and whites.  
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Table 3.1: Estimated power to detect risk ratios comparing drinking groups with never drinkers with alpha=0.05*
Group
(vs. never)
Ischemic 
stroke risk 
among unexp
Hemorrhagic 
stroke risk 
among unexp.
HF risk 
among un-
exposed
Unexposed: 
Exposed
Ratio
Maximum 
Number 
Exposed
RR Power
Light/mod. 3 per 100 n/a n/a 0.81 7305 0.77 0.70
Light/mod. 3 per 100 n/a n/a 0.81 7305 0.74 0.80
Light/mod. 3 per 100 n/a n/a 0.81 7305 0.70 0.90
Light/mod. n/a 4 per 1000 n/a 0.81 7305 1.81 0.70
Light/mod. n/a 4 per 1000 n/a 0.81 7305 1.93 0.80
Light/mod. n/a 4 per 1000 n/a 0.81 7305 2.09 0.90
Light/mod. n/a n/a 7 per 100 0.81 7305 0.84 0.73
Light/mod. n/a n/a 7 per 100 0.81 7305 0.83 0.83
Light/mod. n/a n/a 7 per 100 0.81 7305 0.80 0.91
Heavy 3 per 100 n/a n/a 3.4 1755 1.41 0.70
Heavy 3 per 100 n/a n/a 3.4 1755 1.48 0.81
Heavy 3 per 100 n/a n/a 3.4 1755 1.56 0.91
Heavy n/a 4 per 1000 n/a 3.4 1755 2.25 0.70
Heavy n/a 4 per 1000 n/a 3.4 1755 2.46 0.80
Heavy n/a 4 per 1000 n/a 3.4 1755 2.76 0.90
Heavy n/a n/a 7 per 100 3.4 1755 1.26 0.71
Heavy n/a n/a 7 per 100 3.4 1755 1.30 0.82
Heavy n/a n/a 7 per 100 3.4 1755 1.34 0.90
* Based on calculations from EpiSheet, available at http://members.aol.com/krothman/episheet.xls
Calculations assume 15000 participants, with 39.5% never drinkers, 48.7% light/moderate drinkers, and 11.7% 
heavy drinkers.  For females, estimate that 45% are never, 50% are light/moderate, and 5% are heavy alcohol 
consumers.  For males, estimate that 35% are never, 45% are light/moderate, and 20% are heavy alcohol 
drinkers.
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Figure 3.1:  Stroke Case Ascertainment Diagram
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ongoing community hospital 
surveillance, 1987-1999
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Medical record abstraction
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Computerized diagnostic 
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type, or fatal out-of-hospital
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Figure 3.2: Directed Acyclic Graph (DAG): Alcohol Consumption and Cerebrovascular 
Disease
A
B C
DE
F
GU
H
A:  Sociodemographic characteristics including age, race, gender, and socioeconomic status.
B:  Dietary factors including intake of cholesterol, saturated fat, and antioxidants.
C:  Lifestyle factors including smoking and physical activity, stress.
D:  Disease – ischemic or hemorrhagic stroke.
E:  Exposure – alcohol intake.
F:  Comorbid conditions including diabetes, hypertension, atrial fibrillation, and TIA.
G:  Genetic factors.
H:  Biologic measures including HDL, LDL, blood pressure, fibrinogen, insulin sensitivity, etc.
U:  Unidentified factors.
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Figure 3.3:  Directed Acyclic Graph (DAG): Alcohol and Heart Failure
E
C
A
D
F
H
A:  Sociodemographic characteristics including age, race, gender, and socioeconomic status.
B:  Dietary factors including intake of cholesterol, saturated fat, and antioxidants.
C:  Lifestyle factors including smoking and physical activity, stress.
D:  Disease – hospitalization for congestive heart failure (CHF).
E:  Exposure – alcohol intake.
F:  Comorbid conditions including diabetes, hypertension, atrial fibrillation, and TIA.
G:  Genetic factors.
H:  Biologic measures including HDL, LDL, blood pressure, fibrinogen, insulin sensitivity, etc.
I:  Previous myocardial infarction
J:  Heart disease
U:  Unidentified factors.
B
G
JI
U
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CHAPTER 4
Alcohol Consumption and Stroke Incidence in the Atherosclerosis Risk in 
Communities (ARIC) Study, 1987-2002
4.1 Introduction
In the U.S., an estimated 500,000 new strokes occur every year and the expected 
cost of stroke in 2006 is $57.9 billion (1).  Risk factors for stroke include transient 
ischemic attack, smoking, hypertension, diabetes, female gender, and non-white 
race (1-4).  While controversial, alcohol has been identified as a possible risk factor 
for stroke.  The relationship between alcohol consumption and stroke occurrence 
has been under investigation for decades although no clear association has been 
established.  Previous studies have found differing results for ischemic and 
hemorrhagic strokes (reviewed in Reynolds et al (5)).  For ischemic stroke, the 
evidence for increased stroke rates among heavy drinkers has been fairly consistent 
(6-9) but the data for light to moderate drinkers has been inconclusive, reporting 
either no association (10-14) or a protective effect (8, 15, 16).  In contrast, studies of 
hemorrhagic stroke incidence have found either an increase in stroke rates with 
increasing amounts of alcohol consumption (6, 16-20) or no association between the 
two (11, 15, 21). 
Stroke incidence rates are twice as high for blacks as for whites (1).  The 
majority of previous U.S. studies examining the alcohol and stroke association have 
focused on white populations (10, 15, 16).  Few studies have examined the 
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alcohol/stroke relationship among blacks (22).  The Atherosclerosis Risk in 
Communities (ARIC) study is a large prospective cohort study that includes 
significant numbers of blacks and can therefore be utilized to study the effect of 
alcohol intake on stroke incidence among racial groups.  The aim of this study is to 
evaluate the role of alcohol intake on ischemic and hemorrhagic stroke incidence 
among a middle-aged cohort of black and white men and women in the U.S.  
4.2 Methods
Study Population and Design
The ARIC study is a prospective cohort study of 15,792 men and women ages 45 to 
64 years of age from 4 U.S. communities. Details of the ARIC study have been 
previously published (23).  At the initial visit (from 1987-1989), participants were 
interviewed at home and underwent a physical examination. During annual 
telephone follow-up, interviewers obtained information about hospitalizations and 
medical events within the preceding year.  Additionally, more in-depth visits were 
conducted every 3 years when participants underwent a clinical exam consisting of 
an interview and physical exam (Figure 4.1).  Information collected at visit 1 is from 
1987-1989, visit 2 is from 1990-1992, and visit 3 is from 1993-1995.  Follow-up data 
is available through 2002.
Of the 15,792 study participants, we excluded those who were non-white and non-
black (n=48) and those who had prevalent coronary heart disease or a history of 
stroke at the initial visit (n=1,352).  Participants who did not provide information on 
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alcohol intake at a specific visit were excluded from the analysis for that visit (78 at 
visit 1 and 120 at visit 3) as were participants who had missing covariate information 
at the time of the study visit (347 at visit 1 and 355 at visit 3).  The covariates 
considered were age, race, sex, education, smoking, diabetes, hypertension, low 
density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, 
triglycerides, physical activity, and body mass index.  For the visit 3+ data, we 
excluded an additional 2,554 participants who either had a stroke event, died, or 
were lost to follow-up before the visit 3 date.  A total of 13,967 participants were 
included in the visit 1-visit 3 time period and 11,363 participants were included in the 
visit 3+ time period.
Alcohol Consumption
Alcohol consumption in the ARIC cohort was measured at visit 1 (1986-1989) and at 
visit 3 (1993-1995).  As part of the dietary questionnaire, participants were asked if 
they drank alcoholic beverages and if so, the type and amount.  A total of five 
questions related to alcohol consumption were asked and included:  Do you 
presently drink alcoholic beverages?  Have you ever consumed alcoholic 
beverages?  How many 4-ounce glasses of wine do you usually have per week?  
How many 12-ounce bottles or cans of beer do you usually have per week?  How 
many drinks of hard liquor (1.5-ounce shots) do you usually have per week?
We calculated the amount of ethanol consumed using the following:  one glass of 
wine = 10.8 g alcohol, one bottle/can of beer = 13.2 g alcohol and one 1.5 ounce 
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shot of liquor = 15.1 g alcohol.  The amount reported on a weekly basis was 
summed and divided by seven to obtain a daily estimate of alcohol consumed in 
grams.  One drink was defined as 13 grams/day (the average alcohol contents of 
one glass of wine, one can of beer, and one 1.5oz shot of liquor).  We then 
categorized alcohol consumption into never drinkers (reported never consuming 
alcoholic beverages), former drinkers (reported previously drinking alcoholic 
beverages, but not currently drinking), occasional drinkers (reported presently 
drinking alcohol but the usual amount consumed per week was zero), light to 
moderate drinkers (reported presently drinking up to 1 drink per day for women and 
up to 2 drinks per day for men), and heavy drinkers (reported presently drinking 
more than 1 drink per day for women and more than 2 drinks per day for men).  
These categories of alcohol consumption were chosen in an attempt to create 
groups of participants with similar levels of exposure.  Specifically, former drinkers 
are likely to be different than never drinkers in that former drinkers may have 
stopped drinking for health reasons and may thus be sicker than never drinkers.  
Also, the group of occasional drinkers consists of those who drink but do not do so 
on a regular basis which is likely to be a different pattern of alcohol consumption 
than that of light/moderate drinkers.
Stroke Occurrence
Clinical stroke events were identified by annually contacting all ARIC study 
participants and by reviewing hospitalization discharge summaries and death 
records in the geographic locations surrounding the study areas.  Details of stroke 
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case ascertainment in the ARIC cohort have been previously published (24).  Briefly, 
medical records from hospitalizations with an ICD-9 code of 430-438 
(cerebrovascular disease) and/or a stroke related keyword in the discharge 
summary or nurses notes were identified and reviewed by a trained nurse.  Data 
from medical records were then abstracted.  The abstracted data included 
information on neurological symptoms, medical history, treatments and therapies, 
procedures performed, and, if deceased, autopsy information.  Based on criteria 
from the National Survey of Stroke, strokes were classified by a computer algorithm 
into four categories: subarachnoid hemorrhage, intracerebral hemorrhage, 
thrombotic brain infarction, or embolic brain infarction.  In addition, a physician 
independently reviewed the abstracted data and classified the stroke cases, with 
disagreements between the computer and physician adjudicated by a second 
physician-reviewer.
Covariate Assessment
Covariate information for each participant was assessed at visit 1 and updated at 
visit 3 if the participant was still involved in the study.  Participant age was defined as 
the age at the visit date.  Race was based on self- reported information and was 
either black or white.  Gender was male or female.  Study center was defined as 1 of 
the 4 study sites: Forsyth County NC, Jackson MS, Minneapolis MN, or Washington 
County MD.  Socioeconomic status was based on the highest self-reported 
educational level achieved and was categorized into less than high school graduate, 
high school graduate, or greater than high school graduate.  Smoking was classified 
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as current, previous or never as reported by the participant at the time of the visit.  
Body mass index was calculated by dividing weight (in kg) by height (in meters 
squared) and was categorized into normal (<25.0), overweight (25.0 – 29.9), and 
obese (30.0+).  Physical activity was assessed using the modified Baecke leisure 
time index which includes measures of walking and biking either as a leisure activity 
or as a mode of transportation to work or shopping, along with time spent watching 
television (25, 26).  Physical activity was categorized into quartiles.  Diabetes was 
dichotomized into a yes/no variable, with participants whose fasting blood glucose 
level was > 126mg/dL at the time of the visit classified as having diabetes.  
Hypertension was also dichotomized, with those patients who had systolic blood 
pressure > 140 at the study visit or diastolic blood pressure > 90 at the study visit or 
who had taken blood pressure medication in the last 2 weeks classified as being 
hypertensive.  Cholesterol measures included LDL-cholesterol (mg/dL), HDL-
cholesterol (mg/dL), and triglycerides (mg/dL) as measured at the time of the visit.  
Participants with LDL-cholesterol levels > 100mg/dL were determined to have high 
LDL-cholesterol, participants with HDL-cholesterol levels <40 mg/dL were classified 
as having low HDL-cholesterol, and participants with triglyceride levels > 150 mg/dL
were classified as having high triglycerides.  To account for the fact that these 
covariates change over time, we incorporated data from visit 1 and visit 3.
Statistical Analyses
Stroke incidence rates were calculated as the number of stroke events divided by 
the person-time of follow-up.  Since participants could contribute 1 or 2 observations 
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to the study, each person-visit combination was treated as an observation.  For 
participants with visit 1 data, the follow-up time was calculated as the number of
days from visit 1 until first stroke occurrence, death, loss to follow-up, or visit 3 date 
(whichever came first).  For participants with visit 3 data who did not have a stroke 
before visit 3, follow-up time was calculated as the number of days from visit 3 until 
stroke occurrence, death, loss to follow-up, or December 31, 2002.  Because time at 
risk stopped accruing once a stroke occurred (regardless of the type), the follow-up 
time is the same for all strokes, ischemic strokes, and hemorrhagic strokes.  If a 
participant experienced more than one event, only the first event was included in the 
analysis.  For example, if a participant had an ischemic stroke on 1/1/1995 and 
subsequently had a hemorrhagic stroke on 1/1/1997, only the ischemic stroke event 
is considered.  Incidence rates by alcohol intake levels and visit were calculated for 
all, ischemic, and hemorrhagic strokes separately for the entire cohort and 
separately for blacks and whites.  
Poisson regression multivariate rate ratios (RRs) were estimated to compare 
differing levels of alcohol consumption on stroke incidence.  The outcomes of all 
stroke, ischemic stroke, and hemorrhagic stroke were examined separately.  We 
stratified the results by race to assess if differences existed.  Never drinkers were 
the reference group in all models.  Potential confounders included age, gender, race, 
study center, educational level, body mass index, physical activity, smoking status, 
lipid measurements, and comorbid conditions (diabetes, hypertension).  We 
determined which covariates to include in the models using a directed acyclic graph 
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(DAG) approach (27) (see Appendix for DAG).  The covariates in the minimally 
adjusted models include age, race, sex, and socioeconomic status.  The fully 
adjusted models include covariates in the minimally adjusted model plus smoking, 
physical activity, ARIC study center, body mass index, and diabetes.
All analyses were performed using SAS v8 software (SAS Institute, Cary NC).
4.3 Results
The person-time contributions by covariates and alcohol intake levels for visit 1-3 
and visit 3+ are shown in Table 4.1.  During the visit 1-3 time period, the 13,967 
participants contributed 94,859 person-years (P-Y) of observation, of which 25% 
(24,138P-Y) were among never drinkers, 19% (17,587P-Y) were among former 
drinkers, 17% (16,507P-Y) were among occasional drinkers, 29% (27,506P-Y) were 
among light/moderate drinkers, and 10% (9,121P-Y) were among heavy drinkers.  A 
similar distribution of person-time is evident for the visit 3+ time period.
During the time period from visit 1 to visit 3, the proportion of person-time 
contributed to the never drinking category was similar for blacks and whites (11,720 
person-years for blacks and 12,418 person-years for whites).  Within each of the 
other 4 alcohol consumption categories, the proportion of person-time was higher for 
whites than it was for blacks.  Females contributed more person-time to the never 
and occasional groups and less time to the light/moderate or heavy group as 
compared with males.  Those participants with more than a high school education 
contributed more person-time to the occasional, light/moderate, and heavy drinking 
categories than did those with a high school degree or less.  Participants from 
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Minneapolis MN had higher proportions of person-time in the categories of current 
drinkers (occasional, light/moderate, and heavy) versus participants from the other 3 
study centers.  
In looking at smoking status, the largest proportion of person-time for never 
drinkers was among never smokers during visit 1 to 3 and after visit 3 (never 
smokers made up 68% of the never drinkers between visit1 and 3 and 71% following 
visit 3).  During the time between visit 1 and 3, 48% of person-time for heavy 
drinkers was among current smokers but after visit 3 that percentage was 34%.  
The mean HDL-cholesterol levels ranged from 49.5mg/dL to 60.6mg/dL 
during the visit1 to visit 3 time period and from 49.2mg/dL to 58.3 mg/dL during the 
visit 3+ time period.  The highest HDL-cholesterol levels were seen among the 
heavy drinkers.  
There were 226 strokes of all kinds between visits 1 and 3 and 313 strokes 
after visit 3 (Table 4.2).  From visit 1 to 3, 190 ischemic strokes occurred and after 
visit 3 there were 270 ischemic strokes.  The crude incidence rates (IR) per 100,000 
P-Y for all strokes were 238 from visit 1 to 3 and 342 after visit 3.  After adjusting for 
age, the incidence rates per 100,000 P-Y for all strokes were 228 between visit 1 
and 3 and 370 after visit 3.  From visit 1 to 3 the age-adjusted all stroke incidence 
rates by level of alcohol intake were highest for former drinkers (IR=311 per 100,000 
P-Y) and lowest for occasional drinkers (IR=152 per 100,000 P-Y).  After the 3rd visit, 
the age-adjusted IR were highest for heavy drinkers (IR=542 per 100,000 P-Y) and 
lowest for occasional drinkers (IR=244 per 100,000 P-Y).  The incidence rates for 
ischemic stroke were lower than those for all stroke, with crude ischemic rates of 
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200 per 100,000 P-Y between visit 1 and 3 and 295 per 100,000 P-Y following visit 
3.  Similar patterns of incidence rates by levels of alcohol intake were observed for 
ischemic stroke as for all stroke.  
There were 19 cases of hemorrhagic stroke between visits 1 and 3 and 30 
cases after visit 3.  The age adjusted incidence rates for hemorrhagic stroke were 20 
per 100,000 P-Y between visits 1 and 3 and 32 per 100,000 P-Y after visit 3.  The 
age-adjusted hemorrhagic stroke incidence rates by level of alcohol intake ranged 
from 12 per 100,000 P-Y among occasional drinkers to 34 per 100,000 P-Y among 
heavy drinkers during the visit 1 to 3 time period.  Age-adjusted hemorrhagic stroke 
incidence rates after visit 3 ranged from 19 per 100,000 P-Y for light/moderate 
drinkers to 90 per 100,000 P-Y among heavy drinkers.
Table 4.3 shows the results of stratifying the crude and age-adjusted all and 
ischemic stroke incidence rates by race.  The age-adjusted all stroke incidence rates 
among whites are lowest for light/moderate drinkers (IR=123 per 100,000P-Y) and 
highest for former drinkers (IR=188 per 100,000 P-Y) during the time period from 
visit 1 to visit 3.  After visit 3, the age-adjusted all stroke incidence rates among 
whites are lowest for occasional drinkers (IR=198 per 100,000 P-Y) and highest for 
heavy drinkers (IR=479 per 100,000 P-Y).  Among blacks in the visit 1 to 3 time 
period, the all stroke age-adjusted incidence rates are lowest among never drinkers 
(IR=342 per 100,000 P-Y) and the highest among heavy drinkers (IR=717 per 
100,000 P-Y).  Following visit 3, the age-adjusted IR was highest among occasional 
drinkers (IR=944 per 100,000 P-Y) and lowest among heavy drinkers (IR=506 per 
100,000 P-Y).
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Crude and adjusted rate ratios (RRs) with 95% confidence intervals for all, 
ischemic, and hemorrhagic strokes are shown in Table 4.4.  The crude RRs for all 
stroke showed an inverse association for occasional drinkers (RR=0.57, 95%CI: 
0.42-0.77) and light/moderate drinkers (RR=0.74, 95%CI: 0.59-0.94) as compared 
with never drinkers.  After adjustment for age, race, sex, and socioeconomic status 
the RRs were attenuated (comparing occasional with never drinkers RR=0.91, 
95%CI: 0.67-1.25 and light/moderate with never drinkers RR=0.99, 95%CI: 0.77-
1.28).  Further adjustment for study center, smoking status, diabetes, and leisure 
activity did not have much impact on the RRs.  Results for ischemic stroke were 
similar to those found for all stroke.  The crude RRs for ischemic stroke comparing 
occasional drinkers with never drinkers and light/moderate drinkers with never 
drinkers showed an inverse association (RR=0.50 95%CI: 0.36-0.70 and RR=0.74, 
95%CI: 0.58-0.95, respectively).  Adjusting the models for potential confounders 
attenuated the RRs.  The crude RRs for hemorrhagic stroke were 1.16 (95%CI: 
0.51, 2.63) for former drinkers, 1.13 (95%CI: 0.48, 2.69) for occasional drinkers, 0.74 
(95%CI: 0.32, 1.71) for light/moderate drinkers, and 1.67 (95%CI: 0.66, 4.25) for 
heavy drinkers, as compared with never drinkers.  Adjustment for age, race, sex, 
and socioeconomic status resulted in an increase in the RRs. 
The results of stratifying the Poisson regression models by race are 
presented in Table 4.5.  The minimally adjusted RRs for whites and all stroke are 
1.15 for former drinkers, 1.03 for occasional drinkers, 0.86 for light/moderate 
drinkers, and 1.37 for heavy drinkers compared with never drinkers.  The minimally 
adjusted RRs for blacks and all stroke are 1.07 for former drinkers, 0.54 for 
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occasional drinkers, 1.29 for light/moderate drinkers, and 1.35 for heavy drinkers 
compared with never drinkers.  The results for ischemic stroke are similar to those 
for all stroke.  Results for hemorrhagic stroke by race are not shown because of the 
small number of hemorrhagic stroke events.
4.4 Discussion
In this study of the ARIC cohort, we found no compelling evidence that occasional or 
light to moderate alcohol intake reduces stroke incidence rates.  The unadjusted 
RRs suggest an inverse association between occasional drinking and all stroke or 
ischemic stroke and between light/moderate drinking and all stroke or ischemic 
stroke among the entire cohort.  However, adjustment for confounding factors 
attenuates the association, suggesting that the underlying distribution of covariates 
varies across levels of alcohol intake.  The minimally adjusted stratified results 
indicate a positive association for whites between heavy alcohol intake and all stroke 
incidence as well as between heavy alcohol intake and ischemic stroke incidence.  
Among blacks, light to moderate alcohol intake is associated with increased all 
stroke incidence.  These results indicate that light/moderate alcohol consumption 
may have different effects on all and/or ischemic stroke incidence among blacks and 
whites.  The adjusted RRs examining alcohol intake and hemorrhagic stroke 
incidence suggest that any level of alcohol intake increases hemorrhagic stroke 
incidence rates.
Our results agree with previous studies that found that heavy alcohol intake 
increases ischemic stroke incidence rates among whites (6-9) and that 
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light/moderate alcohol intake is not associated with ischemic stroke in whites (10-14, 
28, 29).  Both the Framingham Heart Study (10) and the Health Professionals 
Follow-up Study (28) reported no reduction in ischemic stroke incidence among light 
to moderate drinkers.  
Our findings differ from studies that found a reduction in stroke incidence for 
light/moderate drinkers compared with non-drinkers. In the Nurses’ Health Study, a 
prospective cohort study of white females, alcohol intake of up to 1.2 drinks per day 
lowered ischemic stroke incidence (16).  Several case-control studies have also 
reported moderate alcohol consumption to be beneficial in ischemic stroke 
occurrence (9, 30).  A meta-analysis of 35 studies found that consumption of 1 drink 
(12 g) per day as compared with no drinks per day had an inverse association with 
all stroke (RR=0.80, 95%CI:0.67-0.96) and with ischemic stroke (RR=0.83, 95%CI: 
0.75-0.91) (5).  
It is not surprising that study results vary, given the differences in study designs, 
method of alcohol ascertainment, definitions for levels of alcohol intake, definitions 
for stroke occurrence, selection of study participants, characteristics of study 
populations, and adjustment for confounding factors.  Cohort and case-control study 
designs have been used to examine the association between alcohol and stroke 
occurrence.  While prospective cohort studies have the advantage of allowing for 
exposures to be assessed prior to disease occurrence, case-control studies are 
valuable when the outcome is rare, as is the case with hemorrhagic stroke. The 
methods of alcohol intake ascertainment and the categorization of alcohol intake 
between studies make comparisons highly problematic.  Alcohol can be assessed by 
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self-report or proxy respondent and can be obtained by interview or questionnaire. 
No gold standard for measuring alcohol intake exists.  Additionally, categorization of 
alcohol intake is not standardized with values for light, moderate, and heavy alcohol 
intake fluctuating across studies.  Methods for determining stroke occurrence also 
vary by study, with some studies relying solely on ICD-9 codes and other studies 
using abstracted medical records or contacting study participants.  Studies also 
differ in terms of the method of selection for the study population with some studies 
following participants over time and others selecting participants based on stroke 
occurrence.  The study population for each study is unique and thus comparisons 
across studies and generalizations to larger populations may be challenging if there 
are gender, racial, or geographic differences. 
This study has several strengths.  The ARIC study is prospective with alcohol 
consumption information was collected prior to stroke occurrence, eliminating the 
possibility of recall bias.  Also, strokes were ascertained by annually contacting 
participants and by searching hospital discharge files and death certificates.  We did 
not rely solely on administrative data sources.  Instead, possible stroke cases were 
reviewed by a physician for validation and were classified into stroke subtypes.  
Another strength of the study is our ability to incorporate changes in alcohol intake 
over time.  Alcohol consumption patterns are known to change over time (31), so 
updating alcohol information is important.  Other studies have used a referent group 
of current non-drinkers, which consists of both never drinkers and former drinkers.  
Since former drinkers may have stopped drinking for health reasons (32), selecting a 
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referent group of never drinkers allows for a more homogeneous referent group and 
is thus preferred.
A limitation of the study is the method of alcohol assessment.  Alcohol intake 
was measured by self-report and studies examining the validity and reliability of 
alcohol consumption reports have shown that it is typically an underestimate (33-37).  
Since alcohol intake was measured before the event, any misclassification of alcohol 
is likely nondifferential (38).  Also, HDL-cholesterol, which has been shown to 
increase with alcohol intake, was highest among the heavy drinkers and lowest 
among the former drinkers suggesting that our measure of alcohol consumption is 
valid.
A major advantage of the ARIC cohort is the inclusion of a large number of 
minority participants.  In the entire ARIC cohort, 72.7% are white, 27.0% are black, 
and 0.3% are other races.  The Northern Manhattan Study examined ischemic 
stroke and alcohol intake among whites, blacks and Hispanics.  This study found an 
inverse association between recent moderate alcohol consumption (at least 1 drink 
per month and no more than two drinks per day) and ischemic stroke incidence 
among Hispanics but not among blacks (22).  Few studies have addressed the black 
population, despite the fact that this group has stroke incidence rates that are twice 
that of whites(1).  Our results suggest that compared with no alcohol intake, 
light/moderate alcohol consumption may increase stroke incidence rates among 
blacks.
Additional studies examining the role of alcohol intake on stroke incidence 
among blacks are warranted.  Current AHA guidelines state that for those who drink 
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alcohol, to do so in moderation (up to one drink/day for women and up to two 
drinks/day for men) and that drinking more than this may increase stroke risk (2).  
While heavy alcohol intake appears to increase overall stroke incidence, the 
perceived benefit of light to moderate alcohol intake may not apply to all populations.  
Since the AHA recommendations are based on results of studies with few minority 
groups, the guidelines should be reconsidered or at least conveyed with caution.  
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Figure 4.1:  Timeline of the ARIC Cohort Participant Evaluations
Date:  1987 1990 1993 1996 1999 2002
Visit 1 Visit 2 Visit 3
Initial Visit:
- home interview
- physical exam
Annual telephone interview:
- hospitalizations or medical events in the preceding year
Subsequent Visits:
- clinic interview
- physical exam
Figure Legend:  ARIC participants were enrolled from 1987-1989 and had an initial visit 
which consisted of a home interview and a physical exam (represented by the single 
broken arrow).  Participants were then contacted annually by telephone and asked about 
any hospital visits or medical events in the prior year (represented by the solid arrows).  
Approximately every three years, participants underwent a subsequent visit at which point 
they underwent an in-clinic interview and a physical exam (represented by the two dotted 
arrows).  The last point of follow-up for the study is the end of 2002.
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Table 4.1:  Person-time contributions in years (%) by covariates, alcohol intake levels*, and visit  
Visit 1-3 
Total
94,859 P-Y 
Never
24,138 P-Y 
Former
17,587 P-Y 
Occasional
16,507 P-Y 
Light/Mod
27,506 P-Y 
Heavy
9,121 P-Y 
Race
   Black
   White
26,088 (28)
68,769 (72)
11,720 (49)
12,418 (51)
5,972 (34)
11,614 (66)
1,406 (9)
15,101 (91)
5,296 (19)
22,210 (81)
1,694 (19)
7,426 (81)
Gender
  Female
  Male
54299 (57)
40,560 (43)
18,926 (78)
5,212 (22)
8,774 (50)
8,813 (50)
11,293 (68)
5,214 (32)
11,420 (42)
16,086 (58)
3,886 (43)
5,235 (57)
Education
<HS
 HS graduate
>HS
22,570 (24)
30,788 (32)
41,503 (44)
7,920 (33)
8,216 (34)
8,003 (33)
6,539 (37)
5,215 (30)
5,833 (33)
2,291 (14)
6,033 (37)
8,184 (50)
4,209 (15)
8,272 (30)
15,025 (55)
1,611 (18)
3,052 (33)
4,458 (49)
Center
  NC
  MS
  MN
  MD
24,523 (26)
22,620 (24)
24,543 (26)
23,174 (24)
6,571 (27)
10,935 (45)
1,078 (4)
5,554 (23)
4,384 (25)
4,902 (28)
3,034 (17)
5,267 (30)
5,119 (31)
857 (5)
6,399 (39)
4,133 (25)
6,218 (23)
4,553 (17)
10,626 (39)
6,110 (22)
2,231 (24)
1,373 (15)
3,406 (37)
2,110 (23)
Smoking
  Never
  Former
  Current
39,582 (42)
29,484 (31)
25,794 (27)
16,457 (68)
3,936 (16)
3,745 (16)
5,251 (30)
6,885 (39)
5,451 (31)
7,406 (45)
4,942 (30)
4,159 (25)
8,924 (32)
10,513 (38)
8,070 (29)
1,544 (17)
3,208 (35)
4,369 (48)
Diabetes
  No
  Yes
84,733 (89)
10,126 (11)
20,497 (85)
3,641 (15)
14,873 (85)
2,713 (15)
15,348 (93)
1,159 (7)
25,459 (93)
2,048 (7)
8,556 (94)
565 (6)
Hypertension
  No
  Yes
63,280 (67)
31,580 (33)
14,160 (59)
9,978 (41)
11,212 (64)
6,375 (36)
12,240 (74)
4,268 (26)
19,706 (72)
7,800 (28)
5,962 (65)
3,159 (35)
Body Mass Index
 <25 
 25 - <30  
>30
 Mean (SD)
 Range
31,757 (33)
37,152 (39)
25,951 (27)
27.6 (5.3)
14.2-65.9
6,564 (28)
8,579 (36)
8,995 (37)
28.9 (6.0)
14.2-60.6
5,151 (29)
6,860 (39)
5,576 (32)
28.3 (5.7)
14.4-65.9
6,248 (38)
6,084 (37)
4,176 (25)
27.1 (5.1)
16.0-54.7
9,847 (36)
12,106 (44)
5,553 (20)
26.8 (4.4)
15.4-54.4
3,947 (43)
3,523 (39)
1,651 (18)
26.3 (4.7)
15.5-56.3
HDL- cholesterol
  >=40
  <40
  Mean (SD)
  Range
74,747 (79)
20,113 (21)
53.8 (17.6)
10-163
19,850 (82)
4,287 (18)
54.7 (16.9)
12-140
12,759 (73)
4,828 (27)
49.5 (15.4)
11-147
12,818 (78)
3,690 (22)
53.0 (16.8)
17-148
21,504 (78)
6,003 (22)
53.8 (17.9)
10-141
7,816 (86)
1,305 (14)
60.6 (21.2)
18-163
LDL-cholesterol
  <100
  >=100
  Mean (SD)
  Range
17,178 (18)
77,682 (82)
134.5 (39.2)
1-395
4,218 (17)
19,920 (83)
136.5 (40.7)
5-395
2,832 (16)
14,755 (84)
137.3 (39.3)
6-368
2,958 (18)
13,550 (82)
133.0 (37.6)
8-370
5,090 (19)
22,416 (81)
133.4 (37.8)
1-380
2,080 (23)
7,041 (77)
129.9 (41.9)
19-315
Triglycerides
  <150
  >=150
  Mean (SD)
  Range
69,620 (73)
25,239 (27)
128.6 (80.8)
24-1277
18,100 (75)
6,038 (25)
126.0 (78.8)
27-1088
12,829 (73)
4,758 (27)
131.4 (82.4)
31-1093
11,811 (72)
4,696 (28)
131.8 (88.1)
29-1277
20,493 (75)
7,013 (25)
125.5 (75.5)
24-897
6,387 (70)
2,734 (30)
133.6 (84.0)
34-745
Leisure Activity
   1st Quartile
   2nd Quartile
   3rd Quartile
   4th Quartile
  Mean (SD)
  Range
19,110 (20)
30,540 (32)
15,579 (16)
29,581 (31)
2.4 (0.6)
1.0-4.5
5,669 (23)
7,721 (32)
3,656 (15)
7,092 (29)
2.3 (0.6)
1.0-4.5
4,439 (25)
5,541 (32)
2,667 (15)
4,939 (28)
2.3 (0.61)
1.0-4.5
2,450 (15)
5,390 (33)
2,911 (18)
5,707 (35)
2.4 (0.5)
1.0-4.25
4,617 (17)
8,673 (32)
4,839 (18)
9,378 (34)
2.4 (0.6)
1.0-4.25
1,935 (21)
3,215 (35)
1,506 (17)
2,465 (27)
2.3 (0.5)
1.0-4.0
* Alcohol intake was categorized into never, former, occasional (current drinkers but no alcohol in last week), light/mod (up to 1 
drink/day for women and up to 2 drinks/day for men), and heavy (more than 1 drink/day for women and more than 2 drinks/day 
for men);  P-Y = person-years; HS=high school; HDL-cholesterol=high density lipoprotein cholesterol; LDL-cholesterol = low 
density lipoprotein cholesterol; Leisure Activity=physical activity level divided into quartiles.
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Table 4.1 (continued):  Person-time contributions in years (%) by covariates, alcohol intake levels, and 
visit 
Visit 3+
Total
91,601 P-Y 
Never
23,362 P-Y 
Former
19,936 P-Y 
Occasional
14,940 P-Y 
Light/Mod
25,919 P-Y 
Heavy
7,444 P-Y 
Race
   Black
  White
20,725 (23)
70,876 (77)
8,288 (35)
15,074 (65)
6,477 (32)
13,459 (68)
1,690 (11)
13,250 (89)
2,727 (11)
23,192 (89)
1,543 (21)
5,901 (79)
Gender
  Female
  Male
53,173 (58)
38,427 (42)
18,225 (78)
5,137 (22)
10,131 (51)
9,805 (49)
10,205 (68)
4,735 (32)
11,397 (44)
14,521 (56)
3,215 (43)
4,229 (57)
Education
<HS
 HS graduate
>HS
17,280 (19)
30,665 (33)
43,656 (48)
6,294 (27)
8,585 (37)
8,482 (36)
5,918 (30)
6,209 (31)
7,809 (39)
1,302 (9)
5,303 (35)
8,336 (56)
2,446 (9)
8,223 (32)
15,250 (59)
1,320 (18)
2,345 (32)
3,779 (51)
Center
  NC
  MS
  MN
  MD
23,815 (26)
18,145 (20)
25,767 (28)
23,876 (26)
8,058 (34)
7,509 (32)
1,591 (7)
6,204 (27)
5,102 (26)
5,505 (28)
3,733 (19)
5,597 (28)
3,142 (21)
1,505 (10)
6,000 (40)
4,294 (29)
5,938 (23)
2,276 (9)
11,648 (45)
6,057 (23)
1,575 (21)
1,350 (18)
2,795 (38)
1,724 (23)
Smoking
  Never
  Former
  Current
39,472 (43)
36,822 (40)
15,307 (17)
16,503 (71)
4,583 (20)
2,275 (10)
6,205 (31)
9,863 (49)
3,868 (19)
7,508 (50)
5,443 (36)
1,990 (13)
8,160 (31)
13,125 (51)
4,634 (18)
1,096 (15)
3,808 (51)
2,540 (34)
Diabetes
  No
  Yes
79,229 (86)
12,373 (14)
19,540 (84)
3,822 (16)
16,131 (81)
3,806 (19)
13,564 (91)
1,377 (9)
23,474 (91)
2,445 (9)
6,520 (88)
923 (12)
Hypertension
  No
  Yes
56,213 (61)
35,388 (39)
12,769 (55)
10,593 (45)
11,152 (56)
8,785 (44)
10,264 (69)
4,676 (31)
17,564 (68)
8,355 (32)
4,464 (60)
2,979 (40)
Body Mass Index
 <25 
 25 - <30
>30
 Mean (SD)
 Range
25,531 (28)
36,281 (40)
29,788 (33)
28.5 (5.6)
14.2-62.0
5,881 (25)
8,337 (36)
9,143 (39)
29.3 (6.2)
16.4-60.2
4,618 (23)
7,895 (40)
7,424 (37)
29.1 (5.8)
14.7-62.0
4,625 (31)
5,668 (38)
4,647 (31)
28.2 (5.3)
14.2-56.6
8,111 (32)
11,289 (44)
6,519 (25)
27.6 (4.8)
14.5-59.1
2,296 (30)
3,092 (42)
2,055 (28)
27.7 (5.2)
16.1-50.6)
HDL- cholesterol
  >=40
  <40
  Mean (SD)
  Range
70,933 (77)
20,669 (23)
53.1 (18.1)
11-195
18,609 (80)
4,753 (20)
53.4 (17.2)
16-147
14,097 (71)
5,840 (29)
49.2 (16.4)
17-146
11,828 (79)
3,112 (21)
53.8 (17.6)
18-119
20,274 (78)
5,645 (22)
53.7 (18.6)
11-149
6,125 (82)
1,319 (18)
58.3 (21.9)
18-195
LDL-cholesterol
  <100
  >=100
  Mean (SD)
  Range
19,047 (21)
72,555 (79)
127.0 (34.4)
7.6-347
4,857 (21)
18,504 (79)
128.0 (34.9)
7.6-279
3,935 (20)
16,002 (80)
128.7 (34.6)
10-290
3,007 (20)
11,934 (80)
126.8 (33.3)
28-317
5,356 (21)
20,563 (79)
126.2 (33.3)
21-279
1,892 (25)
5,552 (75)
122.4 (37.6)
20.6-347
Triglycerides
  <150
  >=150
 Mean (SD)
  Range
62,073 (68)
29,528 (32)
134.8 (66.7)
22-399
15,989 (68)
7,373 (32)
134.1 (67.0)
28-399
13,351 (67)
6,586 (33)
136.4 (67.2)
33-399
10,130 (68)
4,810 (32)
136.8 (66.7)
29-398
17,455 (67)
8,464 (33)
134.2 (66.2)
22-396
5,148 (69)
2,295 (31)
130.5 (66.9)
33-397
Leisure Activity
   1st Quartile
   2nd Quartile
   3rd Quartile
   4th Quartile
  Mean (SD)
  Range
17,345 (19)
31,102 (34)
15,543 (17)
27,609 (30)
2.4 (0.6)
1.0-4.5
4,961 (21)
7,924 (34)
3,635 (16)
6,841 (29)
2.3 (0.6)
1.0-4.5
4,567 (23)
6,769 (34)
3,088 (15)
5,512 (28)
2.3 (0.6)
1.0-4.5
2,230 (15)
5,410 (36)
2,669 (18)
4,631 (31)
2.4 (0.5)
1.0-4.5
3,768 (15)
8,634 (33)
4,994 (19)
8,522 (33)
2.4 (0.5)
1.0-4.5
1,819 (24)
2,365 (32)
1,157 (16)
2,103 (28)
2.3 (0.6)
1.0-4.5
* Alcohol intake was categorized into never, former, occasional (current drinkers but no alcohol in last week), light/mod (up to 1 
drink/day for women and up to 2 drinks/day for men), and heavy (more than 1 drink/day for women and more than 2 drinks/day 
for men);  P-Y = person-years; HS=high school; HDL-cholesterol=high density lipoprotein cholesterol; LDL-cholesterol = low 
density lipoprotein cholesterol; Leisure Activity=physical activity level divided into quartiles.
Table 4.2:  Crude and Age Adjusted Incidence Rates for All, Ischemic, and Hemorrhagic Stroke by Level of Alcohol Intake and Visit 
among ARIC Study Participants, 1987-2002
# of P-Y of Crude IR per AA IR per # of P-Y of Crude IR per AA IR per
Cases Follow-up 100,000 P-Y 100.000 P-Y Cases Follow-up 100,000 P-Y 100.000 P-Y
Visit 1-3 Visit 1-3 Visit 1-3 Visit 1-3 Visit 3+   Visit 3+ Visit 3+ Visit 3+
All Stroke
All 226 94859 238 (207, 269) 228 (215, 241) 313 91601 342 (304, 380) 370 (357, 383)
      Never 63 24138 261 (196, 325) 242 (215, 270) 90 23362 385 (306, 465) 403 (373, 434)
      Former 58 17587 330 (245, 415) 311 (273, 349) 83 19936 416 (327, 506) 410 (378, 441)
      Occasional 26 16508 157 (97, 218) 152 (127, 176) 32 14940 214 (140, 288) 244 (222, 265)
      Light/Moderate 55 27506 200 (147, 253) 194 (173, 216) 73 25919 282 (217, 346) 336 (315, 357)
      Heavy 24 9121 263 (158, 368) 259 (214, 305) 35 7444 470 (314, 626) 542 (494, 590)
Ischemic Stroke
      All 190 94859 200 (172, 229) 191 (179, 203) 270 91601 295 (260, 330) 327 (315, 338)
      Never 54 24138 224 (164, 283) 211 (184, 237) 79 23362 338 (264, 413) 366 (337, 394)
      Former 50 17587 284 (205, 363) 269 (234, 304) 73 19936 366 (282, 450) 364 (335, 392)
      Occasional 20 16508 121 (68, 174) 115 (95, 136) 24 14940 161 (96, 225) 198 (178, 217)
      Light/Moderate 47 27506 171 (122, 220) 165 (146, 184) 64 25919 247 (186, 307) 304 (285, 322)
      Heavy 19 9121 208 (115, 302) 204 (165, 244) 30 7444 403 (259, 547) 452 (408, 496)
Hemorrhagic Stroke
      All 19 94859 20 (11, 29) 19 (16, 24) 30 91601 33 (21, 44) 32 (27, 36)
      Never 5 24138 21 (3, 39) 17 (12, 23) 7 23362 30 (8, 52) 25 (16, 34)
      Former 4 17587 23 (0, 45) 22 (11, 32) 7 19936 35 (9, 61) 35 (22, 48)
      Occasional 2 16508 12 (-5, 29) 12 (5, 19) 7 14940 47 (12, 82) 41 (34, 48)
      Light/Moderate 5 27506 18 (2, 34) 19 (11, 26) 5 25919 19 (2, 36) 19 (11, 26)
      Heavy 3 9121 33 (-4, 70) 34 (15, 54) 4 7444 54 (1, 106) 90 (71, 108)
ARIC=Atherosclerosis Risk in Communities Cohort; P-Y = person-years; IR=incidence rate; AA = age adjusted.
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Table 4.3:  Crude and Age Adjusted Incidence Rates for All and Ischemic Stroke by Race, Level of Alcohol Intake and Visit among ARIC 
Study Participants, 1987-2002
        Visit 1-3 Visit 3+
Cases Follow-up Crude IR* AA IR* Cases Follow-up Crude IR* AA IR*
n P-Y (95% CI) (95%CI) n P-Y (95%CI)            (95%CI)
All Stroke, White
All 112 68769 163 (133, 193) 150 (138, 162) 187 70876 264 (226, 302) 291 (280, 303)
Never 22 12418 177 (103, 251) 142 (116, 167) 37 15074 245 (166, 325) 256 (228, 283)
Former 23 11614 198 (117, 279) 188 (151, 226) 45 13459 334 (237, 432) 338 (308, 368)
Occasional 25 15101 166 (101, 230) 159 (134, 185) 26 13250 196 (121, 272) 198 (176, 220)
Light/Moderate 29 22210 131 (83, 178) 123 (106, 140) 53 23192 229 (167, 290) 286 (267, 304)
Heavy 13 7426 175 (80, 270) 163 (127, 200) 26 5901 441 (271, 610) 479 (437, 520)
All Stroke, Black
All 114 26089 437 (357, 517) 440 (403, 477) 126 20725 608 (502, 714) 643 (605, 682)
Never 41 11720 350 (243, 457) 342 (294, 391) 53 8288 639 (467, 812) 679 (615, 742)
Former 35 5972 586 (392, 780) 565 (479, 651) 38 6477 587 (400, 773) 551 (480, 623)
Occasional 1 1407 71 (-68, 210) 658 (0, 1316) 6 1690 355 (71, 639) 944 (870, 1018)
Light/Moderate 26 5296 491 (302, 680) 524 (434, 614) 20 2727 733 (412, 1055) 812 (690, 934)
Heavy 11 1694 649 (266, 1033) 717 (515, 919) 9 1543 583 (202, 964) 506 (364, 649)
Ischemic Stroke, White
All 96 68769 140 (112, 168) 128 (117, 139) 165 70876 233 (197, 268) 261 (251, 272)
Never 18 12418 145 (78, 212) 115 (93, 138) 33 15074 219 (144, 294) 237 (211, 263)
Former 21 11614 181 (103, 258) 174 (138, 210) 42 13459 312 (218, 406) 310 (285, 335)
Occasional 20 15101 132 (74, 190) 126 (104, 148) 18 13250 136 (73, 199) 147 (127, 167)
Light/Moderate 26 22210 117 (72, 162) 110 (94, 126) 48 23192 207 (148, 266) 267 (250, 284)
Heavy 11 7426 148 (61, 236) 138 (106, 170) 24 5901 407 (244, 569) 418 (377, 459)
Ischemic Stroke, Black
All 94 26089 360 (287, 433) 363 (329, 397) 105 20725 507 (410, 604) 555 (520, 590)
Never 36 11720 307 (207, 408) 304 (257, 351) 46 8288 555 (395, 715) 608 (549, 668)
Former 29 5972 486 (309, 662) 469 (393, 546) 31 6477 479 (310, 647) 458 (393, 523)
Occasional 0 1407 0 0 6 1690 355 (71, 639) 944 (870, 1018)
Light/Moderate 21 5296 397 (227, 566) 434 (354, 514) 16 2727 587 (299, 874) 677 (564, 789)
Heavy 8 1694 472 (145, 800) 534 (339, 729) 6 1543 389 (78, 700) 357 (244, 471)
* Crude IR = crude incidence rate per 100,000 person-years; ARIC=Atherosclerosis Risk in Communities Cohort; P-Y = person-years; IR=incidence rate; AA = age adjusted.
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Table 4.4:  Rate Ratios with 95% Confidence Intervals Comparing Alcohol Intake and Stroke Incidence, ARIC 1987-2002
           Alcohol Intake^
Never Former Occasional Light/Moderate Heavy
All Stroke:
   crude RR (95%CI) reference 1.17 (0.93, 1.47) 0.57 (0.42, 0.77) 0.74 (0.59, 0.94) 1.11 (0.82, 1.49)
   min adjusted* RR (95%CI) reference 1.09 (0.86, 1.38) 0.91 (0.67, 1.25) 0.99 (0.77, 1.28) 1.36 (0.99, 1.86)
   fully adjusted** RR (95%CI) reference 0.97 (0.76, 1.24) 0.89 (0.65, 1.23) 0.94 (0.72, 1.23) 1.14 (0.82, 1.59)
Ischemic Stroke:
   crude RR (95%CI) reference 1.17 (0.92, 1.50) 0.50 (0.36, 0.70) 0.74 (0.58, 0.95) 1.06 (0.76, 1.47)
   min adjusted* RR (95%CI) reference 1.06 (0.82, 1.36) 0.78 (0.55, 1.10) 0.95 (0.72, 1.24) 1.25 (0.88, 1.75)
   fully adjusted** RR (95%CI) reference 0.94 (0.72, 1.22) 0.75 (0.53, 1.08) 0.89 (0.67, 1.20) 1.04 (0.73, 1.50)
Hemorrhagic Stroke:
   crude RR (95%CI) reference 1.16 (0.51, 2.63) 1.13 (0.48, 2.69) 0.74 (0.32, 1.71) 1.67 (0.66, 4.25)
   min adjusted* RR (95%CI) reference 1.23 (0.53, 2.84) 2.33 (0.94, 5.80) 1.29 (0.52, 3.16) 2.57 (0.96, 6.84)
   fully adjusted** RR (95%CI) reference 1.12 (0.47, 2.66) 2.30 (0.91, 5.83) 1.21 (0.47, 3.10) 2.08 (0.74, 5.86)
^Alcohol intake was categorized into never, former, occasional (reported being a current drinker but no alcohol in the last week), light/moderate (up to 1 drink/day 
for women and up to 2 drinks/day for men), and heavy (more than 1 drink/day for women and more than 2 drinks/day for men).
RD = rate difference, RR = rate ratio, CI = confidence interval
* Adjusted for age, race, sex, and socioeconomic status.
** Adjusted for age, race, gender, socioeconomic status, smoking, physical activity, ARIC study center, body mass index, and diabetes.
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Table 4.5:  Rate Ratios with 95% Confidence Intervals Comparing Alcohol Intake and Stroke Incidence by Race, ARIC 1987-2002
           Alcohol Intake^
Never Former Occasional Light/Moderate Heavy
All Stroke, Whites:
   crude RR (95%CI) reference 1.26 (0.89, 1.79) 0.84 (0.58, 1.22) 0.84 (0.60, 1.18) 1.36 (0.91, 2.04)
   min adjusted* RR (95%CI) reference 1.15 (0.80, 1.64) 1.03 (0.70, 1.51) 0.86 (0.61, 1.23) 1.37 (0.90, 2.07)
   fully adjusted** RR (95%CI) reference 0.96 (0.66, 1.40) 0.95 (0.64, 1.41) 0.77 (0.53, 1.12) 1.06 (0.68, 1.67)
All Stroke, Blacks:
   crude RR (95%CI) reference 1.25 (0.92, 1.69) 0.48 (0.22, 1.04) 1.22 (0.86, 1.74) 1.31 (0.81, 2.13)
   min adjusted* RR (95%CI) reference 1.07 (0.78, 1.47) 0.54 (0.25, 1.17) 1.29 (0.88, 1.88) 1.35 (0.81, 2.22)
   fully adjusted** RR (95%CI) reference 0.98 (0.70, 1.36) 0.57 (0.26, 1.25) 1.28 (0.86, 1.90) 1.20 (0.71, 2.02)
Ischemic Stroke, Whites:
   crude RR (95%CI) reference 1.35 (0.94, 1.96) 0.72 (0.47, 1.10) 0.88 (0.62, 1.26) 1.42 (0.92, 2.18)
   min adjusted* RR (95%CI) reference 1.20 (0.82, 1.75) 0.88 (0.58, 1.35) 0.88 (0.61, 1.28) 1.39 (0.89, 2.16)
   fully adjusted** RR (95%CI) reference 1.03 (0.69, 1.72) 0.81 (0.52, 1.27) 0.79 (0.53, 1.19) 1.10 (0.68, 1.77)
Ischemic Stroke, Blacks:
 crude RR (95%CI) reference 1.18 (0.84, 1.64) 0.47 (0.21, 1.08) 1.13 (0.76, 1.66) 1.06 (0.60, 1.86)
   min adjusted* RR (95%CI) reference 0.97 (0.69, 1.38) 0.53 (0.23, 1.23) 1.16 (0.76, 1.76) 1.05 (0.59, 1.89)
   fully adjusted** RR (95%CI) reference 0.87 (0.61, 1.24) 0.56 (0.24, 1.30) 1.15 (0.74, 1.77) 0.94 (0.51, 1.77)
^Alcohol intake was categorized into never, former, occasional (reported being a current drinker but no alcohol in the last week), light/moderate (up to 1 drink/day 
for women and up to 2 drinks/day for men), and heavy (more than 1 drink/day for women and more than 2 drinks/day for men).
RD = rate difference, RR = rate ratio, CI = confidence interval
* Adjusted for age, sex, and socioeconomic status.
** Adjusted for age, gender, socioeconomic status, smoking, physical activity, ARIC study center, body mass index, and diabetes.
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CHAPTER 5
Alcohol Consumption and Heart Failure Incidence in the Atherosclerosis Risk 
in Communities (ARIC) Study, 1987-2002
5.1 Introduction
The burden of heart failure (HF) in the U.S. is staggering.  During 2003, an 
estimated 5 million US adults had HF with 550,000 new cases diagnosed each year 
(1).  Hospital discharges for HF are on the rise, increasing by 174% from 1979 to 
2003.  The estimated direct and indirect cost of HF in the U.S. for 2006 is $29.6 
billion (1).
Despite the importance of studying HF, few prospective cohort studies have 
been designed to do so.  The lack of information on HF is due at least in part to the 
complex nature of the disease.  The underlying causes of HF are complex and 
include ischemic heart disease, hypertension, aortic regurgitation/increased left 
ventricular size, toxins (such as alcohol), or viral infections of the heart (2).  
Determining the biologic mechanisms that cause HF is problematic because it 
depends on the risk factors, underlying conditions, and type of HF.  Risk factors may 
have opposing effects.  For example, coronary artery disease predisposes one to 
MI, which predisposes one to ischemic HF.  While the harmful effects of chronic 
heavy alcohol use on the development of alcoholic cardiomyopathy have been well 
documented (3-5), the role of light to moderate alcohol intake is unclear.  
Prospective observational studies have shown alcohol to be beneficial in protecting 
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against coronary artery disease and myocardial infarction (6), both of which may 
lead to HF.  A beneficial effect of alcohol on HF is hypothesized to be due, at least in 
part, to this association.  The net effect of alcohol intake on the development of HF 
warrants investigation because while current guidelines state that light/moderate 
consumption is beneficial for CAD/MI, the long-term effects of alcohol on other CV 
outcomes has little supporting data.
Few community based studies have examined the association between light 
to moderate alcohol intake and HF in the general population (5, 7).  The aim of this 
study is to examine the relationship between alcohol consumption and heart failure 
incidence in a cohort of black and white men and women in four communities in the 
US.  In this paper we will estimate the total, net effect of alcohol on HF through all 
causal pathways regardless of if they are causative or preventive.
5.2 Methods
Study Population and Design
The ARIC study is a prospective cohort study of 15,792 men and women ages 45 to 
64 years of age from four U.S. communities. Details of the ARIC study have been 
previously published (8).  At the initial visit (from 1987-1989), participants were 
interviewed at home and underwent a physical examination.  During annual 
telephone follow-up, interviewers obtained information about hospitalizations and 
medical events within the preceding year.  Every three years participants underwent 
a clinical exam consisting of an interview and physical exam.  The first visit took 
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place between 1987-1989, the second visit was from 1990-1992, and the third visit 
was from 1993-1995.  Follow-up data is available through December 31, 2002.
We considered observations from study participants who participated in the 
initial visit or the third visit.  This was done because alcohol intake was measured at 
visit 1 and visit 3 and this would allow for alcohol consumption to change over time.  
Thus, a single participant could contribute more than one follow-up interval to the 
analysis.  Figure 5.1 summarizes the exclusion criteria by study visit.  Of the 15,792 
study participants at visit one, we excluded those who were non-white and non-black 
(n=48).  We also excluded those who had prevalent heart failure measured by 
participants reporting that they had taken HF medication in the prior 2 weeks, or 
participants reporting they had at least 2 HF symptoms (edema, paroxysmal 
nocturnal dyspnea, or orthopnea), or participants reporting they were taking diuretics 
or digoxin (n=600).  We further excluded 99 participants who did not provide 
information on alcohol intake and 383 participants who had one or more missing 
covariates (body mass index, cholesterol measures, diabetes, education, 
hypertension, physical activity, or smoking) at visit one.  A total of 12,887 
participants had data available from visit 3.  Of these, we excluded non-whites and 
non-blacks (n=38) and those who had been hospitalized for HF or who had reported 
HF medication use in the two weeks before baseline (n=565).  We also excluded 
139 participants who had missing alcohol information and another 361 who had at 
least one covariate missing.  Thus, 14,662 participants were included in the visit 1-
visit 3 time period and 11,784 participants were included in the visit 3+ time period.
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Alcohol Consumption
Alcohol consumption in the ARIC cohort was measured at visit 1 (1986-1989) and at 
visit 3 (1993-1995) using a dietary questionnaire.  Participants were asked if they 
drank alcoholic beverages and if so, the type and amount.  We calculated the 
amount of ethanol consumed using the following:  one glass of wine = 10.8 g 
alcohol, one bottle/can of beer = 13.2 g alcohol, and one 1.5 ounce shot of liquor = 
15.1 g alcohol.  The amount reported on a weekly basis was summed and divided by 
seven to obtain a daily estimate of alcohol consumed in grams.  We then 
categorized alcohol consumption into never drinkers (reported never consuming 
alcoholic beverages), former drinkers (reported previously drinking alcoholic 
beverages, but not currently drinking), occasional drinkers (reported presently 
drinking alcohol but the usual amount consumed per week was zero), light to 
moderate drinkers (reported presently drinking up to 1 drink per day for women and 
up to 2 drinks per day for men), and heavy drinkers (reported presently drinking 
more than 1 drink per day for women and more than 2 drinks per day for men).  
These categories of alcohol consumption were chosen in an attempt to create 
groups of participants with similar levels of exposure.  Specifically, former drinkers 
are likely to be different than never drinkers in that former drinkers may have 
stopped drinking for health reasons (9) and may thus be sicker than never drinkers.  
Also, the group of occasional drinkers consists of those who drink but do not do so 
on a regular basis whereas the light/moderate drinkers report regular intake.
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Incident HF
Incident HF cases were ascertained through hospitalization discharge records and 
death certificates.  Hospitalization discharge records with a primary or secondary 
ICD-9-CM code of 428.xx and death certificates with an underlying cause of death of 
HF or with a primary ICD-9 code of 428.xx or ICD-10 code of I50 were identified.  To 
eliminate prevalent HF, we excluded participants who reported any of the following:  
taking HF medication in the 2 weeks before the initial visit, having at least 2 HF 
related symptoms (edema, PND, or orthopnea), or taking diuretics or digoxin.  
Person-time was calculated as time from the visit until HF hospitalization, death, loss 
to follow-up, visit 3 (for participants enrolled at visit 1), or the end of the study period 
(December 31, 2002).
Covariates
Covariate information for each participant was assessed at visit 1 and updated at 
visit 3 if the participant was still involved in the study.  This allowed for us to account 
for changes in covariates over time.  Race was based on self -reported information 
and was either black or white.  Study center was defined as 1 of the 4 study sites: 
Forsyth County NC, Jackson MS, Minneapolis MN, or Washington County MD.  
Socioeconomic status was based on the highest self-reported educational level 
achieved and was categorized into less than high school graduate, high school 
graduate, or greater than high school graduate.  Smoking was classified as current, 
previous or never as reported by the participant at the time of the visit.  Body mass 
index was calculated by dividing weight (in kg) by height (in meters squared) and 
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was categorized into normal (<25.0), overweight (25.0 – 29.9), and obese (30.0+).  
Physical activity was assessed using the modified Baecke leisure time index which 
includes measures of walking and biking either as a leisure activity or as a mode of 
transportation to work or shopping, along with time spent watching television (10, 
11).  Physical activity was categorized into quartiles.  Diabetes was dichotomized 
into a yes/no variable, with participants whose fasting blood glucose level was >
126mg/dL at the time of the visit classified as having diabetes.  Hypertension was 
also dichotomized, with those patients who had systolic blood pressure > 140 at the 
study visit or diastolic blood pressure > 90 at the study visit or who had taken blood
pressure medication in the last 2 weeks classified as being hypertensive.  
Cholesterol measures included LDL-cholesterol (mg/dL), HDL-cholesterol (mg/dL), 
and triglycerides (mg/dL) as measured at the time of the visit.  Participants with LDL-
cholesterol levels > 100mg/dL were determined to have high LDL-cholesterol, 
participants with HDL-cholesterol levels <40 mg/dL were classified as having low 
HDL-cholesterol, and participants with triglyceride levels > 150 mg/dL were classified 
as having high triglycerides.
Statistical Analyses
HF incidence rates were calculated as the number of HF cases divided by the 
person-time of follow-up.  Since participants could contribute 1 or 2 observations to 
the study, each person-visit combination was treated as an observation.  For 
participants with visit 1 data, the follow-up time was calculated as the number of 
days from visit 1 until first HF hospitalization, death, loss to follow-up, or visit 3 date 
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(whichever came first).  For participants with visit 3 data who did not have a HF 
hospitalization before visit 3, follow-up time was calculated as the number of days 
from visit 3 until HF occurrence, death, loss to follow-up, or December 31, 2002.  If a 
participant was hospitalized for HF multiple times, only the first hospitalization was 
included in the analysis.
Using Poisson regression multivariate rate ratios (RRs) were estimated to 
compare differing levels of alcohol consumption on HF incidence.  Never drinkers 
were the reference group in all models.  Potential confounders included age, gender, 
race, study center, educational level, physical activity, and smoking status.   We 
stratified the results on race to determine if the relationship between alcohol and HF 
varies for whites and blacks.
All analyses were performed using SAS v8 software (SAS Institute, Cary NC).
5.3 Results
HF incidence rates by sociodemographic characteristics and visit are presented in 
Table 5.1.  During the time period from visit 1 to 3, a total of 514 HF cases were 
identified and the crude incidence rate was 520 per 100,000 person-years.  In the 
time after visit 3, there were 675 HF cases and the crude incidence rate was 718 per 
100,000 person-years.  The crude HF incidence rates increased with age, were 
higher for blacks than whites, were higher for males than females, and decreased 
with increasing education.  The crude HF IRs were higher for hypertensives (904 per 
100,000P-Y vs. 331 per 100,000P-Y during the visit 1-3 time period) and diabetics 
(1843 per 100,000P-Y vs. 362 per 100,000P-Y during the visit 1 to 3 time period).  
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Additionally, the HF IRs were highest among current smokers and lowest among 
never smokers, and were higher among those with a MI.  Occasional drinkers had 
the lowest crude HF incidence rates (339 per 100,000P-Y from visit 1 to 3) and 
former drinkers had the highest rates (877 per 100,000 per 100,000P-Y from visit 1 
to 3). 
The proportion of person-time contributions and number of HF cases by 
covariates, alcohol intake levels, and visit are shown in Table 5.2.  Over the time 
period from visit 1 to 3, there were 98813 P-Y and 514 HF cases.  Of the person-
years, 25% (24247P-Y) were among never drinkers, 19% (18,778P-Y) were among 
former drinkers, 17% (17,119P-Y) were among occasional drinkers, 29% (29,026P-
Y) were among light/moderate drinkers, and 10% (9,643P- Y) were among heavy 
drinkers.  The number of HF cases in each category of alcohol intake was 137 
among never drinkers, 165 among former drinkers, 58 among occasional drinkers, 
108 among light/moderate drinkers, and 46 among heavy drinkers.  Following visit 3, 
there were 94,060P-Y of observation and 675 HF cases.  The distribution of person-
time and HF cases by alcohol intake categories was similar to that seen between 
visits 1 and 3.
Table 5.3 provides crude and age adjusted HF incidence rates by level of 
alcohol intake and visit.  During the time period from visit 1 to visit 3 the crude HF 
incidence rate (cIR) was 5.2 per 1,000P-Y and after adjustment for age was 4.8 per 
1,000P-Y.  The age- adjusted IRs during the time between visit 1 and visit 3 were 
highest for the former drinkers (aIR=8.0) and lowest for the occasional and 
light/moderate drinkers (aIR=3.2 and aIR=3.6, respectively).  After visit 3, the age-
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adjusted IRs were highest among the heavy drinkers (aIR=10.6) and lowest among 
the occasional drinkers (aIR=4.8).  Among both blacks and whites, the age-adjusted 
IRs between visit 1 and 3 were highest for former drinkers; however, the age-
adjusted HF IRs were lowest for occasional blacks drinkers and for never white 
drinkers.  Following visit 3, age-adjusted HF IRs among blacks were lowest for 
occasional and light/moderate drinkers and highest for former drinkers.  During the 
same time period, whites had the highest aIRs for former drinkers and the lowest 
rates among occasional drinkers.
Rate ratios with 95% confidence intervals comparing alcohol intake and HF 
incidence are shown in Table 5.4.  Data are presented overall and by visit for the 
entire cohort as well as for blacks and whites separately. Among the entire cohort 
during the entire study period, the crude rate ratios comparing alcohol intake with 
never drinkers are 1.58 for former drinkers, 0.60 for occasional drinkers, 0.72 for 
light/moderate drinkers, and 1.00 for heavy drinkers.  Adjusting the models for age, 
race, gender, socioeconomic status, smoking, physical activity, and study center 
modified the RRs.  The RRs (95%CIs) comparing each level of alcohol intake with 
never drinkers are 1.12 (0.95, 1.31) for former drinkers, 0.67 (0.54, 0.82) for 
occasional drinkers, 0.65 (0.54, 0.78) for light/moderate drinkers, and 0.75 (0.59, 
0.95) for heavy drinkers.  Similar patterns were seen for blacks and whites during 
the entire time period.  During the time from visit 1 to visit 3, the fully adjusted RRs 
for the entire cohort were 1.07 (0.84, 1.37) for former drinkers, 0.63 (0.46, 0.87) for 
occasional drinkers, 0.55 (0.42, 0.72) for light/moderate drinkers, and 0.61 (0.43, 
0.87) for heavy drinkers.  
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5.4 Discussion
In this study we found a positive association between former drinking and HF 
incidence and an inverse association between current alcohol consumption and HF 
incidence.  While the association between former drinkers and HF incidence is 
evident for whites, the evidence among blacks is less strong.  The strength of the 
inverse association between current alcohol intake levels and HF incidence varies 
with race and time period, but in all of the fully adjusted models comparing those 
who currently drink alcohol (either occasional, light/moderate, or heavy) to the never 
drinkers, the RRs are consistently less than one.
The Framingham Heart Study examined the association between alcohol and 
all cause HF as well as HF without a prior MI (5).  The referent group was never 
drinkers and the former drinkers were classified separately.  The results of this study 
indicate that for males, alcohol intake at any level as compared with nondrinkers 
reduced heart failure incidence.  Among women, alcohol consumption of 3-7 drinks 
per week (approximately the same amount as our measure of light/moderate intake) 
as compared with non-drinkers reduced heart failure incidence (age-adjusted 
HR=0.49, 95%CI: 0.25-0.96).  In contrast to our study findings in which former 
drinkers had increased rates of HF incidence, the Framingham study failed to find 
any level of alcohol intake which was positively associated with HF incidence.  The 
Framingham results comparing former drinkers to never drinkers found age-adjusted 
HR of 0.72 (0.38-1.37) among males and 1.06 (0.66-1.70) among females.
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The Established Populations for the Epidemiologic Study of the Elderly 
program (EPESE) also examined the association between moderate alcohol intake 
and heart failure incidence (7).  The referent group for this study included current 
non-drinkers, a combination of never drinkers and former drinkers.  The EPESE 
study found that compared with non- drinkers, those who consumed up to 1.5 
drinks/day had age/sex adjusted RR=0.71 (0.56-0.92) and those who consumed 2-4 
drinks/day had age/sex adjusted RR=0.47 (0.29-0.76).  The study also found an 
inverse association between alcohol intake and mortality.  Comparisons with our 
findings are somewhat problematic given the differences in reference group and the 
differences in study populations.  
It has been hypothesized that the mechanism by which alcohol consumption 
may reduce the incidence of HF is via the reduction in coronary artery disease and 
MI rates.  Several previous studies have attempted to discern this by stratifying 
based on MI occurrence.  The Framingham Heart Study reported results separately 
for those without an MI, apparently in an attempt to explain the observed inverse 
association between moderate alcohol intake and HF incidence (5).  The EPESE 
study by Abramson et al (7) controlled for history of MI as well as MI occurrence 
during follow-up because of concern that a reduction in MI risk was the reason for 
the findings of an inverse association between alcohol intake and lower HF 
incidence.  Since the occurrence of MI is affected by alcohol intake (i.e. MI is on the 
causal pathway between alcohol and HF), MI should not be an adjustment factor nor 
should it be used for stratification.  Ideally we would be able to separate the 
causative and preventive effects; however the net, total effect of alcohol on HF is not 
147
decomposable (12).  In order to determine causative from preventive effects we 
would need to identify covariates that are hyper-modifiers (covariates creating strata 
within which the net effect goes in opposite directions) but that are not confounders.  
It is impossible to say whether the benefits of alcohol on the prevention of MI are 
offset by the development of HF later on and currently no analytic techniques are 
available to discern these effects.
Our definition of heavy alcohol intake is based on the AHA guidelines and 
corresponds to more than 1 drink per day for women and more than 2 drinks per day 
for men.  Studies examining cardiomyopathy and its association with heavy alcohol 
intake typically consider alcohol intake of 6 or more drinks/day (90-100g/day) to be 
heavy consumption (13).  The ARIC study has few participants with alcohol intake 
greater than 2 drinks per day which limits our ability to examine categories of heavier 
alcohol intake. 
This study has several strengths.  The ARIC study is prospective with alcohol 
consumption information collected prior to HF occurrence, eliminating the possibility 
of recall bias.  Additionally, we were able to incorporate changes in alcohol 
consumption over time.  Other studies have used a referent group of current non-
drinkers, which consists of both never drinkers and former drinkers.  Since former 
drinkers may have stopped drinking for health reasons (9), selecting a referent group 
of never drinkers allows for a more homogeneous referent group and is thus 
preferred.
Two limitations of the study include alcohol assessment and ascertainment of 
HF events.  Alcohol intake was measured by self-report and studies examining the 
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validity and reliability of alcohol consumption reports have shown that it is typically 
an underestimate (14-18).  Since alcohol intake was measured before the event, any 
misclassification of alcohol is likely nondifferential (19).  Also, HDL-cholesterol, 
which has been shown to increase with alcohol intake, was highest among the 
heavy drinkers and lowest among the former drinkers suggesting that our measure 
of alcohol consumption is valid (see Table 5.2).  Second, we used hospital discharge 
records to ascertain HF events so we could have incomplete case ascertainment or 
some of our HF cases may not be incident in nature.
Our study suggests an inverse association between alcohol intake and heart 
failure incidence in a community of black and white Americans.  Given that 
approximately 60% of US adults consume light to moderate amounts of alcohol (20), 
that there are known negative consequences of excessive alcohol intake, and that 
HF incidence and hospitalization rates are high, additional research examining the 
role of alcohol on the development of HF is warranted.  
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Figure 5.1:  Study Population by Visit
Visit 1
N=15,792
Exclude non-white and 
non-black (n=48)
N=15,744
Exclude those missing 
alcohol information (n=99)
N=15,045
Exclude those with 
prevalent HF (n=600)
N=15,144
Exclude those missing 
covariate information (n=383)
N=14,662
Visit 3
N=12,887
Exclude non-white and 
non-black (n=38)
N=12,849
Exclude those missing 
alcohol information (n=139)
N=12,145
Exclude those with 
prevalent HF (n=565)
N=12,284
Exclude those missing 
covariate information (n=361)
N=11,784
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Table 5.1:  Heart Failure Incidence Rates per 100,000 person-years by Sociodemographic 
Characteristics, ARIC population 1987-2002
Visit 1 
Any dx = 428.xx or HF death
Visit 3
Any dx = 428.xx or HF death
# cases
(n=514)
Person-
time 
(years)
Incidence 
Rate per 
100,000P-Y 
# cases
(n=675)
Person-
time
(years)
Incidence 
Rate per 
100,000P-Y 
Overall 514 98813 520 675 94060 718
Age 
   <55
   55-59
   60+
160
136
218
54168
23417
21226
295
581
1027
54
122
499
21295
26036
46727
254
469
1068
Race
   Black
   White
196
318
26383
72429
743
439
188
487
20679
73381
909
664
Gender
   Female
   Male
286
228
54383
44430
526
513
308
367
52958
41102
582
893
Education
   < HS
   HS grad
   > HS
226
151
137
23587
32096
43129
958
470
318
239
219
217
17624
31610
44824
1356
693
484
Center
   MD
   MN
   MS
   NC
102
172
101
139
24961
25402
22838
25611
409
677
442
543
164
167
122
222
25004
26505
18127
24421
656
630
673
909
Hypertension
   Yes
   No
295
219
32632
66181
904
331
427
248
35970
58089
1187
427
Diabetes
   Yes
   No
194
320
10528
88283
1843
362
240
435
12360
81699
1942
532
Smoking
   Never
   Former
   Current
131
160
223
40162
31266
27384
326
512
814
188
302
185
39850
38312
15895
472
788
1164
MI
   Yes
   No
159
355
3285
95526
4840
372
131
544
2464
91594
5317
594
Alcohol
   Never
   Former
   Occasional
   L/M
   Heavy
137
165
58
108
46
24247
18778
17119
29026
9643
565
877
339
372
477
166
231
65
148
65
23313
20589
15301
27024
7833
712
1122
425
544
830
* HF=heart failure, dx=diagnosis, HS=high school, MD=Washington County MD, MN=Minneapolis MN, 
MS=Jackson MS, NC=Forsyth County NC, MI=myocardial infarction, Alcohol refers to level of alcohol intake.
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Table 5.2:  Person-time contributions in years and the number of heart failure cases by covariates, 
alcohol intake levels, and visit, ARIC 1987-2002  
Visit 1-3 
ALL
P-Y (cases)
98,813 (514)
Never
P-Y (cases)
24,247 (137)
Former
P-Y (cases)
18,778 (165)
Occasional
P-Y (cases)
17,119 (58)
Light/Mod
P-Y (cases)
29,026 (108)
Heavy
P-Y (cases)
9,643 (46)
Race
   Black
   White
26,383 (196)
72429 (318)
11522 (92)
12725 (45)
6141 (67)
12636 (98)
1421 (5)
15698 (53)
5531 (26)
23495 (82)
1768 (6)
7875 (40)
Gender
  Female
  Male
54383 (228)
44430 (286)
18708 (104)
5539 (33)
8774 (68)
10004 (97)
11359 (23)
5760 (35)
11604 (24)
17422 (84)
3938 (9)
5705 (37)
Education
<HS
 HS grad
>HS
23587 (226)
32096 (151)
43129 (137)
7739 (73)
8369 (40)
8139 (24)
7132 (93)
5550 (41)
6096 (31)
2388 (16)
6348 (21)
8382 (21)
4605 (33)
8626 (32)
15795 (43)
1723 (11)
3203 (17)
4717 (18)
Center
  NC
  MS
  MN
  MD
25611 (102)
22838 (172)
25402 (101)
24961 (139)
6562 (22)
10819 (88)
1104 (5)
5762 (22)
4748 (37)
5004 (54)
3222 (21)
5804 (53)
5330 (10)
865 (3)
6489 (21)
4434 (24)
6598 (23)
4720 (23)
11052 (37)
6656 (25)
2373 (10)
1430 (4)
3535 (17)
2305 (15)
Smoking
  Never
  Former
  Current
40162 (131)
31266 (160)
27384 (223)
16520 (68)
3895 (31)
3832 (38)
5410 (27)
7449 (56)
5918 (82)
7539 (12)
5192 (18)
4388 (28)
9127 (18)
11288 (44)
8611 (46)
1566 (6)
3442 (11)
4635 (29)
Diabetes
  No
  Yes
88283 (320)
10528 (194)
20637 (63)
3610 (74)
15916 (98)
2862 (67)
15894 (43)
1224 (15)
26819 (77)
2207 (31)
9017 (39)
625 (7)
HTN
  No
  Yes
66181 (219)
32632 (295)
14504 (42)
9743 (95)
12065 (67)
6713 (98)
12723 (32)
4396 (26)
20634 (54)
8392 (54)
6255 (24)
3388 (22)
BMI
 <25 
 25 - <30  
>30
mean (SD)
range
33500 (124)
39154 (189)
26159 (201)
27.5 (5.2)
14.2-60.6
6725 (30)
8832 (36)
8690 (71)
28.7 (5.9)
14.2-60.6
5600 (39)
7479 (63)
5699 (63)
28.1 (5.5)
14.4-53.9
6521 (12)
6335 (26)
4263 (20)
27.1 (5.0)
16.0-54.7
10489 (28)
12771 (46)
5766 (34)
26.8 (4.4)
15.4-54.4
4165 (15)
3737 (18)
1741 (13)
26.3 (4.6)
15.5-56.3
HDL- chol
  >=40
  <40
mean (SD)
range
76814 (319)
21998 (195)
53.3 (17.7)
10.0-168.0
19716 (98)
4531 (39)
54.5 (17.0)
12.0-168.0
13295 (94)
5482 (71)
48.8 (15.2)
11.0-147.0
13099 (29)
4020 (29)
52.6 (16.9)
16.0-148.0
22492 (70)
6534 (38)
53.4 (17.9)
10.0-141.0
8212 (28)
1431 (18)
60.0 (21.3)
12.0-163.0
LDL-chol
  <100
  >=100
mean (SD)
range
17483 (80)
81328 (434)
135.2 (39.4)
1.0-395.0
4133 (29)
20114 (108)
137.3 (41.1)
5.0-395.0
2847 (25)
15930 (140)
138.4 (39.2)
6.0-368.0
3033 (8)
14085 (50)
133.8 (37.9)
8.0-370.0
5337 (14)
23689 (94)
133.8 (37.9)
1.0-380.0
2133 (4)
7510 (42)
130.8 (42.2)
17.0-315.0
Trigly
  <150
  >=150
mean (SD)
range
72085 (297)
26726 (217)
129.6 (81.1)
24.0-1277.0
18136 (83)
6111 (54)
125.9 (77.0)
27.0-1088.0
13530 (89)
5247 (76)
133.7 (84.9)
29.0-1218.0
12198 (36)
4921 (22)
132.9 (88.9)
29.0-1277.0
21515 (61)
7511 (47)
126.5 (75.5)
24.0-897.0
6706 (28)
2936 (18)
134.7 (84.3)
34.0-745.0
Leisure
   Q1
   Q2
   Q3
   Q4
mean (SD)
range
19777 (163)
31951 (169)
29241 (125)
17843 (57)
2.4 (0.6)
1.0-4.5
5576 (52)
8006 (41)
6697 (29)
3969 (15)
2.3 (0.6)
1.0-4.5
4656 (55)
5885 (60)
5029 (36)
3208 (14)
2.3 (0.6)
1.0-4.50
2622 (16)
5520 (17)
5534 (18)
3443 (7)
2.4 (0.5)
1.0-4.25
4852 (29)
9187 (32)
9279 (32)
5707 (15)
2.4 (0.6)
1.0-4.50
2071 (11)
3353 (19)
2702 (10)
1516 (6)
2.3 (0.6)
1.0-4.0
* P-Y = person-years; HS=high school; HTN=hypertension; BMI=body mass index; HDL-chol=high density lipoprotein 
cholesterol; LDL-chol = low density lipoprotein cholesterol; Trigly = triglycerides; Leisure=physical activity level divided into 
quartiles.
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Table 5.2 (continued):  Person-time contributions in years and the number of heart failure cases by 
covariates, alcohol intake levels, and visit, ARIC 1987-2002  
Visit 3+
ALL
P-Y (cases)
94060 (675)
Never
P-Y (cases)
23313 (166)
Former
P-Y (cases)
20589 (231)
Occasional
P-Y (cases)
15301 (65)
Light/Mod
P-Y (cases)
27024 (148)
Heavy
P-Y (cases)
7833 (65)
Race
   Black
   White
20679 (188)
73381 (487)
8042 (72)
15271 (94)
6469 (73)
14120 (158)
1723 (9)
13578 (56)
2826 (16)
24198 (132)
1619 (18)
6214 (47)
Gender
  Female
  Male
52958 (308)
41102 (367)
17861 (124)
5452 (42)
10005 (90)
10584 (141)
10248 (35)
5053 (30)
11612 (42)
15412 (106)
3232 (17)
4601 (48)
Education
<HS
 HS grad
>HS
17624 (239)
31610 (219)
44824 (217)
6056 (78)
8697 (53)
8560 (35)
6197 (104)
6446 (69)
7945 (58)
1319 (13)
5448 (25)
8534 (27)
2673 (23)
8510 (55)
15841 (70)
1379 (21)
2509 (17)
3944 (27)
Center
  NC
  MS
  MN
  MD
24421 (164)
18127 (167)
26505 (122)
25004 (222)
8035 (59)
7318 (64)
1659 (1)
6300 (42)
5303 (50)
5511 (63)
3848 (32)
5926 (86)
3227 (13)
1512 (9)
6063 (19)
4499 (24)
6209 (27)
2364 (15)
12018 (56)
6432 (50)
1647 (15)
1422 (16)
2917 (14)
1847 (20)
Smoking
  Never
  Former
  Current
39850 (188)
38312 (302)
15895 (185)
16432 (87)
4669 (48)
2211 (31)
6319 (49)
10195 (125)
4074 (57)
7625 (15)
5664 (31)
2012 (19)
8343 (32)
13775 (68)
4906 (48)
1131 (5)
4009 (30)
2692 (30)
Diabetes
  No
  Yes
81699 (435)
12360 (240)
19766 (84)
3546 (82)
16749 (146)
3840 (85)
13831 (48)
1470 (17)
24456 (112)
2568 (36)
6897 (45)
936 (20)
HTN
  No
  Yes
58089 (248)
35970 (427)
13048 (51)
10265 (115)
11696 (81)
8892 (150)
10541 (28)
4761 (37)
18234 (66)
8790 (82)
4570 (22)
3262 (43)
BMI
 <25 
 25 - <30  
>30
mean (SD)
range
26678 (143)
37753 (223)
26628 (309)
28.3 (5.4)
14.2-62.0
6043 (33)
8507 (42)
5762 (91)
29.1 (5.9)
16.4-60.2
4879 (44)
8376 (75)
7333 (112)
28.9 (5.6)
14.7-62.0
4785 (14)
5919 (20)
4598 (31)
28.1 (5.2)
14.2-56.6
8577 (38)
11717 (61)
6730 (49)
27.5 (4.8)
14.5-59.1
2394 (14)
3234 (25)
2205 (26)
27.7 (5.0)
16.1-50.6
HDL- chol
  >=40
  <40
mean (SD)
range
59228 (431)
21831 (244)
52.7 (18.1)
11.0-195.0
18384 (120)
4928 (46)
53.2 (17.3)
16.0-147.0
1448 (136)
6141 (95)
48.7 (16.1)
15.0-146.0
12013 (38)
3288 (27)
53.5 (17.6)
18.0-121.0
21003 (92)
6021 (56)
53.4 (18.6)
11.0-177.0
6380 (45)
1453 (20)
57.5 (21.7)
18.0-195.0
LDL-chol
  <100
  >=100
mean (SD)
range
19333 (150)
77426 (525)
127.3 (34.3)
7.6-347.0
4772 (32)
18541 (134)
128.4 (34.9)
7.6-279.0
3915 (52)
16674 (179)
129.1 (34.1)
10.0-289.6
3147 (14)
12154 (51)
126.5 (33.0)
28.2-291.2
5588 (34)
24136 (114)
126.6 (33.6)
21.4-317.8
1911 (18)
5921 (47)
123.6 (37.2)
20.6-347.0
Trigly
  <150
  >=150
mean (SD)
range
63701 (408)
30357 (267)
135.0 (66.7)
22.0-399.0
15948 (99)
7364 (67)
134.4 (66.5)
28.0-399.0
13732 (148)
6856 (83)
136.5 (67.3)
33.0-399.0
10447 (34)
4854 (31)
136.5 (66.6)
29.0-398.0
18198 (82)
8826 (66)
134.4 (66.2)
22.0-396.0
5376 (45)
2457 (20)
131.9 (67.3)
33.0-397.0
Leisure
   Q1
   Q2
   Q3
   Q4
mean (SD)
range
17764 (200)
31840 (204)
27572 (188)
16882 (83)
2.4 (0.6)
1.0-4.5
4788 (54)
7913 (49)
6553 (45)
4059 (18)
2.3 (0.6)
1.0-4.50
4679 (67)
7034 (69)
5534 (62)
3342 (33)
2.3 (0.6)
1.0-4.50
2323 (23)
5516 (16)
4546 (14)
2916 (12)
2.4 (0.5)
1.0-4.50
4002 (30)
8947 (57)
8827 (46)
5247 (15)
2.4 (0.5)
1.0-4.50
1972 (26)
2430 (13)
2112 (21)
1318 (5)
2.3 (0.6)
1.0-4.50
* P-Y = person-years; HS=high school; HTN=hypertension; BMI=body mass index; HDL-chol=high density lipoprotein 
cholesterol; LDL-chol = low density lipoprotein cholesterol; Trigly = triglycerides; Leisure=physical activity level divided into 
quartiles.
Table 5.3:  Crude and Age Adjusted Heart Failure Incidence Rates by Level of Alcohol Intake and Visit among ARIC Study 
Participants, 1987-2002
       Visit 1-3           Visit 3+
Cases Follow-up Crude IR* AA IR* Cases Follow-up Crude IR* AA IR*
n person-years (95% CI) (95%CI) n person-years (95%CI)            (95%CI)
Drinking Status**
     All drinkers 514 98812 520 (475, 565) 484 (466, 502) 675 94058 718 (664, 772) 747 (730, 765)
      Never 137 24247 565 (470, 660) 495 (460, 530) 166 23312 712 (604, 820) 668 (630, 706)
      Former 165 18777 879 (745, 1013) 802 (747, 856) 231 20588 1122 (977,1267) 1060(1013,1108)
      Occasional 58 17119 339 (252, 426) 323 (289, 358) 65 15301 425 (322, 528) 477 (444, 511)
      Light/Moderate 108 29026 372 (302, 442) 355 (327, 383) 148 27024 548 (459, 636) 657 (630, 684)
      Heavy 46 9643 477 (339, 615) 464 (405, 524) 65 7833 830 (628, 1032) 1009(940,1077)
Blacks
     All drinkers 196 26383 743 (639, 847) 735 (692, 778) 188 20679 909 (779, 1039) 887 (839, 935)
     Never 92 11522 798 (365, 962) 749 (687, 812) 72 8042 895 (688, 1102) 805 (729, 881)
     Former 67 6141 1091 (830, 1352)1043 (935, 1152) 73 6469 1128(870,1387)  1117(1024,1211)
     Occasional 5 1421 352 (434, 660) 350 (220, 480) 9 1723 522 (181, 864) 493 (379, 606)
     Light/Moderate 26 5531 470 (289, 651) 467 (388, 546) 16 2826 566 (289, 844) 492 (384, 600)
     Heavy 6 1768 339 (68, 611) 382 (249, 516) 18 1619 1112 (598, 1625) 948 (721,1174)
Whites
     All drinkers 318 72428 439 (391, 487) 401 (382, 419) 487 73379 664 (605, 723) 694 (676,711)
     Never 45 12725 354 (250, 457) 297 (258, 336) 94 15271 616 (491, 740) 570 (531, 608)
     Former 98 12636 776 (622, 929) 690 (629, 751) 158 14120 1119 (944, 1293) 1016(964,1068)
     Occasional 53 15698 338 (247, 429) 321 (285, 357) 56 13578 412 (304, 520) 466 (431, 500)
     Light/Moderate 82 23495 349 (273, 425) 328 (299, 357) 132 24198 545 (452, 639) 644 (617, 670)
     Heavy 40 7875 508 (351, 665) 474 (407, 451) 47 6214 756 (540, 973) 903 (837, 968)
* IR = incidence rate per 1000 person-years
** Drinking status:  Never=lifetime abstainers, Former=previous drinkers but not current drinkers, Occasional=report currently drink but not on a regular basis, 
light/moderate=drink up to 1 drink per day for women and up to 2 drinks per day for men, heavy=drink more than 1 drink per day for women and more than 2 
drinks per day for men.
ARIC=Atherosclerosis Risk in Communities Cohort; P-Y = person-years; IR=incidence rate; AA = age adjusted 
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Table 5.4:  Rate Ratios with 95% Confidence Intervals Comparing Alcohol Intake and Heart Failure Incidence, ARIC 1987-
2002
           Alcohol Intake^
Never Former Occasional Light/Moderate Heavy
All, Visit 1-3
   Crude RR (95%CI) reference 1.56 (1.24, 1.95) 0.60 (0.44, 0.81) 0.66 (0.51, 0.85) 0.84 (0.61, 1.17)
   Min adjusted* RR (95%CI) reference 1.39 (1.11, 1.76) 0.81 (0.59, 1.09) 0.75 (0.58, 0.96) 0.97 (0.70, 1.35)
   Fully adjusted** RR (95%CI) reference 1.07 (0.84, 1.37) 0.63 (0.46, 0.87) 0.55 (0.42, 0.72) 0.61 (0.43, 0.87)
Blacks, Visit 1-3
   Crude RR (95%CI) reference 1.37 (1.00, 1.86) 0.44 (0.18, 1.09) 0.59 (0.38, 0.90) 0.43 (0.19, 0.96)
   Min adjusted* RR (95%CI) reference 1.29 (0.93, 1.79) 0.52 (0.21, 1.28) 0.63 (0.39, 0.99) 0.50 (0.22, 1.14)
   Fully adjusted** RR (95%CI) reference 1.04 (0.74, 1.48) 0.45 (0.18, 1.12) 0.47 (0.29, 0.76) 0.28 (0.14, 0.77)
Whites, Visit 1-3
   Crude RR (95%CI) reference 2.19 (1.54, 3.11) 0.95 (0.64, 1.42) 0.99 (0.69, 1.42) 1.44 (0.94, 2.19)
   Min adjusted* RR (95%CI) reference 1.76 (1.23, 2.51) 1.13 (0.77, 1.70) 1.02 (0.71, 1.46) 1.45 (0.95, 2.21)
   Fully adjusted** RR (95%CI) reference 1.26 (0.87, 1.82) 0.85 (0.57, 1.27) 0.72 (0.49, 1.07) 0.87 (0.55, 1.37)
All, Visit 3+
   Crude RR (95%CI) reference 1.58 (1.29, 1.92) 0.60 (0.45, 0.79) 0.77 (0.62, 0.96) 1.17 (0.87, 1.55)
   Min adjusted* RR (95%CI) reference 1.41 (1.15, 1.73) 0.77 (0.58, 1.03) 0.88 (0.70, 1.11) 1.20 (0.90, 1.61)
   Fully adjusted** RR (95%CI) reference 1.16 (0.94, 1.44) 0.70 (0.53, 0.94) 0.75 (0.59, 0.96) 0.88 (0.64, 1.20)
Blacks, Visit 3+
   Crude RR (95%CI) reference 1.26 (0.91, 1.74) 0.58 (0.29, 1.16) 0.63 (0.37, 1.08) 1.24 (0.74, 2.09)
   Min adjusted* RR (95%CI) reference 1.11 (0.79, 1.55) 0.69 (0.35, 1.36) 0.69 (0.40, 1.18) 1.25 (0.74, 2.12)
   Fully adjusted** RR (95%CI) reference 0.97 (0.68, 1.39) 0.60 (0.30, 1.22) 0.58 (0.32, 1.03) 0.93 (0.53, 1.65)
Whites, Visit 3+
   Crude RR (95%CI) reference 1.82 (1.41, 2.34) 0.67 (0.48, 0.93) 0.89 (0.68, 1.15) 1.23 (0.87, 1.74)
   Min adjusted* RR (95%CI) reference 1.65 (1.28, 2.14) 0.86 (0.62, 1.20) 0.99 (0.76, 1.30) 1.23 (0.86, 1.76)
   Fully adjusted** RR (95%CI) reference 1.34 (1.02, 1.76) 0.81 (0.58, 1.13) 0.85 (0.64, 1.14) 0.91 (0.62, 1.03)
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Table 5.4 (continued):  Rate Ratios with 95% Confidence Intervals Comparing Alcohol Intake and Heart Failure Incidence, 
ARIC 1987-2002
           Alcohol Intake^
Never Former Occasional Light/Moderate Heavy
All
   Crude RR (95%CI) reference 1.58 (1.36, 1.83) 0.60 (0.48, 0.73) 0.72 (0.61, 0.85) 1.00 (0.80, 1.24)
   Min adjusted* RR (95%CI) reference 1.40 (1.20, 1.63) 0.78 (0.63, 0.96) 0.82 (0.69, 0.97) 1.09 (0.87, 1.35)
   Fully adjusted** RR (95%CI) reference 1.12 (0.95, 1.31) 0.67 (0.54, 0.82) 0.65 (0.54, 0.78) 0.75 (0.59, 0.95)
Blacks
   Crude RR (95%CI) reference 1.32 (1.06, 1.66) 0.53 (0.31, 0.92) 0.60 (0.43, 0.84) 0.85 (0.55, 1.30)
   Min adjusted* RR (95%CI) reference 1.18 (0.94, 1.49) 0.61 (0.35, 1.05) 0.64 (0.45, 0.91) 0.90 (0.58, 1.38)
   Fully adjusted** RR (95%CI) reference 1.01 (0.79, 1.29) 0.55 (0.31, 0.95) 0.51 (0.35, 0.74) 0.64 (0.40, 1.01)
Whites
   Crude RR (95%CI) reference 1.93 (1.57, 2.37) 0.75 (0.58, 0.96) 0.90 (0.73, 1.12) 1.24 (0.95, 1.62)
   Min adjusted* RR (95%CI) reference 1.68 (1.37, 2.08) 0.96 (0.75, 1.23) 0.99 (0.80, 1.23) 1.31 (1.00, 1.71)
   Fully adjusted** RR (95%CI) reference 1.29 (1.04, 1.61) 0.81 (0.63, 1.04) 0.79 (0.63, 0.99) 0.88 (0.66, 1.17)
^Alcohol intake was defined as: Never drinkers=lifetime abstainers, former drinkers=previous intake but no current intake, occasional drinkers=report alcohol 
intake but none in the previous month, light/moderate drinkers=up to 1 drink per day for women and up to 2 drinks per day for men, heavy drinkers=more than 1 
drink per day for women and more than 2 drinks per day for men.
RR = rate ratio, CI = confidence interval
* Adjusted for age, race, gender, and socioeconomic status.
** Adjusted for age, race, gender, socioeconomic status, smoking, physical activity, and ARIC study center.
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CHAPTER 6
DISCUSSION
6.1 Summary of Findings
The aims of this study were to evaluate (1) the association between alcohol 
consumption and stroke (all, ischemic, and hemorrhagic) incidence and (2) the 
association between alcohol intake and HF incidence in a cohort of U.S. adults.  To 
assess these relationships, data from the ARIC Cohort Study were analyzed using 
Poisson regression.  
The results provide no compelling evidence that occasional or light to 
moderate alcohol intake reduces stroke incidence rates.  The unadjusted RRs 
suggest an inverse association between occasional drinking and all stroke or 
ischemic stroke, and an inverse association between light/moderate drinking and all 
stroke or ischemic stroke.  Adjustment for confounding factors attenuated the 
association, suggesting that the underlying distribution of covariates varied across 
levels of alcohol intake.  The minimally adjusted race-stratified results indicate a 
positive association for whites between heavy alcohol intake and all stroke incidence 
as well as between heavy alcohol intake and ischemic stroke incidence.  Among 
blacks, light to moderate alcohol intake is associated with increased all stroke 
incidence.  These results indicate that light/moderate alcohol consumption may have 
different effects on all and/or ischemic stroke incidence among blacks and whites.  
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The adjusted RRs examining alcohol intake and hemorrhagic stroke incidence 
suggest that any level of alcohol intake increases hemorrhagic stroke incidence 
rates.
Additionally, the results suggest a positive association between former 
drinking and HF incidence and an inverse association between current alcohol 
consumption and HF incidence.  While the association between former drinkers and 
HF incidence was evident for whites, the evidence among blacks was less strong.  
The strength of the inverse association between current alcohol intake levels and HF 
incidence varies with race and time period, but in all of the fully adjusted models 
comparing those who currently drink alcohol (either occasional, light/moderate, or 
heavy) to the never drinkers, the RRs are consistently less than one.
These study results add to the current knowledge of alcohol and 
cardiovascular disease in several ways.  Previous study results examining the 
association between light to moderate alcohol intake and stroke occurrence are 
conflicting.  A meta-analysis attempting to summarize the alcohol and stroke 
relationship, reported a reduction in ischemic stroke rates for light to moderate intake 
(up to 2 drinks/day) and an increase in both ischemic and hemorrhagic stroke rates 
with heavy intake (5+ drinks/day) versus never drinkers (1).  Using a well-designed 
prospective cohort study I found all stroke and ischemic stroke incidence rates are 
not reduced among those consuming light to moderate amounts of alcohol.  We did 
find that alcohol intake is positively associated with hemorrhagic stroke incidence 
rates.  These results should be considered in re-evaluating the current AHA and 
USDHHS dietary guidelines which state that current light to moderate drinkers may 
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have a cardiovascular health benefit from their alcohol intake behavior (2-4).  On the 
other hand, our results agree with the few studies that have examined the 
relationship between HF incidence and moderate alcohol intake and our results 
extend to a wider population (blacks and those from the southern US).  These 
apparent contradictory effects of alcohol on the different types of cardiovascular 
disease highlight the importance of having alcohol consumption recommendations 
that take into account the many facets of cardiovascular disease.   
6.2 Issues with Alcohol
There are a myriad of problems associated with studying alcohol consumption.  
These include the untangling of the causative and preventive effects of alcohol on 
the cardiovascular system as well as general health, the availability of methods to 
alcohol measurement, and the fact that patterns of alcohol intake change over time.
The potential biologic mechanisms through which alcohol may affect the 
cardiovascular system are complex due to the fact that some mechanisms suggest a 
preventive effect while others suggest a causative effect.  Current evidence 
suggests that moderate alcohol intake (up to 1 drink/day for women and up to 2 
drinks/day for men) increases HDL-cholesterol, reduces LDL-cholesterol oxidation, 
increases insulin sensitivity, and decreases clotting and platelet aggregation (5).  In 
contrast, heavy alcohol intake (more than 1 drink/day for women and more than 2 
drinks/day for men) increases oxidative stress, increase triglycerides, increases 
blood pressure, and decreases HDL-cholesterol (5).  Teasing out the opposing 
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beneficial and preventive effects of alcohol is difficult at best making the analysis of 
alcohol problematic.
The health effects of alcohol are numerous, with alcohol consumption 
estimated to cause 100,000 deaths each year in the US (6).  Those who drink
alcohol have higher mortality rates from injuries, violence, suicide, and cirrhosis as 
compared with abstainers.  Despite these negative health effects, a meta-analysis of 
approximately 50 studies found an inverse association between light to moderate 
drinking (up to 1 drink/day for women and up to 2 drinks/day for men) and all cause-
mortality (7).  It is thought that this relationship is due to the protective effects of 
alcohol intake on CHD.  One way to determine how alcohol consumption affects the 
body and reduces or increases stroke or HF rates would be to conduct a RCT.  
Because of ethical concerns that study participants assigned to drink alcohol may 
become dependent as well as the high cost involved and the difficulty in finding 
participants, no long-term RCT of alcohol use is feasible. 
Measuring alcohol intake is another area in the alcohol research field which 
needs attention.  Current methods to obtain alcohol data rely on self-report, proxy 
report or biomarkers.  None of these methods are reliable or valid, and each varies 
according to the specific study.  Improvements in methods to obtain valid and 
reliable alcohol consumption estimates are needed.  Thirty years ago, there was no 
good test to monitor blood glucose levels in diabetic patients over time.  In the last 
decade it was discovered that the amount of glycosylated hemoglobin (HgbA1C) in 
the blood reflects blood glucose control for the past 120 days (the lifespan of the red 
blood cell).  Today, diabetic patients are able to get an accurate and valid measure 
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of their average blood glucose level with the HgbA1c test.  A biomarker/test that 
could provide an estimate of the amount of alcohol consumed over the past few 
months would be a major step forward in the research arena of alcohol consumption.
Another problem with studying alcohol is that alcohol consumption patterns 
are known to change over time.  In the ARIC data, for example, alcohol intake 
tended to decrease during a six-year follow-up period (8).  The majority of studies 
examining the stroke and alcohol association measured alcohol at baseline, not 
updating drinking levels during the study period.  Determining the impact that this 
has on the associations between alcohol and outcomes is difficult because the 
impact will depend on the amount of change in alcohol drinking over time as well as 
the induction time (i.e. the time it takes for the disease to develop following an 
exposure).  If none of the study participants change their drinking patterns over the 
course of the study and the induction time were short, measurement of alcohol at 
baseline alone would be sufficient.  If however, a large proportion of participants 
changed their behaviors or the induction time were not short, updating alcohol 
information might help to reduce the misclassification of alcohol consumption.  
Another concern regarding the patterns of alcohol drinking relate to the differing 
effects of binge drinking versus steady alcohol intake.  Questions that ask about the 
frequency of alcohol intake need to be able to discern between these two distinct 
types of behaviors.
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6.3 Future Research/Public Health Implications
According to the National Institute on Alcohol Abuse and Alcoholism, 
approximately 35% of US adults are abstainers, 60% are occasional to moderate 
alcohol drinkers, and 5% have alcohol dependence (6).  Given that the US 
population is approximately 300 million, this equates with 180 million occasional to 
moderate alcohol drinkers in the US.  Each year an estimated 500,000 new strokes 
and 550,000 new HF cases occur.  To what extent alcohol contributes to this 
morbidity and mortality is unknown.
The AHA guidelines regarding alcohol intake state that for those who drink, 
doing so in moderation is good for your heart (2).  This recommendation is based on 
the large number of studies (mostly observational) that found moderate alcohol 
intake (up to 30g/day or approximately 2.3 drinks/day) is cardioprotective against 
MI/CHD (9).  Studies examining the association between stroke incidence and 
alcohol have found conflicting results.  Few studies have examined HF incidence 
and alcohol intake in the community.  Our data suggest that there is no benefit in 
terms of stroke prevention but that alcohol intake may be inversely associated with 
HF occurrence.
Additional studies examining the role of alcohol intake on stroke incidence 
among blacks are warranted.  Current AHA guidelines state that for those who drink 
alcohol, to do so in moderation (up to one drink/day for women and up to two 
drinks/day for men) and that drinking more than this may increase stroke risk (2, 3).  
While heavy alcohol intake appears to increase overall stroke incidence, the 
perceived benefit of light to moderate alcohol intake may not apply to all populations.  
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Since the AHA recommendations are based on results of studies with few minority 
groups, the guidelines should be reconsidered or at least conveyed with caution.  
In terms of HF, few studies have examined the association between alcohol intake 
and HF incidence.  Analysis of the ARIC study population and the Framingham 
Heart Study suggest a protective effect of alcohol on heart failure incidence.  
Although the findings appear to be similar, more studies in this area should be 
conducted.  The mechanisms of the association are unclear and the other health 
risks associated with alcohol intake are not trivial.  While the AHA guidelines do not 
recommend abstainers start drinking alcohol, the benefit of light/moderate intake 
needs to be obvious if the guidelines are going to imply that drinking has benefits.  
Given the uncertainty of data derived from observational studies and the varied 
results from previous studies, strong consideration should be given to revising or 
completely abandoning guidelines that imply a health benefit to alcohol use.
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